drugName,cIds,drugNameOfficial,molecularWeight,smilesString,SMILES,Target,CID,IUPACName,MolecularFormula,MW,logP,TPSA,HBD,HBA,RotatableBonds,HeavyAtoms,CanonicalSMILES,InChIKey
Lenalidomide,CIDs00216326,lenalidomide,259.26062,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,CRL4(CRBN) E3 ubiquitin ligase,216326,"3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione",C13H13N3O3,259.26,-0.5,92.5,2,4,1,19,,GOTYRUGSSMKFNF-UHFFFAOYSA-N
Cladribine,CIDs00020279,cladribine,285.68698,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,DNA,20279,"(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol",C10H12ClN5O3,285.69,0.8,119.0,3,7,2,19,,PTOAARAWEBMLNO-KVQBGUIXSA-N
Pentostatin,CIDs00439693,pentostatin,268.26914,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,Adenosine deaminase,439693,"(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol",C11H16N4O4,268.27,-2.1,112.0,4,6,2,19,,FPVKHBSQESCIEP-JQCXWYLXSA-N
Everolimus,CIDs06442177,everolimus,958.22442,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,FK506-binding protein 1A,6442177,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",C53H83NO14,958.2,5.9,205.0,3,14,9,68,,HKVAMNSJSFKALM-GKUWKFKPSA-N
Aminoglutethimide,CIDs00002145,aminoglutethimide,232.27834,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,"Cytochrome P450 19A1, Cytochrome P450 11A1",2145,"3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione",C13H16N2O2,232.28,1.2,72.2,2,3,2,17,,ROBVIMPUHSLWNV-UHFFFAOYSA-N
Letrozole,CIDs00003902,letrozole,285.30274,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,Cytochrome P450 19A1,3902,"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile",C17H11N5,285.3,2.7,78.3,0,4,3,22,,HPJKCIUCZWXJDR-UHFFFAOYSA-N
Pemetrexed disodium,CIDs135413520,,0.0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],"Dihydrofolate reductase, GAR transformylase, Thymidylate synthase",135413520,"disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate",C20H19N5Na2O6,471.4,,193.0,4,7,7,33,,NYDXNILOWQXUOF-GXKRWWSZSA-L
Plinabulin,CIDs09949641,plinabulin,336.3877,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,Tubulin,9949641,"(3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione",C19H20N4O2,336.4,2.8,86.9,3,3,3,25,,UNRCMCRRFYFGFX-TYPNBTCFSA-N
Topotecan hydrochloride,CIDs00060699,topotecan,457.90676,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O.Cl,"DNA topoisomerase I, mitochondrial",60699,"(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride",C23H24ClN3O5,457.9,,103.0,3,7,3,32,,DGHHQBMTXTWTJV-BQAIUKQQSA-N
5-Azacitidine,CIDs00009444,5-azacytidine,244.20468,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,"DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA, RNA",9444,"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C8H12N4O5,244.2,-2.2,141.0,4,5,2,17,,NMUSYJAQQFHJEW-KVTDHHQDSA-N
Actinomycin D,CIDs00457193,Lyovac Cosmegen,1255.41704,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,DNA,457193,"2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",C62H86N12O16,1255.4,3.8,356.0,5,18,8,90,,RJURFGZVJUQBHK-IIXSONLDSA-N
Itraconazole,CIDs00003793,itraconazole oral solution,705.63342,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Cytochrome P450 51,3793,"2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one",C35H38Cl2N8O4,705.6,5.7,101.0,0,9,11,49,,VHVPQPYKVGDNFY-UHFFFAOYSA-N
Hydroxychloroquine sulfate,CIDs00012947,,0.0,,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,"Toll-like receptor 7, Toll-like receptor 9, Ferriprotoporphyrin IX",12947,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid,C18H28ClN3O5S,434.0,,131.0,4,8,9,28,,JCBIVZZPXRZKTI-UHFFFAOYSA-N
Acadesine,CIDs00017513,acadesine,258.23126,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,"AMP-activated protein kinase, AMPK",17513,"5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazole-4-carboxamide",C9H14N4O5,258.23,-2.2,157.0,5,7,3,18,,RTRQQBHATOEIAF-UUOKFMHZSA-N
DCC-2036,CIDs25066467,rebastinib,553.586823,CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5,CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5,Tyrosine-protein kinase ABL,25066467,4-[4-[(3-tert-butyl-1-quinolin-6-ylpyrazol-5-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,C30H28FN7O3,553.6,4.9,123.0,3,7,7,41,,WVXNSAVVKYZVOE-UHFFFAOYSA-N
Dasatinib,CIDs03062316,dasatinib,488.00554,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,"SRC, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Bcr/Abl fusion protein, Tyrosine-protein kinase ABL, Ephrin type-A receptor 2",3062316,"N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",C22H26ClN7O2S,488.0,3.6,135.0,3,9,7,33,,ZBNZXTGUTAYRHI-UHFFFAOYSA-N
Bosutinib,CIDs05328940,bosutinib,530.44616,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"Tyrosine-protein kinase Lyn, Tyrosine-protein kinase SRC, Tyrosine-protein kinase ABL, Tyrosine-protein kinase HCK",5328940,"4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile",C26H29Cl2N5O3,530.4,5.4,82.9,1,8,9,36,,UBPYILGKFZZVDX-UHFFFAOYSA-N
Saracatinib,CIDs10302451,saracatinib,542.02648,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,"Tyrosine-protein kinase SRC, Tyrosine-protein kinase ABL",10302451,"N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine",C27H32ClN5O5,542.0,4.1,90.4,1,10,8,38,,OUKYUETWWIPKQR-UHFFFAOYSA-N
Vandetanib,CIDs03081361,vandetanib,475.353963,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"Epidermal growth factor receptor, Tyrosine-protein kinase TIE-2, Tyrosine-protein kinase SRC, Tyrosine-protein kinase BRK, Vascular endothelial growth factor receptor, Ephrin receptor, Tyrosine-protein kinase receptor RET",3081361,N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine,C22H24BrFN4O2,475.4,4.9,59.5,1,7,6,30,,UHTHHESEBZOYNR-UHFFFAOYSA-N
Gefitinib,CIDs00123631,gefitinib,446.902363,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,Epidermal growth factor receptor erbB1,123631,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,C22H24ClFN4O3,446.9,4.1,68.7,1,8,8,31,,XGALLCVXEZPNRQ-UHFFFAOYSA-N
Neratinib,CIDs09915743,neratinib,557.04266,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4",9915743,(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,C30H29ClN6O3,557.0,4.9,112.0,2,8,11,40,,JWNPDZNEKVCWMY-VQHVLOKHSA-N
Dacomitinib,CIDs11511120,dacomitinib,469.939003,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4",11511120,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,C24H25ClFN5O2,469.9,4.4,79.4,2,7,7,33,,LVXJQMNHJWSHET-AATRIKPKSA-N
AEE-788,CIDs10297043,NVP-AEE788,440.58318,CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4NC(C)C5=CC=CC=C5,CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4NC(C)C5=CC=CC=C5,"Epidermal growth factor receptor erbB1, Vascular endothelial growth factor receptor 2, Receptor protein-tyrosine kinase erbB-2, Vascular endothelial growth factor receptor 1",10297043,"6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",C27H32N6,440.6,4.6,60.1,2,5,7,33,,OONFNUWBHFSNBT-HXUWFJFHSA-N
CUDC-101,CIDs24756910,CUDC-101,434.48764,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,"Histone deacetylase, Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2",24756910,7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,C24H26N4O4,434.5,4.0,106.0,3,7,12,32,,PLIVFNIUGLLCEK-UHFFFAOYSA-N
Pelitinib,CIDs06445562,pelitinib,467.923123,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,Epidermal growth factor receptor erbB1,6445562,(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,C24H23ClFN5O2,467.9,4.5,90.3,2,7,8,33,,WVUNYSQLFKLYNI-AATRIKPKSA-N
Linifanib,CIDs11485656,linifanib,375.398923,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,"Macrophage colony stimulating factor receptor, Vascular endothelial growth factor receptor, Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor",11485656,1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea,C21H18FN5O,375.4,3.9,95.8,4,4,3,28,,MPVGZUGXCQEXTM-UHFFFAOYSA-N
Axitinib,CIDs06450551,axitinib,386.46952,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,Vascular endothelial growth factor receptor,6450551,N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide,C22H18N4OS,386.5,4.2,96.0,2,4,5,28,,RITAVMQDGBJQJZ-FMIVXFBMSA-N
Vatalanib,CIDs00151194,,0.0,,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,"Macrophage colony stimulating factor receptor, Vascular endothelial growth factor receptor, Stem cell growth factor receptor, Platelet-derived growth factor receptor",151194,N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine,C20H15ClN4,346.8,4.5,50.7,1,4,4,25,,YCOYDOIWSSHVCK-UHFFFAOYSA-N
Motesanib,CIDs11667893,motesanib,373.45092,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,"Platelet-derived growth factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase receptor RET, Vascular endothelial growth factor receptor",11667893,"N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide",C22H23N5O,373.5,3.9,78.9,3,5,5,28,,RAHBGWKEPAQNFF-UHFFFAOYSA-N
Tivozanib,CIDs09911830,tivozanib,454.86306,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,Vascular endothelial growth factor receptor,9911830,"1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea",C22H19ClN4O5,454.9,4.0,108.0,2,7,6,32,,SPMVMDHWKHCIDT-UHFFFAOYSA-N
Brivanib,CIDs11234052,brivanib,370.377563,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,"Fibroblast growth factor receptor, Vascular endothelial growth factor receptor",11234052,"(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol",C19H19FN4O3,370.4,3.0,84.7,2,6,5,27,,WCWUXEGQKLTGDX-LLVKDONJSA-N
Telatinib,CIDs09808844,telatinib,409.82574,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,"Vascular endothelial growth factor receptor 3, Vascular endothelial growth factor receptor 2, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta",9808844,"4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide",C20H16ClN5O3,409.8,3.1,102.0,2,7,6,29,,QFCXANHHBCGMAS-UHFFFAOYSA-N
Cediranib,CIDs09933475,cediranib,450.505283,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,"Vascular endothelial growth factor receptor, Stem cell growth factor receptor, Platelet-derived growth factor receptor",9933475,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline,C25H27FN4O3,450.5,4.9,72.5,1,7,8,33,,XXJWYDDUDKYVKI-UHFFFAOYSA-N
BMS-794833,CIDs44155856,BMS 794833,468.840006,C1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F,C1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F,"Vascular endothelial growth factor receptor 2, Hepatocyte growth factor receptor",44155856,N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1H-pyridine-3-carboxamide,C23H15ClF2N4O3,468.8,3.8,106.0,3,8,5,33,,PDYXPCKITKHFOZ-UHFFFAOYSA-N
OSI-632,CIDs09811611,CP-547632,532.402066,C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N,C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N,Vascular endothelial growth factor receptor 2,9811611,"3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide",C20H24BrF2N5O3S,532.4,3.7,138.0,3,8,10,32,,HXHAJRMTJXHJJZ-UHFFFAOYSA-N
Foretinib,CIDs42642645,Foretinib,632.653766,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,"Tyrosine-protein kinase TIE-2, Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Vascular endothelial growth factor receptor, Hepatocyte growth factor receptor",42642645,"1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",C34H34F2N4O6,632.7,5.5,111.0,2,10,12,46,,CXQHYVUVSFXTMY-UHFFFAOYSA-N
Regorafenib,CIDs11167602,regorafenib,482.815413,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,"Vascular endothelial growth factor receptor, Tyrosine-protein kinase TIE-2, Discoidin domain-containing receptor 2, Nerve growth factor receptor Trk-A, Serine/threonine-protein kinase RAF, Serine/threonine-protein kinase B-raf, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase ABL, MAP kinase p38 beta, Tyrosine-protein kinase FRK, Ephrin type-A receptor 2, Fibroblast growth factor receptor 2, Tyrosine-protein kinase receptor RET, Fibroblast growth factor receptor 1",11167602,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,C21H15ClF4N4O3,482.8,4.2,92.4,3,8,5,33,,FNHKPVJBJVTLMP-UHFFFAOYSA-N
Dovitinib,CIDs135398510,,0.0,,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Vascular endothelial growth factor receptor",135398510,4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one,C21H21FN6O,392.4,1.6,90.3,3,6,2,29,,PIQCTGMSNWUMAF-UHFFFAOYSA-N
Masitinib,CIDs10074640,masitinib,498.6424,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,"Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Platelet-derived growth factor receptor",10074640,"4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide",C28H30N6OS,498.6,4.3,102.0,2,7,7,36,,WJEOLQLKVOPQFV-UHFFFAOYSA-N
SG-00529,CIDs11998575,Palomid 529,406.42788,CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O,CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O,Serine/threonine-protein kinase mTOR,11998575,8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]benzo[c]chromen-6-one,C24H22O6,406.4,4.0,74.2,1,6,6,30,,YEAHTLOYHVWAKW-UHFFFAOYSA-N
Amuvatinib,CIDs11282283,amuvatinib,447.50954,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor alpha, Stem cell growth factor receptor, Hepatocyte growth factor receptor",11282283,"N-(1,3-benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide",C23H21N5O3S,447.5,3.5,108.0,1,7,3,32,,FOFDIMHVKGYHRU-UHFFFAOYSA-N
OSI-930,CIDs09868037,OSI-930,443.44155,C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F,C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor",9868037,3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide,C22H16F3N3O2S,443.4,6.2,91.5,2,8,6,31,,FGTCROZDHDSNIO-UHFFFAOYSA-N
Crizotinib,CIDs11626560,crizotinib,450.336683,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"ALK tyrosine kinase receptor, NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor), Hepatocyte growth factor receptor, EML4-ALK",11626560,"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine",C21H22Cl2FN5O,450.3,3.7,78.0,2,6,5,30,,KTEIFNKAUNYNJU-GFCCVEGCSA-N
BMS-777607,CIDs24794418,BMS-777607,512.892566,CCOC1=C(C(=O)N(C=C1)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F,CCOC1=C(C(=O)N(C=C1)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F,Hepatocyte growth factor receptor,24794418,N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide,C25H19ClF2N4O4,512.9,4.0,107.0,2,8,7,36,,VNBRGSXVFBYQNN-UHFFFAOYSA-N
PF-04217903,CIDs17754438,PF-04217903,372.38334,C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1,C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1,Hepatocyte growth factor receptor,17754438,"2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol",C19H16N8O,372.4,0.7,107.0,1,7,5,28,,PDMUGYOXRHVNMO-UHFFFAOYSA-N
JNJ-38877605,CIDs46911863,JNJ-38877605,377.350226,CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2,CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2,Hepatocyte growth factor receptor,46911863,"6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline",C19H13F2N7,377.3,2.1,73.8,0,7,3,28,,JRWCBEOAFGHNNU-UHFFFAOYSA-N
SGX-523,CIDs24779724,SGX-523,359.40772,CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2,CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2,Hepatocyte growth factor receptor,24779724,"6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]quinoline",C18H13N7S,359.4,2.4,99.1,0,6,3,26,,BCZUAADEACICHN-UHFFFAOYSA-N
Linsitinib,CIDs11640390,linsitinib,421.49372,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,"Insulin receptor, Insulin-like growth factor I receptor",11640390,"3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol",C26H23N5O,421.5,4.2,89.3,2,5,3,32,,PKCDDUHJAFVJJB-UHFFFAOYSA-N
LY2157299,CIDs10090485,galunisertib,369.41916,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,TGF-beta receptor type I,10090485,"4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide",C22H19N5O,369.4,2.4,86.7,1,4,3,28,,IVRXNBXKWIJUQB-UHFFFAOYSA-N
Tandutinib,CIDs03038522,tandutinib,562.70298,CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5,CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta",3038522,4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide,C31H42N6O4,562.7,4.6,92.3,1,8,10,41,,UXXQOJXBIDBUAC-UHFFFAOYSA-N
Quizartinib,CIDs24889392,quizartinib,560.66718,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor RET",24889392,"1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea",C29H32N6O4S,560.7,5.6,134.0,2,8,8,40,,CVWXJKQAOSCOAB-UHFFFAOYSA-N
R-406,CIDs11213558,R406 free base,470.453623,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,Tyrosine-protein kinase SYK,11213558,"6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one",C22H23FN6O5,470.5,3.1,129.0,3,11,7,34,,NHHQJBCNYHBUSI-UHFFFAOYSA-N
Pictilisib,CIDs17755052,pictilisib,513.63558,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,PI3-kinase class I,17755052,"4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine",C23H27N7O3S2,513.6,1.6,144.0,1,10,5,35,,LHNIIDJUOCFXAP-UHFFFAOYSA-N
GSK-2126458,CIDs25167777,GSK2126458,505.495986,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,"PI3-kinase class I, Serine/threonine-protein kinase mTOR",25167777,"2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)-3-pyridinyl]benzenesulfonamide",C25H17F2N5O3S,505.5,3.3,115.0,1,10,6,36,,CGBJSGAELGCMKE-UHFFFAOYSA-N
BKM-120,CIDs16654980,NVP-BKM120,410.39355,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PI3-kinase class I,16654980,"5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine",C18H21F3N6O2,410.4,1.5,89.6,1,11,3,29,,CWHUFRVAEUJCEF-UHFFFAOYSA-N
Idelalisib,CIDs11625818,idelalisib,415.423023,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit,11625818,5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one,C22H18FN7O,415.4,3.7,99.2,2,7,5,31,,IFSDAJWBUCMOAH-HNNXBMFYSA-N
AZD-6482,CIDs44137675,AZD-6482,408.45036,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,PI3-kinase class I,44137675,"2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid",C22H24N4O4,408.4,2.0,94.5,2,7,5,30,,IRTDIKMSKMREGO-OAHLLOKOSA-N
MK-2206,CIDs24964624,MK-2206 dihydrochloride,407.46714,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,Serine/threonine-protein kinase AKT,24964624,"8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one",C25H21N5O,407.5,3.0,83.6,2,4,3,31,,ULDXWLCXEDXJGE-UHFFFAOYSA-N
GSK-690693,CIDs16725726,GSK690693,425.48418,CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N,CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N,"Serine/threonine-protein kinase AKT, Protein kinase C (PKC), cAMP-dependent protein kinase (PKA)",16725726,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol",C21H27N7O3,425.5,0.3,137.0,3,9,7,31,,KGPGFQWBCSZGEL-ZDUSSCGKSA-N
BEZ-235,CIDs11977753,NVP-BEZ235,469.53652,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,"PI3-kinase class I, Serine/threonine-protein kinase mTOR",11977753,"2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile",C30H23N5O,469.5,5.2,73.1,0,4,3,36,,JOGKUKXHTYWRGZ-UHFFFAOYSA-N
PF-05212384,CIDs44516953,PKI-587,615.72584,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,"PI3-kinase class I, Serine/threonine-protein kinase mTOR",44516953,"1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea",C32H41N9O4,615.7,2.4,128.0,2,10,7,45,,DWZAEMINVBZMHQ-UHFFFAOYSA-N
GDC-0980,CIDs25254071,Apitolisib,498.6011,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,"PI3-kinase class I, Serine/threonine-protein kinase mTOR",25254071,"(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one",C23H30N8O3S,498.6,0.2,162.0,2,11,5,35,,YOVVNQKCSKSHKT-HNNXBMFYSA-N
AZD-8055,CIDs25262965,AZD8055,465.54474,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,Serine/threonine-protein kinase mTOR,25262965,"[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol",C25H31N5O4,465.5,2.6,93.1,1,9,5,34,,KVLFRAWTRWDEDF-IRXDYDNUSA-N
Salirasib,CIDs05469318,salirasib,358.5374,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,RAS,5469318,"2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid",C22H30O2S,358.5,7.2,62.6,1,3,10,25,,WUILNKCFCLNXOK-CFBAGHHKSA-N
VX-702,CIDs10341154,vx-702,404.317793,C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F,C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F,MAP kinase p38 alpha,10341154,"6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)pyridine-3-carboxamide",C19H12F4N4O2,404.3,2.5,102.0,2,7,4,29,,FYSRKRZDBHOFAY-UHFFFAOYSA-N
VX-745,CIDs03038525,Vx-745,436.262066,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,MAP kinase p38 alpha,3038525,"5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one",C19H9Cl2F2N3OS,436.3,5.1,70.3,0,5,3,28,,VEPKQEUBKLEPRA-UHFFFAOYSA-N
Doramapimod,CIDs00156422,BIRB796,527.65718,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,MAP kinase p38 alpha,156422,1-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea,C31H37N5O3,527.7,5.7,80.7,2,5,8,39,,MVCOAUNKQVWQHZ-UHFFFAOYSA-N
PH-797804,CIDs22049997,PH-797804,477.298666,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C,MAP kinase p38 alpha,22049997,"3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1-pyridinyl]-N,4-dimethylbenzamide",C22H19BrF2N2O3,477.3,4.2,58.6,1,5,5,30,,KCAJXIDMCNPGHZ-UHFFFAOYSA-N
RWJ-67657,CIDs03008319,Rwj 67657,425.497363,C1=CC=C(C=C1)CCCN2C(=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F)C#CCCO,C1=CC=C(C=C1)CCCN2C(=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F)C#CCCO,"MAP kinase p38 beta, MAP kinase p38 alpha",3008319,4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-pyridin-4-ylimidazol-2-yl]but-3-yn-1-ol,C27H24FN3O,425.5,4.6,50.9,1,4,8,32,,QSUSKMBNZQHHPA-UHFFFAOYSA-N
Talmapimod,CIDs09871074,talmapimod,513.003503,CC1CN(C(CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F,CC1CN(C(CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F,MAP kinase p38 alpha,9871074,"2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide",C27H30ClFN4O3,513.0,3.7,65.9,0,5,5,36,,ZMELOYOKMZBMRB-DLBZAZTESA-N
Bardoxolone methyl,CIDs00400769,CDDO-Me,505.68812,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,"Peroxisome proliferator-activated receptor gamma, Inhibitor of nuclear factor kappa B kinase beta subunit, Keap1/Nrf2",400769,"methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate",C32H43NO4,505.7,6.7,84.2,0,5,2,37,,WPTTVJLTNAWYAO-KPOXMGGZSA-N
IMD-0354,CIDs05081913,IKK-2 inhibitor V,383.672939,C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O,C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O,Inhibitor of nuclear factor kappa B kinase beta subunit,5081913,"N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide",C15H8ClF6NO2,383.67,6.2,49.3,2,8,2,25,,CHILCFMQWMQVAL-UHFFFAOYSA-N
cycloheximide,CIDs00006197,cycloheximide,281.34742,CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C,CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C,80S Ribosome,6197,"4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione",C15H23NO4,281.35,0.5,83.5,2,4,3,20,,YPHMISFOHDHNIV-FSZOTQKASA-N
SPC-839,CIDs09820526,A4715,366.39376,CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4,CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4,"Inhibitor of nuclear factor kappa B kinase beta subunit, Tyrosine-protein kinase receptor FLT3",9820526,"1-[(5-methoxy-2-thiophen-2-ylquinazolin-4-yl)amino]-3-methylpyrrole-2,5-dione",C18H14N4O3S,366.4,3.0,113.0,1,7,4,26,,GZGLPBNOIFLLRE-UHFFFAOYSA-N
Sulfasalazine,CIDs00005339,,0.0,,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,"Cyclooxygenase, Arachidonate 5-lipoxygenase",5339,2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid,C18H14N4O5S,398.4,-0.7,150.0,3,9,6,28,,NCEXYHBECQHGNR-UHFFFAOYSA-N
Navitoclax (ABT-263),CIDs24978538,navitoclax,974.61271,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,"Apoptosis regulator Bcl-X, Apoptosis regulator Bcl-2, Apoptosis regulator Bcl-W",24978538,"4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide",C47H55ClF3N5O6S3,974.6,9.6,170.0,2,14,16,65,,JLYAXFNOILIKPP-KXQOOQHDSA-N
AZD-7762,CIDs11152667,AZD7762,362.421763,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,Serine/threonine-protein kinase Chk1,11152667,3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3S)-piperidin-3-yl]thiophene-2-carboxamide,C17H19FN4O2S,362.4,2.3,124.0,4,5,4,25,,IAYGCINLNONXHY-LBPRGKRZSA-N
Flavopiridol,CIDs05287969,flavopiridol,401.8402,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Cyclin-dependent kinase 6, Cyclin-dependent kinase 4",5287969,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one",C21H20ClNO5,401.8,3.3,90.2,3,6,2,28,,BIIVYFLTOXDAOV-YVEFUNNKSA-N
Seliciclib,CIDs00160355,roscovitine,354.44934,CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Cyclin-dependent kinase 5",160355,(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol,C19H26N6O,354.4,3.2,87.9,3,6,8,26,,BTIHMVBBUGXLCJ-OAHLLOKOSA-N
AT-7519,CIDs11338033,AT7519,382.24448,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,Cyclin-dependent kinase,11338033,"4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide",C16H17Cl2N5O2,382.2,2.6,98.9,4,4,4,25,,OVPNQJVDAFNBDN-UHFFFAOYSA-N
SNS-032,CIDs03025986,Sns-032,380.52806,CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3,CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 7",3025986,"N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide",C17H24N4O2S2,380.5,3.0,134.0,2,7,6,25,,OUSFTKFNBAZUKL-UHFFFAOYSA-N
PHA-793887,CIDs46191454,PHA-793887,361.48174,CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C,CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C,Cyclin-dependent kinase,46191454,"N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4-dihydropyrrolo[3,4-d]pyrazol-3-yl]-3-methylbutanamide",C19H31N5O2,361.5,1.0,81.3,2,4,4,26,,HUXYBQXJVXOMKX-UHFFFAOYSA-N
Palbociclib,CIDs05330286,palbociclib,447.53276,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"CDK6/cyclin D1, Cyclin-dependent kinase 4/cyclin D1",5330286,"6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrido[2,3-d]pyrimidin-7-one",C24H29N7O2,447.5,1.8,103.0,2,8,5,33,,AHJRHEGDXFFMBM-UHFFFAOYSA-N
Tozasertib,CIDs05494449,tozasertib,464.58642,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,Serine/threonine-protein kinase Aurora,5494449,N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide,C23H28N8OS,464.6,3.4,127.0,3,8,7,33,,GCIKSSRWRFVXBI-UHFFFAOYSA-N
Alisertib,CIDs24771867,alisertib,518.923503,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,Serine/threonine-protein kinase Aurora-A,24771867,"4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid",C27H20ClFN4O4,518.9,5.0,106.0,2,9,6,37,,ZLHFILGSQDJULK-UHFFFAOYSA-N
Danusertib,CIDs11442891,danusertib,474.5548,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,Serine/threonine-protein kinase Aurora,11442891,"N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide",C26H30N6O3,474.6,1.8,93.8,2,6,6,35,,XKFTZKGMDDZMJI-HSZRJFAPSA-N
CYC-116,CIDs06420138,CYC116,368.456,CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase Aurora",6420138,"4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine",C18H20N6OS,368.5,2.6,117.0,2,8,4,26,,GPSZYOIFQZPWEJ-UHFFFAOYSA-N
Barasertib,CIDs11497983,AZD1152,587.539805,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,Serine/threonine-protein kinase Aurora-B,11497983,2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate,C26H31FN7O6P,587.5,-0.4,175.0,5,12,15,41,,GBJVVSCPOBPEIT-UHFFFAOYSA-N
AMG-900,CIDs24856041,AMG 900,503.57764,CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N,CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N,Serine/threonine-protein kinase Aurora,24856041,N-[4-[[3-(2-aminopyrimidin-4-yl)-2-pyridinyl]oxy]phenyl]-4-(4-methylthiophen-2-yl)phthalazin-1-amine,C28H21N7OS,503.6,5.1,140.0,2,9,6,37,,IVUGFMLRJOCGAS-UHFFFAOYSA-N
ENMD-981693,CIDs16041424,ENMD-2076,375.4701,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)C=CC4=CC=CC=C4,CC1=CC(=NN1)NC2=CC(=NC(=N2)C=CC3=CC=CC=C3)N4CCN(CC4)C,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase Aurora-A, Serine/threonine-protein kinase Aurora-B, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor FLT3",16041424,6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine,C21H25N7,375.5,3.7,73.0,2,6,5,28,,BLQYVHBZHAISJM-CMDGGOBGSA-N
CHIR-265,CIDs11656518,CHIR-265,518.413859,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase B-raf",11656518,1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine,C24H16F6N6O,518.4,5.4,80.7,2,11,5,37,,YABJJWZLRMPFSI-UHFFFAOYSA-N
Vemurafenib,CIDs42611257,vemurafenib,489.922126,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,Serine/threonine-protein kinase B-raf,42611257,"N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide",C23H18ClF2N3O3S,489.9,5.0,100.0,2,7,7,33,,GPXBXXGIAQBQNI-UHFFFAOYSA-N
Refametinib,CIDs44182295,RDEA119,572.33718,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",44182295,"N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide",C19H20F3IN2O5S,572.3,2.8,116.0,4,10,9,31,,RDSACQWTXKSHJT-NSHDSACASA-N
Selumetinib,CIDs10127622,selumetinib,457.681403,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",10127622,6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide,C17H15BrClFN4O3,457.7,3.6,88.4,3,6,6,27,,CYOHGALHFOKKQC-UHFFFAOYSA-N
PD-0325901,CIDs09826528,PD 0325901,482.19304,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",9826528,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide",C16H14F3IN2O4,482.19,3.0,90.8,4,8,7,26,,SUDAHWBOROXANE-SECBINFHSA-N
Trametinib,CIDs11707110,trametinib,615.394793,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,11707110,"N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide",C26H23FIN5O4,615.4,3.4,102.0,2,6,5,37,,LIRYPHYGHXZJBZ-UHFFFAOYSA-N
TAK-733,CIDs24963252,TAK-733,504.226676,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",24963252,"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione",C17H15F2IN4O4,504.23,0.9,105.0,3,8,5,28,,RCLQNICOARASSR-SECBINFHSA-N
Ibrutinib (PCI-32765),CIDs24821094,ibrutinib,440.49706,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,Tyrosine-protein kinase BTK,24821094,"1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one",C25H24N6O2,440.5,3.6,99.2,1,6,5,33,,XYFPWWZEPKGCCK-GOSISDBHSA-N
Midostaurin,CIDs09829523,midostaurin,570.6371,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor, Protein kinase C (PKC), Vascular endothelial growth factor receptor 2",9829523,"N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide",C35H30N4O4,570.6,4.8,77.7,1,4,3,43,,BMGQWWVMWDBQGC-IIFHNQTCSA-N
Enzastaurin,CIDs00176167,,0.0,,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,Protein kinase C beta,176167,"3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione",C32H29N5O2,515.6,3.7,72.2,1,4,5,39,,AXRCEOKUDYDWLF-UHFFFAOYSA-N
Sotrastaurin,CIDs10296883,sotrastaurin,438.48118,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,Protein kinase C (PKC),10296883,"3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione",C25H22N6O2,438.5,2.6,94.2,2,6,3,33,,OAVGBZOFDPFGPJ-UHFFFAOYSA-N
BI-2536,CIDs11364421,BI 2536,521.65436,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,Serine/threonine-protein kinase PLK1,11364421,4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide,C28H39N7O3,521.7,3.7,103.0,2,8,7,38,,XQVVPGYIWAGRNI-JOCHJYFZSA-N
GSK-461364A,CIDs15983966,GSK461364A,543.60373,CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N,CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N,Serine/threonine-protein kinase PLK1,15983966,5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide,C27H28F3N5O2S,543.6,4.7,105.0,1,9,7,38,,ZHJGWYRLJUCMRT-QGZVFWFLSA-N
AZD-1480,CIDs16659841,AZD1480,348.765963,CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F,CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F,Tyrosine-protein kinase JAK2,16659841,"5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine",C14H14ClFN8,348.76,2.4,104.0,3,8,5,24,,PDOQBOJDRPLBQU-QMMMGPOBSA-N
Momelotinib,CIDs25062766,momelotinib,414.45978,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2",25062766,N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide,C23H22N6O2,414.5,2.6,103.0,2,7,6,31,,ZVHNDZWQTBEVRY-UHFFFAOYSA-N
Lestaurtinib,CIDs00126565,lestaurtinib,439.46264,CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,"Nerve growth factor receptor Trk-A, Tyrosine-protein kinase receptor FLT3, NT-3 growth factor receptor, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase receptor RET, Neurotrophic tyrosine kinase receptor type 2",126565,"(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one",C26H21N3O4,439.5,2.2,88.7,3,4,1,33,,UIARLYUEJFELEN-LROUJFHJSA-N
Leflunomide,CIDs00003899,leflunomide,270.20727,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,Dihydroorotate dehydrogenase,3899,"5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide",C12H9F3N2O2,270.21,2.5,55.1,1,6,2,19,,VHOGYURTWQBHIL-UHFFFAOYSA-N
Silmitasertib,CIDs24748573,CX-4945 (Silmitasertib,349.77048,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4,Casein kinase II alpha,24748573,"5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid",C19H12ClN3O2,349.8,4.4,75.1,2,5,3,25,,MUOKSQABCJCOPU-UHFFFAOYSA-N
Taladegib,CIDs49848070,LY2940680,512.501973,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,Smoothened homolog,49848070,4-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide,C26H24F4N6O,512.5,4.3,67.2,0,9,4,37,,SZBGQDXLNMELTB-UHFFFAOYSA-N
Vismodegib,CIDs24776445,vismodegib,421.29706,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,Smoothened homolog,24776445,2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide,C19H14Cl2N2O3S,421.3,3.8,84.5,1,4,4,27,,BPQMGSKTAYIVFO-UHFFFAOYSA-N
RO-4929097,CIDs49867930,RO4929097,469.404516,CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O,CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O,Gamma-secretase,49867930,"2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide",C22H20F5N3O3,469.4,4.6,87.3,3,8,5,33,,OJPLJFIFUQPSJR-INIZCTEOSA-N
Apilimod,CIDs10173277,apilimod,418.49154,CC1=CC=CC(=C1)C=NNC2=NC(=NC(=C2)N3CCOCC3)OCCC4=CC=CC=N4,CC1=CC(=CC=C1)C=NNC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4,1-phosphatidylinositol 3-phosphate 5-kinase,10173277,N-[(E)-(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine,C23H26N6O2,418.5,3.8,84.8,1,8,8,31,,HSKAZIJJKRAJAV-KOEQRZSOSA-N
SGI-1776,CIDs24795070,SGI-1776,405.41679,CN1CCC(CC1)CNC2=NN3C(=NC=C3C4=CC(=CC=C4)OC(F)(F)F)C=C2,CN1CCC(CC1)CNC2=NN3C(=NC=C3C4=CC(=CC=C4)OC(F)(F)F)C=C2,Serine/threonine-protein kinase PIM,24795070,"N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine",C20H22F3N5O,405.4,4.3,54.7,1,8,5,29,,MHXGEROHKGDZGO-UHFFFAOYSA-N
MK-1775,CIDs24856436,MK-1775,500.59538,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,Serine/threonine-protein kinase WEE1,24856436,"1-[6-(2-hydroxypropan-2-yl)-2-pyridinyl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one",C27H32N8O2,500.6,3.1,101.0,2,9,7,37,,BKWJAKQVGHWELA-UHFFFAOYSA-N
TG-101348,CIDs16722836,fedratinib,524.67814,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,"Tyrosine-protein kinase receptor FLT3, Tyrosine-protein kinase JAK2",16722836,N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide,C27H36N6O3S,524.7,4.8,117.0,3,9,11,37,,JOOXLOJCABQBSG-UHFFFAOYSA-N
CNF-2024,CIDs16736529,BIIB021,318.7615,CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N,CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N,Heat shock protein HSP90,16736529,"6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]purin-2-amine",C14H15ClN6O,318.76,1.9,91.7,1,6,3,22,,QULDDKSCVCJTPV-UHFFFAOYSA-N
Vorinostat (SAHA),CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 3, Histone deacetylase 2, Histone deacetylase 1, Histone deacetylase 6",5311,N'-hydroxy-N-phenyloctanediamide,C14H20N2O3,264.32,1.9,78.4,3,3,8,19,,WAEXFXRVDQXREF-UHFFFAOYSA-N
Belinostat,CIDs06918638,belinostat,318.34766,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,Histone deacetylase,6918638,(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide,C15H14N2O4S,318.3,1.7,104.0,3,5,5,22,,NCNRHFGMJRPRSK-MDZDMXLPSA-N
Mocetinostat,CIDs09865515,MGCD0103,396.4445,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,"Histone deacetylase 2, Histone deacetylase 11, Histone deacetylase 1, Histone deacetylase 3, Histone deacetylase 8",9865515,N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide,C23H20N6O,396.4,2.8,106.0,3,6,6,30,,HRNLUBSXIHFDHP-UHFFFAOYSA-N
Romidepsin,CIDs05352062,depsipeptide,540.69584,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,Histone deacetylase,5352062,"(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone",C24H36N4O6S2,540.7,2.2,193.0,4,8,2,36,,OHRURASPPZQGQM-GCCNXGTGSA-N
Entinostat,CIDs00004261,entinostat,376.4085,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,Histone deacetylase,4261,pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate,C21H20N4O3,376.4,2.0,106.0,3,5,7,28,,INVTYAOGFAGBOE-UHFFFAOYSA-N
Veliparib,CIDs11960529,veliparib,244.29234,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"PARP 1, 2 and 3",11960529,2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide,C13H16N4O,244.29,0.5,83.8,3,3,2,18,,JNAHVYVRKWKWKQ-CYBMUJFWSA-N
Olaparib,CIDs23725625,olaparib,434.462823,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,"PARP 1, 2 and 3",23725625,4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one,C24H23FN4O3,434.5,1.9,82.1,1,5,4,32,,FDLYAMZZIXQODN-UHFFFAOYSA-N
Rucaparib,CIDs09931954,,0.0,,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,"PARP 1, 2 and 3",9931954,"6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one",C19H18FN3O,323.4,2.5,56.9,3,3,3,24,,HMABYWSNWIZPAG-UHFFFAOYSA-N
Ixazomib,CIDs25183872,ixazomib,361.02866,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,26S proteasome,25183872,"[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid",C14H19BCl2N2O4,361.0,,98.7,4,4,7,23,,MXAYKZJJDUDWDS-LBPRGKRZSA-N
Carfilzomib,CIDs11556711,carfilzomib,719.90988,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,26S proteasome,11556711,(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide,C40H57N5O7,719.9,4.7,158.0,4,8,20,52,,BLMPQMFVWMYDKT-NZTKNTHTSA-N
Bortezomib,CIDs00387447,bortezomib,384.2372,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,26S proteasome,387447,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,C19H25BN4O4,384.2,,124.0,4,6,9,28,,GXJABQQUPOEUTA-RDJZCZTQSA-N
Tosedostat,CIDs15547703,tosedostat,406.4727,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,Aminopeptidase,15547703,cyclopentyl (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-2-phenylacetate,C21H30N2O6,406.5,2.3,125.0,4,6,10,29,,FWFGIHPGRQZWIW-SQNIBIBYSA-N
Hydrocortisone,CIDs00005754,cortisol,362.4599,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Glucocorticoid receptor,5754,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C21H30O5,362.5,1.6,94.8,3,5,2,26,,JYGXADMDTFJGBT-VWUMJDOOSA-N
Dexamethasone,CIDs00005743,dexamethasone,392.461063,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Glucocorticoid receptor,5743,"(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C22H29FO5,392.5,1.9,94.8,3,6,2,28,,UREBDLICKHMUKA-CXSFZGCWSA-N
Cortivazol,CIDs00066249,corticoid,530.65452,CC1CC2C3C=C(C4=CC5=C(CC4(C3C(CC2(C1(C(=O)COC(=O)C)O)C)O)C)C=NN5C6=CC=CC=C6)C,CC1CC2C3C=C(C4=CC5=C(CC4(C3C(CC2(C1(C(=O)COC(=O)C)O)C)O)C)C=NN5C6=CC=CC=C6)C,Glucocorticoid receptor,66249,"[2-[(1S,2R,13S,14S,16R,17R,18S,20S)-17,20-dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9,11-tetraen-17-yl]-2-oxoethyl] acetate",C32H38N2O5,530.7,3.9,102.0,2,6,5,39,,RKHQGWMMUURILY-UHRZLXHJSA-N
Abiraterone,CIDs00132971,abiraterone,349.50904,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,"Cytochrome P450 17A1, Steroid 5-alpha-reductase, Androgen Receptor",132971,"(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol",C24H31NO,349.5,4.6,33.1,1,2,1,26,,GZOSMCIZMLWJML-VJLLXTKPSA-N
Doxercalciferol,CIDs05281107,doxercalciferol,412.64776,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor,5281107,"trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C28H44O2,412.6,6.3,40.5,2,2,5,30,,HKXBNHCUPKIYDM-CGMHZMFXSA-N
Seocalcitol,CIDs05288149,seocalcitol,454.68444,CCC(CC)(C=CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O,CCC(CC)(C=CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O,Vitamin D receptor,5288149,"trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3E,5E)-7-ethyl-7-hydroxynona-3,5-dien-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C30H46O3,454.7,5.8,60.7,3,3,7,33,,LVLLALCJVJNGQQ-SEODYNFXSA-N
Bicalutamide,CIDs00002375,bicalutamide,430.373373,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Androgen Receptor,2375,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,C18H14F4N2O4S,430.4,2.3,116.0,2,9,5,29,,LKJPYSCBVHEWIU-UHFFFAOYSA-N
Enzalutamide,CIDs15951529,enzalutamide,464.435953,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,Androgen Receptor,15951529,"4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide",C21H16F4N4O2S,464.4,3.6,109.0,1,8,3,32,,WXCXUHSOUPDCQV-UHFFFAOYSA-N
Pioglitazone hydrochloride,CIDs00060560,,0.0,,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,Peroxisome proliferator-activated receptor gamma,60560,"5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride",C19H21ClN2O3S,392.9,,93.6,2,5,7,26,,GHUUBYQTCDQWRA-UHFFFAOYSA-N
GW-501516,CIDs09803963,GW 501516,453.49773,CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O,CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O,Peroxisome proliferator-activated receptor delta,9803963,"2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid",C21H18F3NO3S2,453.5,5.9,113.0,1,9,7,30,,YDBLKRPLXZNVNB-UHFFFAOYSA-N
Telmisartan,CIDs00065999,telmisartan,514.6169,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Type-1 angiotensin II receptor,65999,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,C33H30N4O2,514.6,6.9,72.9,1,4,7,39,,RMMXLENWKUUMAY-UHFFFAOYSA-N
Apratastat,CIDs11452716,apratastat,414.49638,CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C,CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C,"Matrix metalloproteinase 13, ADAM17",11452716,"(3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide",C17H22N2O6S2,414.5,0.3,150.0,3,8,5,27,,MAVDNGWEBZTACC-HNNXBMFYSA-N
Omeprazole,CIDs00004594,omeprazole,345.41606,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,Potassium-transporting ATPase,4594,"6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole",C17H19N3O3S,345.4,2.2,96.3,1,6,5,24,,SUBDBMMJDZJVOS-UHFFFAOYSA-N
Sildenafil citrate,CIDs135413523,,0.0,,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Phosphodiesterase 5A,135413523,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid",C28H38N6O11S,666.7,,250.0,5,15,12,46,,DEIYFTQMQPDXOT-UHFFFAOYSA-N
Riluzole,CIDs00005070,riluzole,234.19831,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,Sodium channel alpha subunit,5070,"6-(trifluoromethoxy)-1,3-benzothiazol-2-amine",C8H5F3N2OS,234.2,3.6,76.4,1,7,1,15,,FTALBRSUTCGOEG-UHFFFAOYSA-N
Ivacaftor,CIDs16220172,ivacaftor,392.49072,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,Cystic fibrosis transmembrane conductance regulator,16220172,"N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide",C24H28N2O3,392.5,5.6,78.4,3,4,4,29,,PURKAOJPTOLRMP-UHFFFAOYSA-N
Ivabradine hydrochloride,CIDs03045381,,0.0,,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,3045381,"3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;hydrochloride",C27H37ClN2O5,505.0,,60.5,1,6,10,35,,HLUKNZUABFFNQS-ZMBIFBSDSA-N
Meclinertant,CIDs00119192,Meclinertant,587.06534,COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,Neurotensin receptor 1,119192,"2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid",C32H31ClN4O5,587.1,5.8,116.0,2,7,7,42,,DYLJVOXRWLXDIG-UHFFFAOYSA-N
Zibotentan,CIDs09910224,zibotentan,424.43314,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,Endothelin receptor ET-A,9910224,"N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide",C19H16N6O4S,424.4,1.4,141.0,1,10,6,30,,FJHHZXWJVIEFGJ-UHFFFAOYSA-N
Turofexorate isopropyl,CIDs10026128,WAY-362450,438.466466,CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F,CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F,Bile acid receptor FXR,10026128,"propan-2-yl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate",C25H24F2N2O3,438.5,5.1,62.4,1,5,4,32,,INASOKQDNHHMRE-UHFFFAOYSA-N
Aprepitant,CIDs135413536,,0.0,,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,Neurokinin 1 receptor,135413536,"3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one",C23H21F7N4O3,534.4,4.2,75.2,2,12,6,37,,ATALOFNDEOCMKK-OITMNORJSA-N
Rolofylline,CIDs00064627,rolofylline,356.46192,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5,Adenosine A1 receptor,64627,"1,3-dipropyl-8-(3-tricyclo[3.3.1.03,7]nonanyl)-7H-purine-2,6-dione",C20H28N4O2,356.5,4.9,69.3,1,3,5,26,,PJBFVWGQFLYWCB-UHFFFAOYSA-N
Veliflapon,CIDs00123723,BAYx 1005,361.43362,C1CCC(C1)C(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O,C1CCC(C1)C(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O,5-lipoxygenase activating protein,123723,(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid,C23H23NO3,361.4,5.4,59.4,1,4,6,27,,ZEYYDOLCHFETHQ-JOCHJYFZSA-N
Zileuton,CIDs00060490,zileuton,236.29018,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,Arachidonate 5-lipoxygenase,60490,1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea,C11H12N2O2S,236.29,1.6,94.8,2,3,2,16,,MWLSOWXNZPKENC-UHFFFAOYSA-N
Celecoxib,CIDs00002662,celecoxib,381.37217,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Cyclooxygenase-2,2662,4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,C17H14F3N3O2S,381.4,3.4,86.4,1,7,3,26,,RZEKVGVHFLEQIL-UHFFFAOYSA-N
Simvastatin,CIDs00054454,simvastatin,418.56622,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,HMG-CoA reductase,54454,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate",C25H38O5,418.6,4.7,72.8,1,5,7,30,,RYMZZMVNJRMUDD-HGQWONQESA-N
Dalcetrapib,CIDs06918540,dalcetrapib,389.5945,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,Cholesteryl ester transfer protein,6918540,S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate,C23H35NO2S,389.6,7.1,71.5,1,3,9,27,,YZQLWPMZQVHJED-UHFFFAOYSA-N
Ezetimibe,CIDs00150311,ezetimibe,409.425246,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,Niemann-Pick C1-like protein 1,150311,"(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one",C24H21F2NO3,409.4,4.0,60.8,2,5,6,30,,OLNTVTPDXPETLC-XPWALMASSA-N
Ibutamoren mesilate,CIDs06450830,,0.0,,CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N.CS(=O)(=O)O,Ghrelin receptor,6450830,"2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide;methanesulfonic acid",C28H40N4O8S2,624.8,,193.0,3,10,8,42,,DUGMCDWNXXFHDE-VZYDHVRKSA-N
Dapagliflozin,CIDs09887712,dapagliflozin,408.8726,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,Sodium/glucose cotransporter 2,9887712,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol",C21H25ClO6,408.9,2.3,99.4,4,6,6,28,,JVHXJTBJCFBINQ-ADAARDCZSA-N
Efavirenz,CIDs00064139,efavirenz,315.67497,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Human immunodeficiency virus type 1 reverse transcriptase,64139,"(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one",C14H9ClF3NO2,315.67,4.0,38.3,1,5,1,21,,XPOQHMRABVBWPR-ZDUSSCGKSA-N
Etoposide,CIDs00036462,etoposide,588.55658,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,DNA topoisomerase II,36462,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",C29H32O13,588.6,0.6,161.0,3,13,5,42,,VJJPUSNTGOMMGY-MRVIYFEKSA-N
Paclitaxel,CIDs00036314,paclitaxel,853.90614,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Tubulin,36314,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate",C47H51NO14,853.9,2.5,221.0,4,14,14,62,,RCINICONZNJXQF-MZXODVADSA-N
Cytarabine,CIDs00006253,,0.0,,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,"DNA, DNA polymerase (alpha/delta/epsilon), RNA",6253,"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C9H13N3O5,243.22,-2.1,129.0,4,5,2,17,,UHDGCWIWMRVCDJ-CCXZUQQUSA-N
Mitomycin C,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA,5746,"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",C15H18N4O5,334.33,-0.4,147.0,3,8,4,24,,NWIBSHFKIJFRCO-WUDYKRTCSA-N
Raltitrexed,CIDs135400182,,0.0,,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,Thymidylate synthase,135400182,(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid,C21H22N4O6S,458.5,1.4,177.0,4,9,9,32,,IVTVGDXNLFLDRM-HNNXBMFYSA-N
Methotrexate,CIDs00126941,methotrexate,454.43928,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dihydrofolate reductase,126941,"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid",C20H22N8O5,454.4,-1.8,211.0,5,12,9,33,,FBOZXECLQNJBKD-ZDUSSCGKSA-N
Pralatrexate,CIDs00148121,pralatrexate,477.47262,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dihydrofolate reductase,148121,"(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid",C23H23N7O5,477.5,-0.9,207.0,5,11,10,35,,OGSBUKJUDHAQEA-WMCAAGNKSA-N
Pyrimethamine,CIDs00004993,pyrimethamine,248.71142,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Dihydrofolate reductase,4993,"5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine",C12H13ClN4,248.71,2.7,77.8,2,4,2,17,,WKSAUQYGYAYLPV-UHFFFAOYSA-N
Cytisine,CIDs00010235,cytisine,190.24166,C1C2CNCC1C3=CC=CC(=O)N3C2,C1C2CNCC1C3=CC=CC(=O)N3C2,Neuronal acetylcholine receptor; alpha4/beta2,10235,"(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one",C11H14N2O,190.24,0.2,32.3,1,2,0,14,,ANJTVLIZGCUXLD-DTWKUNHWSA-N
Prazosin hydrochloride,CIDs00068546,,0.0,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,Adrenergic receptor alpha-1,68546,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone;hydrochloride",C19H22ClN5O4,419.9,,107.0,2,8,4,29,,WFXFYZULCQKPIP-UHFFFAOYSA-N
Ciclopirox,CIDs00002749,ciclopirox,207.26888,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,"Iron, Aluminium",2749,6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one,C12H17NO2,207.27,2.0,40.5,1,2,1,15,,SCKYRAXSEDYPSA-UHFFFAOYSA-N
Chloroxine,CIDs00002722,halquinol,214.0481,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,DNA,2722,"5,7-dichloroquinolin-8-ol",C9H5Cl2NO,214.04,3.5,33.1,1,2,0,13,,WDFKMLRRRCGAKS-UHFFFAOYSA-N
Prochlorperazine,CIDs00004917,prochlorperazine,373.94266,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dopamine D2 receptor,4917,2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,C20H24ClN3S,373.9,4.9,35.0,0,4,4,25,,WIKYUJGCLQQFNW-UHFFFAOYSA-N
Marizomib,CIDs11347535,salinosporamide A,313.7766,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,20S proteasome,11347535,"(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione",C15H20ClNO4,313.77,1.8,75.6,2,4,4,21,,NGWSFRIPKNWYAO-SHTIJGAHSA-N
Mebendazole,CIDs00004030,mebendazole,295.29272,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Tubulin,4030,methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate,C16H13N3O3,295.29,2.8,84.1,2,4,4,22,,OPXLLQIJSORQAM-UHFFFAOYSA-N
Fingolimod hydrochloride,CIDs00107969,fingolimod,343.93176,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,Sphingosine 1-phosphate receptor,107969,"2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride",C19H34ClNO2,343.9,,66.5,4,3,12,23,,SWZTYAVBMYWFGS-UHFFFAOYSA-N
BMS-754807,CIDs24785538,BMS-754807,461.494763,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,"Insulin receptor, Insulin-like growth factor I receptor",24785538,"(2S)-1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methylpyrrolidine-2-carboxamide",C23H24FN9O,461.5,2.9,116.0,3,8,6,34,,LQVXSNNAFNGRAH-QHCPKHFHSA-N
Dinaciclib (SCH727965),CIDs46926350,dinaciclib,396.48602,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 5",46926350,"2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol",C21H28N6O2,396.5,1.9,91.2,2,6,7,29,,PIMQWRZWLQKKBJ-SFHVURJKSA-N
PF-04691502,CIDs25033539,PF-04691502,425.48088,CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC,CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC,"PI3-kinase class I, Serine/threonine-protein kinase mTOR",25033539,"2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methylpyrido[2,3-d]pyrimidin-7-one",C22H27N5O4,425.5,1.6,124.0,2,8,6,31,,XDLYKKIQACFMJG-UHFFFAOYSA-N
Fostamatinib,CIDs11671467,fostamatinib,580.459505,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,Tyrosine-protein kinase SYK,11671467,"[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate",C23H26FN6O9P,580.5,1.6,187.0,4,15,10,40,,GKDRMWXFWHEQQT-UHFFFAOYSA-N
Birinapant,CIDs49836020,birinapant,806.940846,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,cIAP1/cIAP2,49836020,"(2S)-N-[(2S)-1-[(2R,4S)-2-[[6-fluoro-2-[6-fluoro-3-[[(2R,4S)-4-hydroxy-1-[(2S)-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]methyl]-1H-indol-2-yl]-1H-indol-3-yl]methyl]-4-hydroxypyrrolidin-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide",C42H56F2N8O6,806.9,3.3,195.0,8,10,15,58,,PKWRMUKBEYJEIX-DXXQBUJASA-N
Raloxifene hydrochloride,CIDs00054900,,0.0,,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,Estrogen receptor beta,54900,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride,C28H28ClNO4S,510.0,,98.2,3,6,7,35,,BKXVVCILCIUCLG-UHFFFAOYSA-N
Niclosamide,CIDs00004477,niclosamide,327.11962,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,DNA,4477,5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,C13H8Cl2N2O4,327.12,4.0,95.2,2,4,2,21,,RJMUSRYZPJIFPJ-UHFFFAOYSA-N
Emricasan,CIDs12000240,Emricasan,569.502093,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,Caspase,12000240,"(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid",C26H27F4N3O7,569.5,3.6,151.0,4,11,11,40,,SCVHJVCATBPIHN-SJCJKPOMSA-N
VX-765,CIDs11398092,belnacasan,508.99502,CCOC1C(CC(=O)O1)NC(=O)C2CCCN2C(=O)C(C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl,CCOC1C(CC(=O)O1)NC(=O)C2CCCN2C(=O)C(C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl,Caspase-1,11398092,"(2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide",C24H33ClN4O6,509.0,2.3,140.0,3,7,8,35,,SJDDOCKBXFJEJB-MOKWFATOSA-N
Odanacatib,CIDs10152654,odanacatib,525.558793,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,Cathepsin K,10152654,"(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide",C25H27F4N3O3S,525.6,4.1,107.0,2,9,9,36,,FWIVDMJALNEADT-SFTDATJTSA-N
Olmesartan,CIDs00158781,olmesartan,446.50164,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,Type-1 angiotensin II receptor,158781,5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,C24H26N6O3,446.5,3.2,130.0,3,7,8,33,,VTRAEEWXHOVJFV-UHFFFAOYSA-N
Enalapril maleate,CIDs05388961,enalapril,492.51888,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,Angiotensin-converting enzyme,5388961,(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,C24H32N2O9,492.5,,171.0,4,10,12,35,,OYFJQPXVCSSHAI-QFPUQLAESA-N
Ramipril,CIDs05362129,ramipril,416.51058,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Angiotensin-converting enzyme,5362129,"(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid",C23H32N2O5,416.5,1.4,95.9,2,6,10,30,,HDACQVRGBOVJII-JBDAPHQKSA-N
Venetoclax (ABT-199),CIDs49846579,venetoclax,868.4392,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,Apoptosis regulator Bcl-2,49846579,"4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",C45H50ClN7O7S,868.4,8.2,183.0,3,11,12,61,,LQBVNQSMGBZMKD-UHFFFAOYSA-N
AMG-232,CIDs58573469,AMG-232,568.5522,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,Tumour suppressor p53/oncoprotein Mdm2,58573469,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-propan-2-ylsulfonylbutan-2-yl]-2-oxopiperidin-3-yl]acetic acid",C28H35Cl2NO5S,568.6,5.8,100.0,1,5,9,37,,DRLCSJFKKILATL-YWCVFVGNSA-N
Idasanutlin,CIDs53358942,RG7388,616.482466,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,Tumour suppressor p53/oncoprotein Mdm2,53358942,"4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid",C31H29Cl2F2N3O4,616.5,4.3,111.0,3,8,8,42,,TVTXCJFHQKSQQM-LJQIRTBHSA-N
R-Etodolac,CIDs00667528,R-etodolac,287.35354,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Retinoid X receptor alpha,667528,"2-[(1R)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid",C17H21NO3,287.35,2.8,62.3,2,3,4,21,,NNYBQONXHNTVIJ-QGZVFWFLSA-N
M2698,CIDs89808643,SCHEMBL15262358,449.85667,C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N,C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N,"Ribosomal protein S6 kinase (P70S6K), Serine/threonine-protein kinase AKT, Serine/threonine-protein kinase AKT3",89808643,4-[[(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl]amino]quinazoline-8-carboxamide,C21H19ClF3N5O,449.9,3.9,84.1,2,8,6,31,,HXAUJHZZPCBFPN-QGZVFWFLSA-N
Ipatasertib,CIDs24788740,GDC-0068,457.99618,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,Serine/threonine-protein kinase AKT,24788740,"(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one",C24H32ClN5O2,458.0,2.5,81.6,2,6,6,32,,GRZXWCHAXNAUHY-NSISKUIASA-N
GSK2141795,CIDs51042438,uprosertib,429.248046,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,Serine/threonine-protein kinase AKT,51042438,"N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)furan-2-carboxamide",C18H16Cl2F2N4O2,429.2,3.4,86.1,2,6,6,28,,AXTAPYRUEKNRBA-JTQLQIEISA-N
BAY-1125976,CIDs70817911,AGN-PC-0J36CX,383.44574,C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N,C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N,"Serine/threonine-protein kinase AKT2, Serine/threonine-protein kinase AKT",70817911,"2-[4-(1-aminocyclobutyl)phenyl]-3-phenylimidazo[1,2-b]pyridazine-6-carboxamide",C23H21N5O,383.4,2.4,99.3,2,4,4,29,,JBGYKRAZYDNCNV-UHFFFAOYSA-N
Miransertib,CIDs53262401,AGN-PC-0HD3LN,432.51966,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N,Serine/threonine-protein kinase AKT,53262401,"3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine",C27H24N6,432.5,3.8,95.6,2,5,4,33,,HNFMVVHMKGFCMB-UHFFFAOYSA-N
AZD-5363,CIDs25227436,AZD5363,428.9152,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,Serine/threonine-protein kinase AKT,25227436,"4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide",C21H25ClN6O2,428.9,1.7,120.0,4,6,6,30,,JDUBGYFRJFOXQC-KRWDZBQOSA-N
Triciribine phosphate,CIDs00043860,TCN-P,400.283842,CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)COP(=O)(O)O)O)O)C(=N1)N,CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)COP(=O)(O)O)O)O)C(=N1)N,Serine/threonine-protein kinase AKT,43860,"[(2R,3S,4R,5R)-5-(5-amino-7-methyl-2,6,7,9,11-pentazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",C13H17N6O7P,400.28,-3.3,189.0,5,11,4,27,,URLYINUFLXOMHP-HTVVRFAVSA-N
Afuresertib (GSK2110183),CIDs46843057,,0.0,,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,Serine/threonine-protein kinase AKT,46843057,N-[(2S)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methylpyrazol-5-yl)thiophene-2-carboxamide,C18H17Cl2FN4OS,427.3,4.0,101.0,2,5,6,27,,AFJRDFWMXUECEW-LBPRGKRZSA-N
AT-13148,CIDs24905401,AT-13148,313.78144,C1=CC(=CC=C1C2=CNN=C2)C(CN)(C3=CC=C(C=C3)Cl)O,C1=CC(=CC=C1C2=CNN=C2)C(CN)(C3=CC=C(C=C3)Cl)O,"Rho-associated protein kinase, MAP kinase-activated protein kinase 2",24905401,(1S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)phenyl]ethanol,C17H16ClN3O,313.8,2.2,74.9,3,3,4,22,,IIRWNGPLJQXWFJ-KRWDZBQOSA-N
MKC-1,CIDs05327686,MKC-1,400.38684,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C,"Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor, Fibroblast growth factor receptor, Tyrosine-protein kinase receptor FLT3, SRC, Serine/threonine-protein kinase Aurora-A",5327686,"3-(1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione",C22H16N4O4,400.4,2.6,102.0,1,4,2,30,,OVSKGTONMLKNPZ-UHFFFAOYSA-N
ASP-3026,CIDs25134326,ASP3026,580.7447,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC=NC(=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,ALK tyrosine kinase receptor,25134326,"2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine",C29H40N8O3S,580.7,4.8,124.0,2,11,9,41,,MGGBYMDAPCCKCT-UHFFFAOYSA-N
Vactosertib,CIDs54766013,EW-7197,399.423623,CC1=CC=CC(=N1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,TGF-beta receptor type I,54766013,"2-fluoro-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline",C22H18FN7,399.4,3.2,83.8,2,6,5,30,,FJCDSQATIJKQKA-UHFFFAOYSA-N
TPX-0005,CIDs135565923,,0.0,,CC1CNC(=O)C2=C3N=C(C=CN3N=C2)NC(C4=C(O1)C=CC(=C4)F)C,"Nerve growth factor receptor Trk-A, CD74-ROS1, Proto-oncogene tyrosine-protein kinase ROS, Neurotrophic tyrosine kinase receptor type 2, ROS1-SDC4, NT-3 growth factor receptor",135565923,"(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one",C18H18FN5O2,355.4,2.1,80.6,2,6,0,26,,FIKPXCOQUIZNHB-WDEREUQCSA-N
AP-26113,CIDs68165256,AGN-PC-0HUR20,584.092422,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,"ALK tyrosine kinase receptor, Epidermal growth factor receptor erbB1",68165256,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",C29H39ClN7O2P,584.1,4.6,85.9,2,9,8,40,,AILRADAXUVEEIR-UHFFFAOYSA-N
Ceritinib,CIDs57379345,ceritinib,558.13514,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor), ALK tyrosine kinase receptor, EML4-ALK",57379345,"5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine",C28H36ClN5O3S,558.1,6.4,114.0,3,8,9,38,,VERWOWGGCGHDQE-UHFFFAOYSA-N
Lorlatinib,CIDs71731823,MolPort-035-789-724,406.412963,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,"ALK tyrosine kinase receptor, EML4-ALK",71731823,"(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile",C21H19FN6O2,406.4,1.5,110.0,1,7,0,30,,IIXWYSCJSQVBQM-LLVKDONJSA-N
Ensartinib,CIDs56960363,SCHEMBL15131489,561.435383,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,ALK tyrosine kinase receptor,56960363,"6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-[(3R,5S)-3,5-dimethylpiperazine-1-carbonyl]phenyl]pyridazine-3-carboxamide",C26H27Cl2FN6O3,561.4,3.6,122.0,3,8,6,38,,GLYMPHUVMRFTFV-QLFBSQMISA-N
BAY-1895344,CIDs118869362,,0.0,,CC1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C,Serine-protein kinase ATR,118869362,"(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine",C20H21N7O,375.4,1.6,84.8,1,6,3,28,,YBXRSCXGRPSTMW-CYBMUJFWSA-N
Berzosertib,CIDs59472121,VE-822,463.552,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,Serine-protein kinase ATR,59472121,"3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine",C24H25N5O3S,463.6,2.3,132.0,2,8,7,33,,JZCWLJDSIRUGIN-UHFFFAOYSA-N
AZD-6738,CIDs54761306,SCHEMBL9979340,412.50856,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,Serine-protein kinase ATR,54761306,"imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane",C20H24N6O2S,412.5,2.6,116.0,2,7,4,29,,OHUHVTCQTUDPIJ-JYCIKRDWSA-N
Selonsertib,CIDs71245288,AGN-PC-0JIBUS,445.492063,CC1=C(C=C(C(=C1)F)C(=O)NC2=CC=CC(=N2)C3=NN=CN3C(C)C)N4C=C(N=C4)C5CC5,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,Mitogen-activated protein kinase kinase kinase 5,71245288,"5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)-2-pyridinyl]benzamide",C24H24FN7O,445.5,2.7,90.5,1,6,6,33,,YIDDLAAKOYYGJG-UHFFFAOYSA-N
PF-03814735,CIDs51346455,W-5656,474.47881,CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F,CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F,"Serine/threonine-protein kinase Aurora-A, Serine/threonine-protein kinase Aurora-B",51346455,"N-[2-[(1R,8S)-4-[[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-11-azatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-yl]-2-oxoethyl]acetamide",C23H25F3N6O2,474.5,3.0,99.3,3,9,6,34,,RYYNGWLOYLRZLK-RBUKOAKNSA-N
MLN-8054,CIDs11712649,MLN8054,476.862006,C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O,C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O,Serine/threonine-protein kinase Aurora-A,11712649,"4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid",C25H15ClF2N4O2,476.9,5.2,87.5,2,8,4,34,,HHFBDROWDBDFBR-UHFFFAOYSA-N
TAK-901,CIDs16124208,TAK-901,504.64368,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=CC(=CN=C4N3)C)C)C(=O)NC5CCN(CC5)C,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C,Serine/threonine-protein kinase Aurora-B,16124208,"5-(3-ethylsulfonylphenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide",C28H32N4O3S,504.6,4.5,104.0,2,5,5,36,,WKDACQVEJIVHMZ-UHFFFAOYSA-N
GSK-1070916A,CIDs46885626,GSK1070916A,507.62932,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC(=CC=C5)CN(C)C,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C,"Serine/threonine-protein kinase Aurora-C, Serine/threonine-protein kinase Aurora-B",46885626,"3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylurea",C30H33N7O,507.6,3.9,82.1,2,4,7,38,,QTBWCSQGBMPECM-UHFFFAOYSA-N
AZD1152,CIDs11497983,AZD1152,587.539805,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,Serine/threonine-protein kinase Aurora-B,11497983,2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate,C26H31FN7O6P,587.5,-0.4,175.0,5,12,15,41,,GBJVVSCPOBPEIT-UHFFFAOYSA-N
Gilteritinib,CIDs49803313,Gilteritinib,552.71146,CCC1=NC(=C(N=C1NC2CCOCC2)NC3=CC(=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC)C(=O)N,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,"Tyrosine-protein kinase receptor FLT3, Tyrosine-protein kinase receptor UFO",49803313,6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide,C29H44N8O3,552.7,3.5,121.0,3,10,9,40,,GYQYAJJFPNQOOW-UHFFFAOYSA-N
Bemcentinib,CIDs46215462,R-428,506.64456,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,Tyrosine-protein kinase receptor UFO,46215462,"1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine",C30H34N8,506.6,5.5,97.8,2,7,4,38,,KXMZDGSRSGHMMK-VWLOTQADSA-N
KW-2449,CIDs11427553,KW-2449,332.399,C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43,C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43,"Tyrosine-protein kinase receptor FLT3, Serine/threonine-protein kinase Aurora-A, Tyrosine-protein kinase ABL, Serine/threonine-protein kinase Aurora-B",11427553,[4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone,C20H20N4O,332.4,2.7,61.0,2,3,3,25,,YYLKKYCXAOBSRM-JXMROGBWSA-N
Bafetinib,CIDs11387605,bafetinib,576.61535,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5,"Tyrosine-protein kinase ABL, Tyrosine-protein kinase Lyn",11387605,4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide,C30H31F3N8O,576.6,4.2,99.2,2,11,8,42,,ZGBAJMQHJDFTQJ-DEOSSOPVSA-N
Asciminib,CIDs72165228,SCHEMBL15388306,449.838426,C1CN(CC1O)C2=NC=C(C=C2C3=CC=NN3)C(=O)NC4=CC=C(C=C4)OC(F)(F)Cl,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,Tyrosine-protein kinase ABL,72165228,N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide,C20H18ClF2N5O3,449.8,3.0,103.0,3,8,6,31,,VOVZXURTCKPRDQ-CQSZACIVSA-N
GZD-824,CIDs51038269,GZD824,532.55949,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,Bcr/Abl fusion protein,51038269,"4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[5,4-b]pyridin-5-yl)ethynyl]benzamide",C29H27F3N6O,532.6,4.6,77.2,2,8,6,39,,TZKBVRDEOITLRB-UHFFFAOYSA-N
Acalabrutinib,CIDs71226662,SCHEMBL14637368,465.50652,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,Tyrosine-protein kinase BTK,71226662,"4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide",C26H23N7O2,465.5,3.0,119.0,2,6,4,35,,WDENQIQQYWYTPO-IBGZPJMESA-N
Evobrutinib,CIDs71479709,AGN-PC-0J7FYQ,429.51418,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,Tyrosine-protein kinase BTK,71479709,1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one,C25H27N5O2,429.5,4.2,93.4,2,6,7,32,,QUIWHXQETADMGN-UHFFFAOYSA-N
RG-7845 (GDC-0853),CIDs86567195,SCHEMBL14912882,664.79646,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,Tyrosine-protein kinase BTK,86567195,"10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]-2-pyridinyl]amino]-6-oxo-3-pyridinyl]-2-pyridinyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one",C37H44N8O4,664.8,2.3,119.0,2,9,7,49,,WNEODWDFDXWOLU-QHCPKHFHSA-N
SB-1317,CIDs16739650,SB1317/TG02,372.46286,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Tyrosine-protein kinase JAK2, Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Tyrosine-protein kinase receptor FLT3",16739650,"(16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene",C23H24N4O,372.5,4.2,50.3,1,5,0,28,,VXBAJLGYBMTJCY-NSCUHMNNSA-N
R-547,CIDs06918852,R-547,441.452246,COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C,COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 2, Cyclin-dependent kinase 4",6918852,"[4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(2,3-difluoro-6-methoxyphenyl)methanone",C18H21F2N5O4S,441.5,2.1,136.0,2,11,6,30,,JRNJNYBQQYBCLE-UHFFFAOYSA-N
Milciclib,CIDs16718576,milciclib,460.57458,CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C,CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C,"Cyclin-dependent kinase 1, Nerve growth factor receptor Trk-A, Cyclin-dependent kinase 2, Cyclin-dependent kinase 4",16718576,"N,1,4,4-tetramethyl-8-[4-(4-methylpiperazin-1-yl)anilino]-5H-pyrazolo[4,5-h]quinazoline-3-carboxamide",C25H32N8O,460.6,2.8,91.2,2,7,4,34,,RXZMYLDMFYNEIM-UHFFFAOYSA-N
AZD-5438,CIDs16747683,AZD5438,371.45664,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C,Cyclin-dependent kinase,16747683,4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine,C18H21N5O2S,371.5,2.2,98.2,1,6,5,26,,WJRRGYBTGDJBFX-UHFFFAOYSA-N
Ribociclib (LEE011),CIDs44631912,ribociclib,434.5373,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,"Cyclin-dependent kinase 4, Cyclin-dependent kinase 6",44631912,"7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide",C23H30N8O,434.5,2.2,91.2,2,7,5,32,,RHXHGRAEPCAFML-UHFFFAOYSA-N
Abemaciclib,CIDs46220502,abemaciclib,506.593386,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,"Cyclin-dependent kinase 4, Cyclin-dependent kinase 6",46220502,N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine,C27H32F2N8,506.6,3.8,75.0,1,9,7,37,,UZWDCWONPYILKI-UHFFFAOYSA-N
TAK-931,CIDs135564531,,0.0,,CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)C4CC5CCN4CC5,Cell division cycle 7-related protein kinase,135564531,"2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)-3H-thieno[3,2-d]pyrimidin-4-one",C17H19N5OS,341.4,2.0,102.0,2,5,2,24,,XGVXKJKTISMIOW-ZDUSSCGKSA-N
Rabusertib,CIDs11955855,LY2603618,436.30298,CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3,CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3,Serine/threonine-protein kinase Chk1,11955855,1-[5-bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea,C18H22BrN5O3,436.3,1.4,97.4,3,6,5,27,,SYYBDNPGDKKJDU-ZDUSSCGKSA-N
MK-8776,CIDs46239015,Y0217,376.25432,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,Serine/threonine-protein kinase Chk1,46239015,"6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine",C15H18BrN7,376.25,0.8,86.1,2,5,2,23,,GMIZZEXBPRLVIV-SECBINFHSA-N
SCH 900776,CIDs46239015,Y0217,376.25432,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,Serine/threonine-protein kinase Chk1,46239015,"6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine",C15H18BrN7,376.25,0.8,86.1,2,5,2,23,,GMIZZEXBPRLVIV-SECBINFHSA-N
Prexasertib,CIDs46700756,,0.0,,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,"Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2",46700756,5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile,C18H19N7O2,365.4,1.4,135.0,3,8,8,27,,DOTGPNHGTYJDEP-UHFFFAOYSA-N
Pexidartinib,CIDs25151352,Pexidartinib,417.81481,C1=CC(=NC=C1CC2=CNC3=NC=C(C=C23)Cl)NCC4=CN=C(C=C4)C(F)(F)F,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,"Macrophage colony stimulating factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase receptor FLT3",25151352,"5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]pyridin-2-amine",C20H15ClF3N5,417.8,4.5,66.5,2,7,5,29,,JGWRKYUXBBNENE-UHFFFAOYSA-N
CC-115,CIDs58298318,AGN-PC-0H9OGU,336.35124,CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C,CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C,"Serine/threonine-protein kinase mTOR, DNA-dependent protein kinase",58298318,"5-ethyl-3-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one",C16H16N8O,336.35,0.7,113.0,2,7,3,25,,GMYLVKUGJMYTFB-UHFFFAOYSA-N
BAY-1161909,CIDs71599640,SCHEMBL15036597,559.611243,CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3,CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3,Dual specificity protein kinase TTK,71599640,"(2R)-2-(4-fluorophenyl)-N-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide",C29H26FN5O4S,559.6,4.9,123.0,2,8,8,40,,NRJKIOCCERLIDG-GOSISDBHSA-N
BAY-1217389,CIDs78320750,SCHEMBL15555839,561.503176,CC1=C(C=CC(=C1)C2=CN=C3N2N=C(C=C3NCCC(F)(F)F)OC4=C(C(=C(C=C4)OC)F)F)C(=O)NC5CC5,CC1=C(C=CC(=C1)C2=CN=C3N2N=C(C=C3NCCC(F)(F)F)OC4=C(C(=C(C=C4)OC)F)F)C(=O)NC5CC5,Dual specificity protein kinase TTK,78320750,"N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide",C27H24F5N5O3,561.5,5.7,89.8,2,11,9,40,,WNEILUNVMHVMPH-UHFFFAOYSA-N
AC-480,CIDs10437018,BMS-599626,530.553483,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4",10437018,"[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",C27H27FN8O3,530.6,2.8,120.0,3,9,8,39,,LUJZZYWHBDHDQX-QFIPXVFZSA-N
TAK-285,CIDs11620908,TAK-285,547.95661,CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O,CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2",11620908,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide",C26H25ClF3N5O3,548.0,4.4,101.0,3,9,9,38,,ZYQXEVJIFYIBHZ-UHFFFAOYSA-N
Avitinib,CIDs72734520,SCHEMBL15455613,487.528743,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,"Epidermal growth factor receptor erbB1, Tyrosine-protein kinase BTK",72734520,"N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide",C26H26FN7O2,487.5,4.2,98.4,3,8,7,36,,UOFYSRZSLXWIQB-UHFFFAOYSA-N
XL647,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4, Receptor protein-tyrosine kinase erbB-2",10458325,"7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",C24H25Cl2FN4O2,491.4,5.8,59.5,1,7,6,33,,HVXKQKFEHMGHSL-GOOCMWNKSA-N
Tesevatinib,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4, Receptor protein-tyrosine kinase erbB-2",10458325,"7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",C24H25Cl2FN4O2,491.4,5.8,59.5,1,7,6,33,,HVXKQKFEHMGHSL-GOOCMWNKSA-N
CEP-32496,CIDs56846693,CEP-32496,517.45719,CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F,CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F,"Epidermal growth factor receptor erbB1, Tyrosine-protein kinase receptor RET, Serine/threonine-protein kinase B-raf",56846693,"1-[3-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-3-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]urea",C24H22F3N5O5,517.5,5.0,121.0,2,11,7,37,,DKNUPRMJNUQNHR-UHFFFAOYSA-N
Poziotinib,CIDs25127713,poziotinib,491.342243,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,Epidermal growth factor receptor,25127713,"1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one",C23H21Cl2FN4O3,491.3,5.4,76.6,1,7,6,33,,LPFWVDIFUFFKJU-UHFFFAOYSA-N
BMS-599626,CIDs10437018,BMS-599626,530.553483,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4",10437018,"[(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",C27H27FN8O3,530.6,2.8,120.0,3,9,8,39,,LUJZZYWHBDHDQX-QFIPXVFZSA-N
AZD-3759,CIDs78209992,SCHEMBL16010006,459.901123,CC1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,CC1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,Epidermal growth factor receptor erbB1,78209992,"[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate",C22H23ClFN5O3,459.9,4.1,79.8,1,8,5,32,,MXDSJQHFFDGFDK-CYBMUJFWSA-N
Osimertinib mesylate,CIDs78357807,,0.0,,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O,Epidermal growth factor receptor erbB1,78357807,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid,C29H37N7O5S,595.7,,150.0,3,10,10,42,,FUKSNUHSJBTCFJ-UHFFFAOYSA-N
Rociletinib,CIDs57335384,rociletinib,555.55153,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,Epidermal growth factor receptor erbB1,57335384,N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide,C27H28F3N7O3,555.6,4.0,112.0,3,11,8,40,,HUFOZJXAKZVRNJ-UHFFFAOYSA-N
PF-06747775,CIDs91668194,"N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]-9-methyl-purin-2-yl]pyrrolidin-3-yl]acrylamide",415.424783,CN1C=C(C(=N1)OC)NC2=NC(=NC3=C2N=CN3C)N4CC(C(C4)F)NC(=O)C=C,CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C,Epidermal growth factor receptor erbB1,91668194,"N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide",C18H22FN9O2,415.4,1.2,115.0,2,9,6,30,,JYIUNVOCEFIUIU-GHMZBOCLSA-N
Mubritinib,CIDs06444692,mubritinib,468.47093,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,Receptor protein-tyrosine kinase erbB-2,6444692,"4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",C25H23F3N4O2,468.5,5.4,66.0,0,8,10,34,,ZTFBIUXIQYRUNT-MDWZMJQESA-N
Tucatinib,CIDs51039094,Irbinitinib,480.52116,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,Receptor protein-tyrosine kinase erbB-2,51039094,"6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine",C26H24N8O2,480.5,4.0,111.0,2,8,6,36,,SDEAXTCZPQIFQM-UHFFFAOYSA-N
Sapitinib,CIDs11488320,Sapitinib,473.927703,CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC,CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor tyrosine-protein kinase erbB-3",11488320,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,C23H25ClFN5O3,473.9,4.0,88.6,2,8,7,33,,DFJSJLGUIXFDJP-UHFFFAOYSA-N
AST-1306,CIDs24739943,AST-1306,448.876723,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2",24739943,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]prop-2-enamide,C24H18ClFN4O2,448.9,5.4,76.1,2,6,7,32,,MVZGYPSXNDCANY-UHFFFAOYSA-N
CH-5183284,CIDs66555680,AGN-PC-0H0OY8,356.38064,CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)N,CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)N,"Fibroblast growth factor receptor 3, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 1",66555680,[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone,C20H16N6O,356.4,3.9,105.0,3,4,3,27,,BEMNJULZEQTDJY-UHFFFAOYSA-N
Erdafitinib,CIDs67462786,AGN-PC-0HG6YB,446.5447,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,Fibroblast growth factor receptor,67462786,"N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine",C25H30N6O2,446.5,3.2,77.3,1,7,9,33,,OLAHOMJCDNXHFI-UHFFFAOYSA-N
Derazantinib,CIDs46834118,SCHEMBL2805038,468.565163,COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F,COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F,Fibroblast growth factor receptor,46834118,"(6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine",C29H29FN4O,468.6,5.3,59.1,2,6,9,35,,KPJDVVCDVBFRMU-AREMUKBSSA-N
Infigratinib,CIDs53235510,NVP-BGJ398,560.47544,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,Fibroblast growth factor receptor,53235510,"3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea",C26H31Cl2N7O3,560.5,4.7,95.1,2,8,8,38,,QADPYRIHXKWUSV-UHFFFAOYSA-N
NVP-FGF-401,CIDs118036971,,0.0,,CN1CCN(C(=O)C1)CC2=C(N=C3C(=C2)CCCN3C(=O)NC4=NC=C(C(=C4)NCCOC)C#N)C=O,Fibroblast growth factor receptor 4,118036971,"N-[5-cyano-4-(2-methoxyethylamino)-2-pyridinyl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide",C25H30N8O4,506.6,0.6,144.0,2,9,8,37,,BHKDKKZMPODMIQ-UHFFFAOYSA-N
Suramin sodium,CIDs00008514,,0.0,,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],Acidic fibroblast growth factor,8514,"hexasodium;8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonatonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonate",C51H34N6Na6O23S6,1429.2,,551.0,6,23,10,92,,VAPNKLKDKUDFHK-UHFFFAOYSA-H
Semaxanib,CIDs05329098,romiplostim,238.28446,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,"Vascular endothelial growth factor receptor, Stem cell growth factor receptor",5329098,"(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one",C15H14N2O,238.28,2.5,44.9,2,1,1,18,,WUWDLXZGHZSWQZ-WQLSENKSSA-N
AST-487,CIDs11409972,NVP-AST487,529.55731,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F,"Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3",11409972,1-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea,C26H30F3N7O2,529.6,3.8,94.7,3,10,8,38,,ODPGGGTTYSGTGO-UHFFFAOYSA-N
GSK-2256098,CIDs46214930,AGN-PC-0A9VW2,414.88862,CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C,CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C,Focal adhesion kinase 1,46214930,2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]-4-pyridinyl]amino]-N-methoxybenzamide,C20H23ClN6O2,414.9,4.5,93.1,3,6,7,29,,BVAHPPKGOOJSPU-UHFFFAOYSA-N
Defactinib,CIDs25117126,Defactinib,510.49275,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,"Focal adhesion kinase 1, Protein tyrosine kinase 2 beta",25117126,N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide,C20H21F3N8O3S,510.5,1.4,150.0,3,13,8,35,,FWLMVFUGMHIOAA-UHFFFAOYSA-N
LY-2090314,CIDs10029385,LY2090314,512.534903,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7,"Glycogen synthase kinase-3 beta, Glycogen synthase kinase-3 alpha",10029385,"3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione",C28H25FN6O3,512.5,2.5,92.0,1,5,2,38,,HRJWTAWVFDCTGO-UHFFFAOYSA-N
Valproic acid sodium salt,CIDs16760703,,0.0,,CCCC(CCC)C(=O)[O-].[Na+],Succinate semialdehyde dehydrogenase,16760703,sodium 2-propylpentanoate,C8H15NaO2,166.19,,40.1,0,2,5,11,,AEQFSUDEHCCHBT-UHFFFAOYSA-M
Tideglusib,CIDs11313622,tideglusib,334.39166,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,Glycogen synthase kinase-3 beta,11313622,"4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione",C19H14N2O2S,334.4,4.3,65.9,0,3,3,24,,PMJIHLSCWIDGMD-UHFFFAOYSA-N
AMG-337,CIDs44181686,SCHEMBL4304600,463.464283,CC(C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=NC=C(C=C5C4=O)OCCOC,CC(C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=C(C4=O)C=C(C=N5)OCCOC,Hepatocyte growth factor receptor,44181686,"6-[(1R)-1-[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one",C23H22FN7O3,463.5,1.5,99.7,0,8,7,34,,DWHXUGDWKAIASB-CQSZACIVSA-N
Savolitinib,CIDs68289010,Savolitinib,345.3613,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,Hepatocyte growth factor receptor,68289010,"3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine",C17H15N9,345.4,1.5,91.6,0,6,3,26,,XYDNMOZJKOGZLS-NSHDSACASA-N
AMG-208,CIDs24864821,AMG-208,383.40268,COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5,COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5,Hepatocyte growth factor receptor,24864821,"7-methoxy-4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline",C22H17N5O2,383.4,3.1,74.4,0,6,5,29,,HEAIZQNMNCHNFD-UHFFFAOYSA-N
Tivantinib,CIDs11494412,tivantinib,369.41586,C1CC2=CC=CC3=C2N(C1)C=C3C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,Hepatocyte growth factor receptor,11494412,"(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione",C23H19N3O2,369.4,2.9,66.9,2,2,2,28,,UCEQXRCJXIVODC-PMACEKPBSA-N
Capmatinib,CIDs25145656,INCB28060,412.419083,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,Hepatocyte growth factor receptor,25145656,"2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide",C23H17FN6O,412.4,2.9,85.1,1,6,4,31,,LIOLIMKSCNQPLV-UHFFFAOYSA-N
MK-8033,CIDs45142457,MK-8033,471.53094,CN1C=C(C=N1)C2=CN=C3C=CC4=C(C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)C(=O)C3=C2,CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)N=C2,"Hepatocyte growth factor receptor, Macrophage-stimulating protein receptor",45142457,"1-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide",C25H21N5O3S,471.5,2.1,115.0,1,7,6,34,,VMJFTOSOFDEKTM-UHFFFAOYSA-N
Altiratinib,CIDs54576299,Altiratinib,510.46455,C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F,C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F,"Hepatocyte growth factor receptor, Tyrosine-protein kinase TIE-2, Neurotrophic tyrosine kinase receptor, Vascular endothelial growth factor receptor 2",54576299,"1-N'-[4-[[2-(cyclopropanecarbonylamino)-4-pyridinyl]oxy]-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",C26H21F3N4O4,510.5,4.3,109.0,3,8,8,37,,GNNDEPIMDAZHRQ-UHFFFAOYSA-N
Brigatinib,CIDs68165256,AGN-PC-0HUR20,584.092422,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,"Epidermal growth factor receptor erbB1, ALK tyrosine kinase receptor",68165256,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine",C29H39ClN7O2P,584.1,4.6,85.9,2,9,8,40,,AILRADAXUVEEIR-UHFFFAOYSA-N
XL-228,CIDs59757974,XL228,437.54124,CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)NC3=NNC(=C3)C4CC4)N5CCN(CC5)C,CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)N3CCN(CC3)C)NC4=NNC(=C4)C5CC5,"Insulin-like growth factor I receptor, SRC, Tyrosine-protein kinase ABL",59757974,"4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine",C22H31N9O,437.5,3.0,111.0,3,9,8,32,,ALKJNCZNEOTEMP-UHFFFAOYSA-N
Entrectinib,CIDs25141092,RXDX-101,560.637466,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,"Proto-oncogene tyrosine-protein kinase ROS, Neurotrophic tyrosine kinase receptor, ALK tyrosine kinase receptor",25141092,"N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",C31H34F2N6O2,560.6,5.7,85.5,3,8,7,41,,HAYYBYPASCDWEQ-UHFFFAOYSA-N
Picropodophyllin,CIDs00072435,picropodophyllin,414.40528,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,Insulin-like growth factor I receptor,72435,"(5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one",C22H22O8,414.4,2.0,92.7,1,8,4,30,,YJGVMLPVUAXIQN-HAEOHBJNSA-N
Cerdulatinib,CIDs44595079,Cerdulatinib,445.53848,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK3, Tyrosine-protein kinase TYK2, Tyrosine-protein kinase SYK",44595079,4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide,C20H27N7O3S,445.5,1.9,142.0,3,9,8,31,,BGLPECHZZQDNCD-UHFFFAOYSA-N
Solcitinib,CIDs44603362,solcitinib,389.45032,CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C,CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C,Tyrosine-protein kinase JAK1,44603362,"N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide",C22H23N5O2,389.4,2.8,79.6,1,4,4,29,,MPYACSQFXVMWNO-UHFFFAOYSA-N
Itacitinib,CIDs53380437,AGN-PC-09S7E5,553.514133,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,Tyrosine-protein kinase JAK1,53380437,"2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile",C26H23F4N9O,553.5,1.6,120.0,1,11,5,40,,KTBSXLIQKWEBRB-UHFFFAOYSA-N
Filgotinib,CIDs49831257,GLPG0634,425.50402,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK3, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase TYK2",49831257,"N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide",C21H23N5O3S,425.5,1.4,105.0,1,6,5,30,,RIJLVEAXPNLDTC-UHFFFAOYSA-N
Gandotinib,CIDs46213929,gandotinib,469.942303,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,Tyrosine-protein kinase JAK2,46213929,"3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine",C23H25ClFN7O,469.9,3.8,83.4,2,7,6,33,,SQSZANZGUXWJEA-UHFFFAOYSA-N
BMS-911543,CIDs50922691,BMS-911543,432.52142,CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6,CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6,Tyrosine-protein kinase JAK2,50922691,"N,N-dicyclopropyl-7-[(1,5-dimethylpyrazol-3-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaene-11-carboxamide",C23H28N8O,432.5,2.9,85.8,1,5,6,32,,JCINBYQJBYJGDM-UHFFFAOYSA-N
Baricitinib,CIDs44205240,baricitinib,371.41688,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2",44205240,"2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile",C16H17N7O2S,371.4,-0.5,129.0,1,7,5,26,,XUZMWHLSFXCVMG-UHFFFAOYSA-N
Decernotinib,CIDs59422203,decernotinib,392.37827,CCC(C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3,CCC(C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3,Tyrosine-protein kinase JAK3,59422203,"(2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide",C18H19F3N6O,392.4,3.1,95.6,3,8,6,28,,ASUGUQWIHMTFJL-QGZVFWFLSA-N
PF-06651600,CIDs118115473,,0.0,,CC1CCC(CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3,"Tyrosine-protein kinase JAK3, TEC family kinase",118115473,"1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one",C15H19N5O,285.34,2.1,73.9,2,4,3,21,,CBRJPFGIXUFMTM-WDEREUQCSA-N
Olmutinib,CIDs54758501,AGN-PC-0AC0Q9,486.58864,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,Epidermal growth factor receptor erbB1,54758501,"N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide",C26H26N6O2S,486.6,4.7,111.0,2,8,7,35,,FDMQDKQUTRLUBU-UHFFFAOYSA-N
CC-401,CIDs10430360,cc-401,388.46556,C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5,C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5,"c-Jun N-terminal kinase 2, c-Jun N-terminal kinase 1, c-Jun N-terminal kinase 3",10430360,"3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole",C22H24N6O,388.5,3.8,82.7,2,5,6,29,,XDJCLCLBSGGNKS-UHFFFAOYSA-N
AS-602801,CIDs10195250,bentamapimod,457.54742,C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4,C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4,"c-Jun N-terminal kinase, JNK",10195250,"2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile",C25H23N5O2S,457.5,3.3,112.0,0,8,7,33,,XCPPIJCBCWUBNT-UHFFFAOYSA-N
Tolimidone,CIDs00039065,Tolimidone,202.2093,CC1=CC(=CC=C1)OC2=CNC(=O)N=C2,CC1=CC(=CC=C1)OC2=CNC(=O)N=C2,Tyrosine-protein kinase Lyn,39065,5-(3-methylphenoxy)-1H-pyrimidin-2-one,C11H10N2O2,202.21,1.4,50.7,1,2,2,15,,HJQILFPVRNHTIG-UHFFFAOYSA-N
Merestinib,CIDs44603533,LY2801653,552.530886,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,Hepatocyte growth factor receptor,44603533,N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide,C30H22F2N6O3,552.5,4.7,105.0,2,7,6,41,,QHADVLVFMKEIIP-UHFFFAOYSA-N
ARRY-162,CIDs10288191,binimetinib,441.226806,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",10288191,6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide,C17H15BrF2N4O3,441.2,3.1,88.4,3,7,6,27,,ACWZRVQXLIRSDF-UHFFFAOYSA-N
Pimasertib,CIDs44187362,pimasertib,431.200773,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",44187362,"N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide",C15H15FIN3O3,431.2,1.7,94.5,4,6,6,23,,VIUAUNHCRHHYNE-JTQLQIEISA-N
PD-184352,CIDs06918454,Ci-1040,478.659536,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",6918454,"2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide",C17H14ClF2IN2O2,478.7,5.6,50.4,2,5,6,25,,GFMMXOIFOQCCGU-UHFFFAOYSA-N
Cobimetinib,CIDs16222096,cobimetinib,531.31002,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",16222096,"[3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone",C21H21F3IN3O2,531.3,3.9,64.6,3,7,4,30,,BSMCAPRUBJMWDF-KRWDZBQOSA-N
RO-4987655,CIDs11548630,RO4987655,565.28164,C1CC(=O)N(OC1)CC2=C(C(=C(C(=C2)C(=O)NOCCO)NC3=C(C=C(C=C3)I)F)F)F,C1CC(=O)N(OC1)CC2=CC(=C(C(=C2F)F)NC3=C(C=C(C=C3)I)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",11548630,"3,4-difluoro-2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-5-[(3-oxooxazinan-2-yl)methyl]benzamide",C20H19F3IN3O5,565.3,3.0,100.0,3,9,8,32,,FIMYFEGKMOCQKT-UHFFFAOYSA-N
AZD-8330,CIDs16666708,ARRY 704,461.226753,CC1=CC(=C(N(C1=O)C)NC2=C(C=C(C=C2)I)F)C(=O)NOCCO,CC1=CC(=C(N(C1=O)C)NC2=C(C=C(C=C2)I)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",16666708,"2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide",C16H17FIN3O4,461.23,2.2,90.9,3,6,6,25,,RWEVIPRMPFNTLO-UHFFFAOYSA-N
Ravoxertinib,CIDs71727581,GDC-0994,440.858023,CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)C(CO)C4=CC(=C(C=C4)Cl)F,CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)C(CO)C4=CC(=C(C=C4)Cl)F,"MAP kinase ERK1, MAP kinase ERK2",71727581,1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one,C21H18ClFN6O2,440.9,2.0,96.2,2,7,6,31,,RZUOCXOYPYGSKL-GOSISDBHSA-N
Ulixertinib,CIDs11719003,VRT752271,433.33098,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,"MAP kinase ERK1, MAP kinase ERK2",11719003,N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)-4-pyridinyl]-1H-pyrrole-2-carboxamide,C21H22Cl2N4O2,433.3,4.1,90.0,4,4,7,29,,KSERXGMCDHOLSS-LJQANCHMSA-N
LY-3214996,CIDs121408882,,0.0,,CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C,Mitogen-activated protein kinase; ERK1/ERK2,121408882,"6,6-dimethyl-2-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5-(2-morpholin-4-ylethyl)thieno[2,3-c]pyrrol-4-one",C22H27N7O2S,453.6,1.4,117.0,1,8,6,32,,JNPRPMBJODOFEC-UHFFFAOYSA-N
CC-223,CIDs58298316,AGN-PC-0CBJ2I,397.47078,CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O,CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O,Serine/threonine-protein kinase mTOR,58298316,"3-[6-(2-hydroxypropan-2-yl)-3-pyridinyl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one",C21H27N5O3,397.5,1.1,100.0,2,7,4,29,,UFKLYTOEMRFKAD-UHFFFAOYSA-N
Temsirolimus,CIDs06918289,temsirolimus,1030.28708,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,FK506-binding protein 1A,6918289,"[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate",C56H87NO16,1030.3,5.6,242.0,4,16,11,73,,CBPNZQVSJQDFBE-FUXHJELOSA-N
Ridaforolimus,CIDs11520894,ridaforolimus,990.206122,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,Serine/threonine-protein kinase mTOR,11520894,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",C53H84NO14P,990.2,5.9,202.0,2,14,8,69,,BUROJSBIWGDYCN-GAUTUEMISA-N
INK-128,CIDs45375953,INK-128,309.3259,CC(C)N1C2=C(C(=N1)C3=CC4=C(C=C3)OC(=N4)N)C(=NC=N2)N,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,Serine/threonine-protein kinase mTOR,45375953,"5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine",C15H15N7O,309.33,1.7,122.0,2,7,2,23,,GYLDXIAOMVERTK-UHFFFAOYSA-N
Vistusertib,CIDs25262792,AZD2014,462.5441,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,Serine/threonine-protein kinase mTOR,25262792,"3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide",C25H30N6O3,462.5,2.8,92.7,1,8,4,34,,JUSFANSTBFGBAF-IRXDYDNUSA-N
Voxtalisib,CIDs16123056,SAR245409,270.28986,CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N,CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N,"Serine/threonine-protein kinase mTOR, PI3-kinase class I",16123056,"2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one",C13H14N6O,270.29,0.5,101.0,2,5,2,20,,RGHYDLZMTYDBDT-UHFFFAOYSA-N
eFT508,CIDs118598754,,0.0,,CC1=C2C(=O)NC3(N2C(=O)C(=C1)NC4=NC=NC(=C4)N)CCCCC3,MAP kinase-interacting serine/threonine-protein kinase 1/2,118598754,"6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione",C17H20N6O2,340.4,1.3,113.0,3,6,2,25,,HKTBYUWLRDZAJK-UHFFFAOYSA-N
Iguratimod,CIDs00124246,iguratimod,374.36786,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,"E3 ubiquitin ligase TRAF3IP2, Macrophage migration inhibitory factor, Cyclooxygenase-2",124246,N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide,C17H14N2O6S,374.4,1.4,119.0,2,7,5,26,,ANMATWQYLIFGOK-UHFFFAOYSA-N
Capsaicin,CIDs01548943,capsaicin,305.41188,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,Vanilloid receptor,1548943,(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide,C18H27NO3,305.4,3.6,58.6,2,3,9,22,,YKPUWZUDDOIDPM-SOFGYWHQSA-N
Erythromycin,CIDs00012560,erythromycin,733.92678,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Bacterial 70S ribosome,12560,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",C37H67NO13,733.9,2.7,194.0,5,14,7,51,,ULGZDMOVFRHVEP-RWJQBGPGSA-N
Dimethyl fumarate,CIDs00637568,dimethyl fumarate,144.12532,COC(=O)C=CC(=O)OC,COC(=O)C=CC(=O)OC,Kelch-like ECH-associated protein 1,637568,dimethyl (E)-but-2-enedioate,C6H8O4,144.12,0.7,52.6,0,4,4,10,,LDCRTTXIJACKKU-ONEGZZNKSA-N
PF-3758309,CIDs25227462,PF-3758309,490.6237,CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)NC(CN(C)C)C5=CC=CC=C5)SC=C2,CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)NC(CN(C)C)C5=CC=CC=C5)SC=C2,Serine/threonine-protein kinase PAK 4,25227462,"N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-d]pyrazole-5-carboxamide",C25H30N8OS,490.6,3.1,130.0,3,7,6,35,,AYCPARAPKDAOEN-LJQANCHMSA-N
SD-06,CIDs09865587,SD-06,397.8581,C1CN(CCC1C2=C(C(=NN2)C3=CC=C(C=C3)Cl)C4=NC=NC=C4)C(=O)CO,C1CN(CCC1C2=C(C(=NN2)C3=CC=C(C=C3)Cl)C4=NC=NC=C4)C(=O)CO,MAP kinase p38 alpha,9865587,1-[4-[3-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-5-yl]piperidin-1-yl]-2-hydroxyethanone,C20H20ClN5O2,397.9,1.9,95.0,2,5,4,28,,CATQHDWESBRRQA-UHFFFAOYSA-N
TAK-715,CIDs09952773,Tak-715,399.50804,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC(=C4)C,MAP kinase p38 alpha,9952773,"N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridinyl]benzamide",C24H21N3OS,399.5,5.6,83.1,1,4,5,29,,HEKAIDKUDLCBRU-UHFFFAOYSA-N
AMG-548,CIDs11167112,AMG-548,461.55758,CN1C(=O)C(=C(N=C1NCC(CC2=CC=CC=C2)N)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4,CN1C(=O)C(=C(N=C1NCC(CC2=CC=CC=C2)N)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4,MAP kinase p38 alpha,11167112,2-[[(2S)-2-amino-3-phenylpropyl]amino]-3-methyl-5-naphthalen-2-yl-6-pyridin-4-ylpyrimidin-4-one,C29H27N5O,461.6,3.8,83.6,2,4,7,35,,RQVKVJIRFKVPBF-VWLOTQADSA-N
Losmapimod,CIDs11552706,losmapimod,383.459143,CC1=C(C=C(C=C1C2=NC=C(C=C2)C(=O)NCC(C)(C)C)C(=O)NC3CC3)F,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,"MAP kinase p38 beta, MAP kinase p38 alpha",11552706,"6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide",C22H26FN3O2,383.5,3.8,71.1,2,4,6,28,,KKYABQBFGDZVNQ-UHFFFAOYSA-N
Pexmetinib,CIDs24765037,ARRY-614,556.630523,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO,"Tyrosine-protein kinase TIE-2, MAP kinase p38 alpha",24765037,1-[3-tert-butyl-1-(4-methylphenyl)pyrazol-5-yl]-3-[[5-fluoro-2-[1-(2-hydroxyethyl)indazol-5-yl]oxyphenyl]methyl]urea,C31H33FN6O3,556.6,5.3,106.0,3,6,9,41,,LNMRSSIMGCDUTP-UHFFFAOYSA-N
BMS-582949,CIDs10409068,3Z6GAP3R9Q,406.48084,CCCNC(=O)C1=CN2C(=C1C)C(=NC=N2)NC3=C(C=CC(=C3)C(=O)NC4CC4)C,CCCNC(=O)C1=CN2C(=C1C)C(=NC=N2)NC3=C(C=CC(=C3)C(=O)NC4CC4)C,MAP kinase p38 alpha,10409068,"4-[5-(cyclopropylcarbamoyl)-2-methylanilino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",C22H26N6O2,406.5,3.0,100.0,3,5,7,30,,GDTQLZHHDRRBEB-UHFFFAOYSA-N
Crenolanib,CIDs10366136,crenolanib,443.54076,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,"Platelet-derived growth factor receptor, Tyrosine-protein kinase receptor FLT3",10366136,1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine,C26H29N5O2,443.5,3.7,78.4,1,6,5,33,,DYNHJHQFHQTFTP-UHFFFAOYSA-N
TAK-593,CIDs24767976,TAK-593,445.47382,CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C,CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C,"Platelet-derived growth factor receptor, Vascular endothelial growth factor receptor",24767976,"N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide",C23H23N7O3,445.5,2.4,115.0,2,6,6,33,,DZFZXPPHBWCXPQ-UHFFFAOYSA-N
DCC-2618,CIDs71584930,AGN-PC-0JHIDR,510.358243,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,"Stem cell growth factor receptor, Platelet-derived growth factor receptor alpha",71584930,"1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea",C24H21BrFN5O2,510.4,4.1,86.4,3,5,5,33,,CEFJVGZHQAGLHS-UHFFFAOYSA-N
OSU-03012,CIDs10027278,OSU-03012,460.45047,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,3-phosphoinositide dependent protein kinase-1,10027278,2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide,C26H19F3N4O,460.4,5.2,72.9,2,6,4,34,,YULUCECVQOCQFQ-UHFFFAOYSA-N
Serabelisib,CIDs70798655,AGN-PC-0JHA5V,363.36998,C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N,C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N,PI3-kinase p110-alpha subunit,70798655,"[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone",C19H17N5O3,363.4,2.3,98.9,1,6,2,27,,BLGWHBSBBJNKJO-UHFFFAOYSA-N
Gedatolisib,CIDs44516953,PKI-587,615.72584,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,"Serine/threonine-protein kinase mTOR, PI3-kinase class I",44516953,"1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea",C32H41N9O4,615.7,2.4,128.0,2,10,7,45,,DWZAEMINVBZMHQ-UHFFFAOYSA-N
Seletalisib,CIDs56928390,64CW205BDD,482.84507,C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5,C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5,PI3-kinase p110-delta subunit,56928390,"N-[(1R)-1-[8-chloro-2-(1-oxidopyridin-1-ium-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl]pyrido[3,2-d]pyrimidin-4-amine",C23H14ClF3N6O,482.8,4.0,89.1,1,9,4,34,,LNLJHGXOFYUARS-OAQYLSRUSA-N
Alpelisib,CIDs56649450,NVP-BYL719,441.47049,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PI3-kinase p110-alpha subunit,56649450,"(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide",C19H22F3N5O2S,441.5,3.2,129.0,2,8,4,30,,STUWGJZDJHPWGZ-LBPRGKRZSA-N
Copanlisib,CIDs135565596,,0.0,,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,"PI3-kinase p110-delta subunit, PI3-kinase p110-alpha subunit",135565596,"2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide",C23H28N8O4,480.5,0.3,140.0,2,9,7,35,,MWYDSXOGIBMAET-UHFFFAOYSA-N
Tenalisib,CIDs86291103,3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromone,415.419723,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit",86291103,3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromen-4-one,C23H18FN5O2,415.4,4.2,92.8,2,7,5,31,,HDXDQPRPFRKGKZ-INIZCTEOSA-N
IPI-549,CIDs91933883,,0.0,,CC(C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5N,PI3-kinase p110-gamma subunit,91933883,"2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide",C30H24N8O2,528.6,3.2,123.0,2,6,6,40,,XUMALORDVCFWKV-IBGZPJMESA-N
LY-3023414,CIDs57519748,SCHEMBL10322619,406.47754,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC,"Serine/threonine-protein kinase mTOR, PI3-kinase class I",57519748,"8-[5-(2-hydroxypropan-2-yl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one",C23H26N4O3,406.5,1.7,78.8,1,5,5,30,,ACCFLVVUVBJNGT-AWEZNQCLSA-N
ZSTK-474,CIDs11647372,ZSTK474,417.412546,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5,PI3-kinase class I,11647372,"4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine",C19H21F2N7O2,417.4,2.3,81.4,0,10,4,30,,HGVNLRPZOWWDKD-UHFFFAOYSA-N
XL-147,CIDs56599306,pilaralisib,541.0218,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,PI3-kinase class I,56599306,2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide,C25H25ClN6O4S,541.0,3.4,157.0,4,9,8,37,,QINPEPAQOBZPOF-UHFFFAOYSA-N
TG-100115,CIDs10427712,TG100-115,346.34276,C1=CC(=CC(=C1)O)C2=NC3=C(N=C2C4=CC(=CC=C4)O)N=C(N=C3N)N,C1=CC(=CC(=C1)O)C2=NC3=C(N=C(N=C3N=C2C4=CC(=CC=C4)O)N)N,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit",10427712,"3-[2,4-diamino-7-(3-hydroxyphenyl)pteridin-6-yl]phenol",C18H14N6O2,346.3,1.7,144.0,4,8,2,26,,UJIAQDJKSXQLIT-UHFFFAOYSA-N
GDC-0084,CIDs57384863,AGN-PC-0BTCQD,382.41968,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,PI3-kinase class I,57384863,"5-(6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyrimidin-2-amine",C18H22N8O2,382.4,-0.3,117.0,1,9,2,28,,LGWACEZVCMBSKW-UHFFFAOYSA-N
CUDC-907,CIDs54575456,CUDC-907,508.55286,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,"PI3-kinase p110-delta subunit, PI3-kinase p110-beta subunit, Histone deacetylase, PI3-kinase p110-alpha subunit",54575456,"N-hydroxy-2-[[2-(6-methoxy-3-pyridinyl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide",C23H24N8O4S,508.6,1.3,167.0,2,12,7,36,,JOWXJLIFIIOYMS-UHFFFAOYSA-N
PX-866,CIDs09849735,Px-866,525.5901,CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN(CC=C)CC=C)C4=C(C3=O)O)COC)C)C,CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN(CC=C)CC=C)C4=C(C3=O)O)COC)C)C,PI3-kinase class I,9849735,"[(3aR,6E,9S,9aR,10R,11aS)-6-[[bis(prop-2-enyl)amino]methylidene]-5-hydroxy-9-(methoxymethyl)-9a,11a-dimethyl-1,4,7-trioxo-2,3,3a,9,10,11-hexahydroindeno[4,5-h]isochromen-10-yl] acetate",C29H35NO8,525.6,1.7,119.0,1,9,9,38,,QIUASFSNWYMDFS-NILGECQDSA-N
AZD-8186,CIDs52913813,SCHEMBL1636956,457.469806,CC(C1=C2C(=CC(=C1)C(=O)N(C)C)C(=O)C=C(O2)N3CCOCC3)NC4=CC(=CC(=C4)F)F,CC(C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F,"PI3-kinase p110-delta subunit, PI3-kinase p110-beta subunit",52913813,"8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide",C24H25F2N3O4,457.5,3.0,71.1,1,8,5,33,,LMJFJIDLEAWOQJ-CQSZACIVSA-N
GDC-0077,CIDs124173720,,0.0,,CC(C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4C(COC4=O)C(F)F,PI3-kinase p110-alpha subunit,124173720,"(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide",C18H19F2N5O4,407.4,1.5,112.0,2,8,5,29,,SGEUNORSOZVTOL-CABZTGNLSA-N
GSK-615,CIDs23582824,GSK1059615,333.36384,C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4,C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4,PI3-kinase class I,23582824,"(5Z)-5-[(4-pyridin-4-ylquinolin-6-yl)methylidene]-1,3-thiazolidine-2,4-dione",C18H11N3O2S,333.4,3.0,97.3,1,5,2,24,,QDITZBLZQQZVEE-YBEGLDIGSA-N
Pilaralisib,CIDs56599306,pilaralisib,541.0218,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,PI3-kinase class I,56599306,2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide,C25H25ClN6O4S,541.0,3.4,157.0,4,9,8,37,,QINPEPAQOBZPOF-UHFFFAOYSA-N
CH-5132799,CIDs49784945,CH5132799,377.42146,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,PI3-kinase class I,49784945,"5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine",C15H19N7O3S,377.4,-0.6,136.0,1,10,3,26,,JEGHXKRHKHPBJD-UHFFFAOYSA-N
GSK-2636771,CIDs56949517,GSK2636771,433.42359,CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C2C=C(C=C3C(=O)O)N4CCOCC4)C,CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C(C=C(C=C32)N4CCOCC4)C(=O)O)C,PI3-kinase p110-beta subunit,56949517,2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid,C22H22F3N3O3,433.4,4.0,67.6,1,8,4,31,,XTKLTGBKIDQGQL-UHFFFAOYSA-N
Duvelisib,CIDs50905713,IPI-145,416.86298,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit",50905713,8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one,C22H17ClN6O,416.9,4.1,86.8,2,5,4,30,,SJVQHLPISAIATJ-ZDUSSCGKSA-N
Acalisib,CIDs11618268,Acalisib,401.396443,CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit,11618268,6-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinazolin-4-one,C21H16FN7O,401.4,3.2,99.2,2,7,4,30,,DOCINCLJNAXZQF-LBPRGKRZSA-N
AMG-319,CIDs68947304,3VC,385.397043,CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5,CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit,68947304,N-[(1S)-1-(7-fluoro-2-pyridin-2-ylquinolin-3-yl)ethyl]-7H-purin-6-amine,C21H16FN7,385.4,3.3,92.3,2,7,4,29,,KWRYMZHCQIOOEB-LBPRGKRZSA-N
LGH-447,CIDs44814409,SCHEMBL3215332,440.46083,CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F,CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F,Serine/threonine-protein kinase PIM,44814409,"N-[4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]-3-pyridinyl]-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide",C24H23F3N4O,440.5,3.9,80.9,2,7,4,32,,VRQXRVAKPDCRCI-ZNMIVQPWSA-N
GDC-0349,CIDs59239165,GDC-0349,452.54928,CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C,CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C,Serine/threonine-protein kinase mTOR,59239165,"1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea",C24H32N6O3,452.5,1.4,91.9,2,7,5,33,,RGJOJUGRHPQXGF-INIZCTEOSA-N
TAK-960,CIDs53357478,yl)benzamide,561.59917,CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC,CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC,Serine/threonine-protein kinase PLK1,53357478,"4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide",C27H34F3N7O3,561.6,3.6,103.0,2,11,6,40,,GWRSATNRNFYMDI-UHFFFAOYSA-N
Briciclib,CIDs11248490,Briciclib,474.418682,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O,G1/S-specific cyclin D1,11248490,"[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl] dihydrogen phosphate",C19H23O10PS,474.4,1.3,146.0,2,10,10,31,,LXENKEWVEVKKGV-BQYQJAHWSA-N
IVX-214,CIDs09888590,HMN-214,424.4696,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,Serine/threonine-protein kinase PLK1,9888590,N-(4-methoxyphenyl)sulfonyl-N-[2-[(E)-2-(1-oxidopyridin-1-ium-4-yl)ethenyl]phenyl]acetamide,C22H20N2O5S,424.5,2.6,97.5,0,5,6,30,,OCKHRKSTDPOHEN-BQYQJAHWSA-N
NMS-P937,CIDs49792852,NMS-P937,532.51819,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,Serine/threonine-protein kinase PLK1,49792852,"1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,5-h]quinazoline-3-carboxamide",C24H27F3N8O3,532.5,2.0,135.0,3,12,7,38,,QHLVBNKYJGBCQJ-UHFFFAOYSA-N
PLX-8394,CIDs90116675,SCHEMBL15666953,542.53285,C1CC1C2=NC=C(C=N2)C3=CN=C4C(=C3)C(=CN4)C(=O)C5=C(C=CC(=C5F)NS(=O)(=O)N6CCC(C6)F)F,C1CC1C2=NC=C(C=N2)C3=CC4=C(NC=C4C(=O)C5=C(C=CC(=C5F)NS(=O)(=O)N6CCC(C6)F)F)N=C3,Serine/threonine-protein kinase B-raf,90116675,"(3R)-N-[3-[5-(2-cyclopropylpyrimidin-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]-3-fluoropyrrolidine-1-sulfonamide",C25H21F3N6O3S,542.5,2.8,129.0,2,11,7,38,,YYACLQUDUDXAPA-MRXNPFEDSA-N
RO-5126766,CIDs16719221,CHEBI:78825,471.461523,CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F,CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2",16719221,3-[[3-fluoro-2-(methylsulfamoylamino)-4-pyridinyl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one,C21H18FN5O5S,471.5,2.0,141.0,2,11,7,33,,LMMJFBMMJUMSJS-UHFFFAOYSA-N
RAF-265 derivative,CIDs11656518,CHIR-265,518.413859,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase B-raf",11656518,1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine,C24H16F6N6O,518.4,5.4,80.7,2,11,5,37,,YABJJWZLRMPFSI-UHFFFAOYSA-N
MLN-2480,CIDs25161177,MLN 2480,506.28909,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,RAF serine/threonine protein kinase,25161177,"2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)-2-pyridinyl]-1,3-thiazole-5-carboxamide",C17H12Cl2F3N7O2S,506.3,3.0,164.0,3,11,5,32,,VWMJHAFYPMOMGF-ZCFIWIBFSA-N
LY-3009120,CIDs71721540,DP-4978,424.514363,CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F,CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F,"Serine/threonine-protein kinase RAF, Serine/threonine-protein kinase A-Raf, Serine/threonine-protein kinase B-raf",71721540,"1-(3,3-dimethylbutyl)-3-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea",C23H29FN6O,424.5,4.7,91.8,3,6,6,31,,HHCBMISMPSAZBF-UHFFFAOYSA-N
Encorafenib,CIDs50922675,encorafenib,540.010683,CC(C)N1C=C(C(=N1)C2=CC(=CC(=C2F)NS(=O)(=O)C)Cl)C3=NC(=NC=C3)NCC(C)NC(=O)OC,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,Serine/threonine-protein kinase B-raf,50922675,methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate,C22H27ClFN7O4S,540.0,2.7,149.0,3,10,10,36,,CMJCXYNUCSMDBY-ZDUSSCGKSA-N
LY-2584702,CIDs25118925,LY2584702 tosylate,445.416073,CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,Ribosomal protein S6 kinase 1,25118925,"4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[5,4-d]pyrimidine",C21H19F4N7,445.4,3.6,75.5,1,9,3,32,,FYXRSVDHGLUMHB-UHFFFAOYSA-N
GSK-2982772,CIDs77108121,SCHEMBL15956219,377.39656,CN1C2=CC=CC=C2OCC(C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4,CN1C2=CC=CC=C2OCC(C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4,Receptor-interacting serine/threonine-protein kinase 1,77108121,"5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide",C20H19N5O3,377.4,2.4,100.0,2,5,4,28,,LYPAFUINURXJSG-AWEZNQCLSA-N
KD-025,CIDs11950170,KD-025,452.50776,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,Rho-associated protein kinase 2,11950170,2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide,C26H24N6O2,452.5,4.8,105.0,3,6,7,34,,GKHIVNAUVKXIIY-UHFFFAOYSA-N
Y-39983,CIDs09810884,Y-39983,280.32444,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N,Rho-associated protein kinase,9810884,"4-[(1R)-1-aminoethyl]-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide",C16H16N4O,280.32,1.4,83.8,3,3,3,21,,JTVBXQAYBIJXRP-SNVBAGLBSA-N
Ripasudil,CIDs09863672,,0.0,,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F,Rho-associated protein kinase,9863672,"4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline",C15H18FN3O2S,323.4,1.5,70.7,1,6,2,22,,QSKQVZWVLOIIEV-NSHDSACASA-N
ABC-294640,CIDs15604015,ABC294640,380.9104,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,Sphingosine kinase 2,15604015,3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,C23H25ClN2O,380.9,4.7,42.0,1,2,4,27,,CAOTVXGYTWCKQE-UHFFFAOYSA-N
M-475271,CIDs05330175,Methoxy Aniline 7,442.93848,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=CC(=C4)OC)Cl)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=CC(=C4)OC)Cl)OC,"Tyrosine-protein kinase ABL, Tyrosine-protein kinase SRC",5330175,N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine,C23H27ClN4O3,442.9,4.7,68.7,1,7,7,31,,WPOXAFXHRJYEIC-UHFFFAOYSA-N
TG-100801,CIDs11973736,TG 100801,580.076,CC1=C2C(=CC(=C1)C3=C(C=CC(=C3)OC(=O)C4=CC=CC=C4)Cl)N=NC(=N2)NC5=CC=C(C=C5)OCCN6CCCC6,CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCCN4CCCC4)C5=C(C=CC(=C5)OC(=O)C6=CC=CC=C6)Cl,"Platelet-derived growth factor receptor beta, SRC, Fibroblast growth factor receptor 1, Vascular endothelial growth factor receptor 2, Vascular endothelial growth factor receptor 1, Ephrin type-B receptor 4, Fibroblast growth factor receptor 2",11973736,"[4-chloro-3-[5-methyl-3-[4-(2-pyrrolidin-1-ylethoxy)anilino]-1,2,4-benzotriazin-7-yl]phenyl] benzoate",C33H30ClN5O3,580.1,7.0,89.5,1,8,10,42,,JMGXJHWTVBGOKG-UHFFFAOYSA-N
KX-01,CIDs23635314,KX2-391,431.52676,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,Tyrosine-protein kinase SRC,23635314,N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]-2-pyridinyl]acetamide,C26H29N3O3,431.5,2.9,63.7,1,5,9,32,,HUNGUWOZPQBXGX-UHFFFAOYSA-N
Entospletinib,CIDs59473233,entospletinib,411.45914,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,Tyrosine-protein kinase SYK,59473233,"6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine",C23H21N7O,411.5,3.6,83.4,2,6,4,31,,XSMSNFMDVXXHGJ-UHFFFAOYSA-N
Galunisertib,CIDs10090485,galunisertib,369.41916,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,TGF-beta receptor type I,10090485,"4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide",C22H19N5O,369.4,2.4,86.7,1,4,3,28,,IVRXNBXKWIJUQB-UHFFFAOYSA-N
Larotrectinib,CIDs46188928,"US8865698, 14",428.435186,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,Neurotrophic tyrosine kinase receptor,46188928,"(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide",C21H22F2N6O2,428.4,1.7,86.0,2,7,3,31,,NYNZQNWKBKUAII-KBXCAEBGSA-N
Sunitinib malate,CIDs06456015,sunitinib malate,532.561223,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,"Stem cell growth factor receptor, Tyrosine-protein kinase receptor RET, Platelet-derived growth factor receptor, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor",6456015,"N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid",C26H33FN4O7,532.6,,172.0,6,9,10,38,,LBWFXVZLPYTWQI-IPOVEDGCSA-N
Fruquintinib,CIDs44480399,AGN-PC-076MKL,393.39266,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,Vascular endothelial growth factor receptor,44480399,"6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide",C21H19N3O5,393.4,3.4,95.7,1,7,5,29,,BALLNEJQLSTPIO-UHFFFAOYSA-N
Glesatinib,CIDs25181472,AGN-PC-04XEQ8,619.704586,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=C(C=C5)F)F,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=C(C=C5)F)F,"Macrophage-stimulating protein receptor, Tyrosine-protein kinase TIE-2, Vascular endothelial growth factor receptor, Hepatocyte growth factor receptor",25181472,"N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide",C31H27F2N5O3S2,619.7,5.1,158.0,3,10,11,43,,YRCHYHRCBXNYNU-UHFFFAOYSA-N
BFH-772,CIDs24756034,AGN-PC-0H2ZNQ,439.38665,C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC=NC(=C4)CO)C(F)(F)F,C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC=NC(=C4)CO)C(F)(F)F,Vascular endothelial growth factor receptor 2,24756034,6-[6-(hydroxymethyl)pyrimidin-4-yl]oxy-N-[3-(trifluoromethyl)phenyl]naphthalene-1-carboxamide,C23H16F3N3O3,439.4,4.2,84.3,2,8,5,32,,JNLSTLQFDDAULK-UHFFFAOYSA-N
Sulfatinib,CIDs52920501,AGN-PC-09LPDY,480.58252,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,"Fibroblast growth factor receptor 1, Vascular endothelial growth factor receptor",52920501,N-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide,C24H28N6O3S,480.6,3.4,121.0,3,8,10,34,,TTZSNFLLYPYKIL-UHFFFAOYSA-N
Golvatinib,CIDs16118392,golvatinib,633.688186,CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,"Vascular endothelial growth factor receptor 2, Hepatocyte growth factor receptor",16118392,"1-N'-[2-fluoro-4-[[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]-4-pyridinyl]oxy]phenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",C33H37F2N7O4,633.7,4.1,119.0,3,9,8,46,,UQRCJCNVNUFYDX-UHFFFAOYSA-N
SU-014813,CIDs10138259,SU14813,442.483283,CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O,CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor, Vascular endothelial growth factor receptor",10138259,"5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide",C23H27FN4O4,442.5,0.9,107.0,4,6,6,32,,CTNPALGJUAXMMC-PMFHANACSA-N
AG-13958,CIDs09934283,RS0092,467.497583,CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C,CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C,Vascular endothelial growth factor receptor,9934283,"N-[2-fluoro-5-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]amino]phenyl]-2,5-dimethylpyrazole-3-carboxamide",C26H22FN7O,467.5,4.3,101.0,3,6,6,35,,JXSVVZKPEDIRTN-DHZHZOJOSA-N
Orantinib,CIDs05329099,orantinib,310.34712,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,"Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor, Fibroblast growth factor receptor",5329099,"3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid",C18H18N2O3,310.3,2.2,82.2,3,3,4,23,,NHFDRBXTEDBWCZ-ZROIWOOFSA-N
KRN-633,CIDs09549295,KRN-633,416.85814,CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl,CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl,Vascular endothelial growth factor receptor,9549295,"1-[2-chloro-4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-3-propylurea",C20H21ClN4O4,416.9,3.9,94.6,2,6,7,29,,VPBYZLCHOKSGRX-UHFFFAOYSA-N
Anlotinib,CIDs25017411,AGN-PC-0BT9LA,407.437483,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,"Vascular endothelial growth factor receptor 2, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Vascular endothelial growth factor receptor 3",25017411,1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine,C23H22FN3O3,407.4,3.7,82.4,2,6,6,30,,KSMZEXLVHXZPEF-UHFFFAOYSA-N
BMS-690514,CIDs11349170,BMS-690514,368.43286,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N,"Receptor protein-tyrosine kinase erbB-4, Vascular endothelial growth factor receptor, Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2",11349170,"(3R,4R)-4-amino-1-[[4-(3-methoxyanilino)pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol",C19H24N6O2,368.4,0.7,101.0,3,7,5,27,,CSGQVNMSRKWUSH-IAGOWNOFSA-N
Abexinostat,CIDs11749858,Abexinostat,397.42442,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,Histone deacetylase,11749858,3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide,C21H23N3O5,397.4,2.2,104.0,3,6,8,29,,MAUCONCHVWBMHK-UHFFFAOYSA-N
Quisinostat,CIDs11538455,quisinostat,394.47014,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,Histone deacetylase,11538455,N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide,C21H26N6O2,394.5,1.3,95.3,3,6,6,29,,PAWIYAYFNXQGAP-UHFFFAOYSA-N
Tacedinaline,CIDs00002746,acetyldinaline,269.2985,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N,Histone deacetylase,2746,4-acetamido-N-(2-aminophenyl)benzamide,C15H15N3O2,269.3,1.3,84.2,3,3,3,20,,VAZAPHZUAVEOMC-UHFFFAOYSA-N
ACY-1215,CIDs53340666,ricolinostat,433.50288,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,Histone deacetylase 6,53340666,N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide,C24H27N5O3,433.5,3.4,107.0,3,6,11,32,,QGZYDVAGYRLSKP-UHFFFAOYSA-N
SRT-2104,CIDs25108829,sirtuin modulator,516.63776,CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6,CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6,NAD-dependent deacetylase sirtuin 1,25108829,"4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide",C26H24N6O2S2,516.6,4.2,141.0,1,8,6,36,,LAMQVIQMVKWXOC-UHFFFAOYSA-N
GSK-126,CIDs68210102,EZH2 inhibitor,526.67242,CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C,CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C,Histone-lysine N-methyltransferase EZH2,68210102,"1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-yl-3-pyridinyl)indole-4-carboxamide",C31H38N6O2,526.7,3.9,91.3,3,5,7,39,,FKSFKBQGSFSOSM-QFIPXVFZSA-N
GSK-3326595,CIDs90241742,SCHEMBL15826074,452.54928,CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O,CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O,Protein arginine N-methyltransferase 5,90241742,"6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide",C24H32N6O3,452.5,1.1,111.0,3,7,7,33,,JLCCNYVTIWRPIZ-NRFANRHFSA-N
Birabresib,CIDs09936746,,0.0,,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,Bromodomain and extra-terminal motif (BET),9936746,"2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-(4-hydroxyphenyl)acetamide",C25H22ClN5O2S,492.0,4.5,121.0,2,6,4,34,,GNMUEVRJHCWKTO-FQEVSTJZSA-N
I-BET762,CIDs46943432,I-BET762,423.89538,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,Bromodomain and extra-terminal motif (BET),46943432,"2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide",C22H22ClN5O2,423.9,2.9,81.4,1,5,5,30,,AAAQFGUYHFJNHI-SFHVURJKSA-N
BMS-986158,CIDs118196485,,0.0,,CC1=C(N(N=N1)C)C2=CC3=C(C4=C(N3C(C5CCOCC5)C6=CC=CC=C6)C=C(C=C4)C(C)(C)O)N=C2,Bromodomain and extra-terminal motif (BET),118196485,"2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol",C30H33N5O2,495.6,4.1,78.0,1,5,5,37,,KGERZPVQIRYWRK-GDLZYMKVSA-N
CPI-0610,CIDs57389999,SCHEMBL15926539,365.81294,CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl,CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl,Bromodomain and extra-terminal motif (BET),57389999,"2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide",C20H16ClN3O2,365.8,3.0,81.5,1,4,3,26,,GCWIQUVXWZWCLE-INIZCTEOSA-N
BMN-673,CIDs135565082,,0.0,,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2",135565082,"(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one",C19H14F2N6O,380.4,2.3,84.2,2,7,2,28,,HWGQMRYQVZSGDQ-HZPDHXFCSA-N
E-7449,CIDs135565981,,0.0,,C1C2=CC=CC=C2CN1CC3=NC4=NNC(=O)C5=C4C(=CC=C5)N3,"Tankyrase 1/2, Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2",135565981,"11-(1,3-dihydroisoindol-2-ylmethyl)-2,3,10,12-tetrazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8,11-pentaen-4-one",C18H15N5O,317.3,1.1,69.1,2,3,2,24,,JLFSBHQQXIAQEC-UHFFFAOYSA-N
Niraparib,CIDs24958200,niraparib,320.3883,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2",24958200,2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide,C19H20N4O,320.4,2.2,72.9,2,3,3,24,,PCHKPVIQAHNQLW-CQSZACIVSA-N
Methacycline hydrochloride,CIDs54685047,,0.0,,CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl,Bacterial 70S ribosome,54685047,"(4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride",C22H23ClN2O8,478.9,,182.0,7,9,2,33,,VXPSARQTYDZXAO-CCHMMTNSSA-N
Oxytetracycline,CIDs54675779,oxytetracycline,460.43396,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,Bacterial 70S ribosome,54675779,"(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide",C22H24N2O9,460.4,-1.6,202.0,7,10,2,33,,OWFJMIVZYSDULZ-PXOLEDIWSA-N
Triapine,CIDs09571836,Triapine,195.24486,C1=CC(=C(N=C1)C=NNC(=S)N)N,C1=CC(=C(N=C1)C=NNC(=S)N)N,Ribonucleotide reductase,9571836,[(E)-(3-amino-2-pyridinyl)methylideneamino]thiourea,C7H9N5S,195.25,-0.2,121.0,3,4,2,13,,XMYKNCNAZKMVQN-NYYWCZLTSA-N
Hydroxyurea,CIDs00003657,hydroxyurea,76.05466,C(=O)(N)NO,C(=O)(N)NO,Ribonucleoside-diphosphate reductase RR1,3657,hydroxyurea,CH4N2O2,76.055,-1.8,75.4,3,2,0,5,,VSNHCAURESNICA-UHFFFAOYSA-N
Tioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"DNA, Inosine-5'-monophosphate dehydrogenase (IMPDH)",2723601,"2-amino-3,7-dihydropurine-6-thione",C5H5N5S,167.19,-0.1,111.0,3,2,0,11,,WYWHKKSPHMUBEB-UHFFFAOYSA-N
Fludarabine phosphate,CIDs00030751,FAMP,365.211685,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)COP(=O)(O)O)O)O)F)N,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon)",30751,"[(2R,3S,4S,5R)-5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",C10H13FN5O7P,365.21,-3.1,186.0,5,12,4,24,,GIUYCYHIANZCFB-FJFJXFQQSA-N
Nelarabine,CIDs03011155,nelarabine,297.2673,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,DNA,3011155,"(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C11H15N5O5,297.27,-0.7,149.0,4,9,3,21,,IXOXBSCIXZEQEQ-UHTZMRCNSA-N
Azathioprine,CIDs00002265,azathioprine,277.26258,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"DNA, Amidophosphoribosyltransferase",2265,6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine,C9H7N7O2S,277.27,0.1,143.0,1,7,2,19,,LMEKQMALGUDUQG-UHFFFAOYSA-N
Fluorouracil,CIDs00003385,5-fluorouracil,130.077223,C1=C(C(=O)NC(=O)N1)F,C1=C(C(=O)NC(=O)N1)F,"DNA, RNA, Thymidylate synthase",3385,"5-fluoro-1H-pyrimidine-2,4-dione",C4H3FN2O2,130.08,-0.9,58.2,2,3,0,9,,GHASVSINZRGABV-UHFFFAOYSA-N
Flucytosine,CIDs00003366,flucytosine,129.092463,C1=NC(=O)NC(=C1F)N,C1=NC(=O)NC(=C1F)N,Thymidylate synthase,3366,6-amino-5-fluoro-1H-pyrimidin-2-one,C4H4FN3O,129.09,-0.9,67.5,2,3,0,9,,XRECTZIEBJDKEO-UHFFFAOYSA-N
Floxuridine,CIDs00005790,FUdR,246.192443,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,Thymidylate synthase,5790,"5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",C9H11FN2O5,246.19,-1.2,99.1,3,6,2,17,,ODKNJVUHOIMIIZ-RRKCRQDMSA-N
Tegafur,CIDs00005386,tegafur,200.167063,C1CC(OC1)N2C=C(C(=O)NC2=O)F,C1CC(OC1)N2C=C(C(=O)NC2=O)F,"DNA, RNA, Thymidylate synthase",5386,"5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione",C8H9FN2O3,200.17,-0.3,58.6,1,4,1,14,,WFWLQNSHRPWKFK-UHFFFAOYSA-N
Capecitabine,CIDs00060953,capecitabine,359.350083,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"DNA, RNA, Thymidylate synthase",60953,"pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate",C15H22FN3O6,359.35,0.6,121.0,3,7,7,25,,GAGWJHPBXLXJQN-UORFTKCHSA-N
Decitabine,CIDs00451668,decitabine,228.20528,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,"DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA",451668,"4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C8H12N4O4,228.21,-1.2,121.0,3,4,2,16,,XAUDJQYHKZQPEU-KVQBGUIXSA-N
Aciclovir,CIDs135398513,,0.0,,C1=NC2=C(N1COCCO)N=C(NC2=O)N,Human herpesvirus 1 DNA polymerase,135398513,2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one,C8H11N5O3,225.2,-1.9,115.0,3,5,4,16,,MKUXAQIIEYXACX-UHFFFAOYSA-N
Ganciclovir,CIDs135398740,,0.0,,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,Human herpesvirus 1 DNA polymerase,135398740,"2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one",C9H13N5O4,255.23,-2.5,135.0,4,6,5,18,,IRSCQMHQWWYFCW-UHFFFAOYSA-N
Brincidofovir,CIDs00483477,HDP-CDV,561.691442,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,DNA polymerase,483477,[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid,C27H52N3O7P,561.7,4.9,144.0,3,7,26,38,,WXJFKKQWPMNTIM-VWLOTQADSA-N
Clofarabine,CIDs00119182,clofarabine,303.677443,C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon), DNA",119182,"(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol",C10H11ClFN5O3,303.68,0.9,119.0,3,8,2,20,,WDDPHFBMKLOVOX-AYQXTPAHSA-N
Adefovir dipivoxil,CIDs00060871,adefovir dipivoxil,501.470542,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C,DNA polymerase/reverse transcriptase,60871,"[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate",C20H32N5O8P,501.5,1.8,167.0,1,12,15,34,,WOZSCQDILHKSGG-UHFFFAOYSA-N
Troxacitabine,CIDs00454194,Q-4344,213.19064,C1C(OC(O1)CO)N2C=CC(=NC2=O)N,C1C(OC(O1)CO)N2C=CC(=NC2=O)N,DNA polymerase (alpha/delta/epsilon),454194,"4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one",C8H11N3O4,213.19,-1.7,97.4,2,4,2,15,,RXRGZNYSEHTMHC-BQBZGAKWSA-N
Telbivudine,CIDs00159269,telbivudine,242.22856,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,DNA polymerase/reverse transcriptase,159269,"1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",C10H14N2O5,242.23,-1.2,99.1,3,5,2,17,,IQFYYKKMVGJFEH-CSMHCCOUSA-N
Doxifluridine,CIDs00018343,5'-DFUR,246.192443,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,"DNA, RNA, Thymidylate synthase",18343,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione",C9H11FN2O5,246.19,-1.7,99.1,3,6,1,17,,ZWAOHEXOSAUJHY-ZIYNGMLESA-N
Trifluridine,CIDs00006256,trifluridine,296.19995,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,DNA,6256,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione",C10H11F3N2O5,296.2,-0.5,99.1,3,8,2,20,,VSQQQLOSPVPRAZ-RRKCRQDMSA-N
Pemetrexed,CIDs135410875,,0.0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,"Thymidylate synthase, GAR transformylase, Dihydrofolate reductase",135410875,"(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid",C20H21N5O6,427.4,0.2,187.0,6,7,9,31,,WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
Chlorambucil,CIDs00002708,chlorambucil,304.21216,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,DNA,2708,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid,C14H19Cl2NO2,304.2,1.7,40.5,1,3,9,19,,JCKYGMPEJWAADB-UHFFFAOYSA-N
Carmustine,CIDs00002578,BCNU,214.04986,C(CCl)NC(=O)N(CCCl)N=O,C(CCl)NC(=O)N(CCCl)N=O,"DNA, RNA, Glutathione reductase",2578,"1,3-bis(2-chloroethyl)-1-nitrosourea",C5H9Cl2N3O2,214.05,1.5,61.8,1,3,4,12,,DLGOEMSEDOSKAD-UHFFFAOYSA-N
Melphalan,CIDs00460612,melphalan,305.20022,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,DNA,460612,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,C13H18Cl2N2O2,305.2,-0.5,66.6,2,4,8,19,,SGDBTWWWUNNDEQ-LBPRGKRZSA-N
Busulfan,CIDs00002478,busulfan,246.30176,CS(=O)(=O)OCCCCOS(=O)(=O)C,CS(=O)(=O)OCCCCOS(=O)(=O)C,DNA,2478,4-methylsulfonyloxybutyl methanesulfonate,C6H14O6S2,246.3,-0.5,104.0,0,6,7,14,,COVZYZSDYWQREU-UHFFFAOYSA-N
Chlormethine,CIDs00004033,nitrogen mustard,156.05354,CN(CCCl)CCCl,CN(CCCl)CCCl,DNA,4033,2-chloro-N-(2-chloroethyl)-N-methylethanamine,C5H11Cl2N,156.05,0.9,3.2,0,1,4,8,,HAWPXGHAZFHHAD-UHFFFAOYSA-N
Dacarbazine,CIDs135398738,,0.0,,CN(C)N=NC1=C(NC=N1)C(=O)N,DNA,135398738,4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide,C6H10N6O,182.18,-0.6,99.7,2,5,3,13,,FDKXTQMXEQVLRF-ZHACJKMWSA-N
Lomustine,CIDs00003950,lomustine,233.69524,C1CCC(CC1)NC(=O)N(CCCl)N=O,C1CCC(CC1)NC(=O)N(CCCl)N=O,DNA,3950,1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea,C9H16ClN3O2,233.69,2.8,61.8,1,3,3,15,,GQYIWUVLTXOXAJ-UHFFFAOYSA-N
Fotemustine,CIDs00104799,fotemustine,315.691022,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,DNA,104799,1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea,C9H19ClN3O5P,315.69,0.9,97.3,1,6,8,19,,YAKWPXVTIGTRJH-UHFFFAOYSA-N
Altretamine,CIDs00002123,hexamethylmelamine,210.27942,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,DNA,2123,"2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine",C9H18N6,210.28,2.7,48.4,0,6,3,15,,UUVWYPNAQBNQJQ-UHFFFAOYSA-N
Procarbazine hydrochloride,CIDs00009703,,0.0,,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,DNA,9703,4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride,C12H20ClN3O,257.76,,53.2,4,3,5,17,,DERJYEZSLHIUKF-UHFFFAOYSA-N
Apaziquone,CIDs05813717,apaziquone,288.29854,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,DNA,5813717,"5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione",C15H16N2O4,288.3,-0.5,82.5,2,5,4,21,,MXPOCMVWFLDDLZ-NSCUHMNNSA-N
Evofosfamide,CIDs11984561,TH-302,449.036202,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,DNA,11984561,2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine,C9H16Br2N5O4P,449.04,0.6,114.0,2,7,9,21,,UGJWRPJDTDGERK-UHFFFAOYSA-N
Trabectedin,CIDs00108150,trabectedin,761.83722,CC1=C(C(=C2C3C4C5C6=C(C(N4C(C(N3C)CC2=C1)O)COC(=O)C7(CS5)C8=CC(=C(C=C8CCN7)O)OC)C9=C(C(=C6OC(=O)C)C)OCO9)O)OC,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,DNA,108150,"[(1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline]-22-yl] acetate",C39H43N3O11S,761.8,3.4,194.0,4,15,4,54,,PKVRCIRHQMSYJX-AIFWHQITSA-N
Tirapazamine,CIDs135413511,,0.0,,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],DNA,135413511,"1,4-dioxido-1,2,4-benzotriazine-1,4-diium-3-amine",C7H6N4O2,178.15,-0.3,89.8,1,4,0,13,,ORYDPOVDJJZGHQ-UHFFFAOYSA-N
SJG-136,CIDs00393111,NSC-694501,556.60898,COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC,COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC,DNA,393111,"(6aS)-3-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one",C31H32N4O6,556.6,1.9,102.0,0,8,8,41,,RWZVMMQNDHPRQD-SFTDATJTSA-N
Exatecan,CIDs00151115,,0.0,,CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O,DNA topoisomerase I,151115,"(10S,23S)-23-amino-10-ethyl-18-fluoro-10-hydroxy-19-methyl-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaene-5,9-dione",C24H22FN3O4,435.4,0.4,106.0,2,7,1,32,,ZVYVPGLRVWUPMP-FYSMJZIKSA-N
Amrubicin,CIDs00114897,amrubicin,519.92824,CC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N.Cl,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N.Cl,DNA topoisomerase II alpha,114897,"(7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride",C25H26ClNO9,519.9,,177.0,6,10,3,36,,BHMLHEQFWVQAJS-IITOGVPQSA-N
Belotecan,CIDs06456014,belotecan,433.49958,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O,DNA topoisomerase I,6456014,"(19S)-19-ethyl-19-hydroxy-10-[2-(propan-2-ylamino)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione",C25H27N3O4,433.5,1.6,91.8,2,6,5,32,,LNHWXBUNXOXMRL-VWLOTQADSA-N
Amsacrine,CIDs00002179,amsacrine,393.45886,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,DNA topoisomerase II,2179,N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide,C21H19N3O3S,393.5,4.0,88.7,2,6,5,28,,XCPGHVQEEXUHNC-UHFFFAOYSA-N
Vosaroxin,CIDs09952884,vosaroxin,401.43956,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,"DNA, DNA topoisomerase II",9952884,"7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid",C18H19N5O4S,401.4,-0.3,136.0,2,10,5,28,,XZAFZXJXZHRNAQ-STQMWFEESA-N
Valrubicin,CIDs00454216,valrubicin,723.64375,CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,"DNA topoisomerase II alpha, DNA",454216,"[2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate",C34H36F3NO13,723.6,4.0,215.0,5,16,11,51,,ZOCKGBMQLCSHFP-KQRAQHLDSA-N
Daunorubicin,CIDs00030323,daunorubicin,527.51986,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,"DNA topoisomerase II alpha, DNA",30323,"(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",C27H29NO10,527.5,1.8,186.0,5,11,4,38,,STQGQHZAVUOBTE-VGBVRHCVSA-N
Temozolomide,CIDs00005394,temozolomide,194.15084,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,DNA,5394,"3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide",C6H6N6O2,194.15,-1.1,106.0,1,5,1,14,,BPEGJWRSRHCHSN-UHFFFAOYSA-N
Dexrazoxane hydrochloride,CIDs06918223,,0.0,,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,"Iron, DNA topoisomerase II",6918223,"4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione;hydrochloride",C11H17ClN4O4,304.73,,98.8,3,6,3,20,,BIFMNMPSIYHKDN-FJXQXJEOSA-N
Teniposide,CIDs00452548,teniposide,656.65368,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,DNA topoisomerase II,452548,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",C32H32O13S,656.7,1.2,189.0,3,14,6,46,,NRUKOCRGYNPUPR-QBPJDGROSA-N
Norfloxacin,CIDs00004539,norfloxacin,319.330823,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,"Topoisomerase IV, Bacterial DNA gyrase",4539,1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,C16H18FN3O3,319.33,-1.0,72.9,2,7,3,23,,OGJPXUAPXNRGGI-UHFFFAOYSA-N
Ciprofloxacin,CIDs00002764,ciprofloxacin,331.341523,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,"Topoisomerase IV, Bacterial DNA gyrase",2764,1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,C17H18FN3O3,331.34,-1.1,72.9,2,7,3,24,,MYSWGUAQZAJSOK-UHFFFAOYSA-N
Gatifloxacin,CIDs00005379,gatifloxacin,375.394083,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,"Topoisomerase IV, DNA gyrase",5379,1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,C19H22FN3O4,375.4,-0.7,82.1,2,8,4,27,,XUBOMFCQGDBHNK-UHFFFAOYSA-N
Sparfloxacin,CIDs00060464,sparfloxacin,392.399786,CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,"Topoisomerase IV, Bacterial DNA gyrase",60464,"5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid",C19H22F2N4O3,392.4,0.1,98.9,3,9,3,28,,DZZWHBIBMUVIIW-DTORHVGOSA-N
Sitafloxacin hydrate,CIDs06918203,,0.0,,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F.O,"Topoisomerase IV, Bacterial DNA gyrase",6918203,"7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;hydrate",C19H20ClF2N3O4,427.8,,87.9,3,9,3,29,,ANCJYRJLOUSQBW-JJZGMWGRSA-N
Moxifloxacin hydrochloride,CIDs00101526,moxifloxacin,437.892303,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,"Topoisomerase IV, Bacterial DNA gyrase",101526,"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride",C21H25ClFN3O4,437.9,,82.1,3,8,4,30,,IDIIJJHBXUESQI-DFIJPDEKSA-N
Epothilone B,CIDs00448013,patupilone,507.68254,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,Tubulin,448013,"(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione",C27H41NO6S,507.7,4.2,137.0,2,8,2,35,,QXRSDHAAWVKZLJ-PVYNADRNSA-N
Epothilone D,CIDs00447865,epothilone D,491.68314,CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C,CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C,Tubulin,447865,"(4S,7R,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione",C27H41NO5S,491.7,5.0,125.0,2,7,2,34,,XOZIUKBZLSUILX-GIQCAXHBSA-N
Lexibulin hydrochloride,CIDs11351021,CYT997,434.534,CCCC(C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC,CCCC(C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC,Tubulin,11351021,1-ethyl-3-[2-methoxy-4-[5-methyl-4-[[(1S)-1-pyridin-3-ylbutyl]amino]pyrimidin-2-yl]phenyl]urea,C24H30N6O2,434.5,3.6,101.0,3,6,9,32,,MTJHLONVHHPNSI-IBGZPJMESA-N
Cabazitaxel,CIDs09854073,cabazitaxel,835.93238,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,Tubulin,9854073,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate",C45H57NO14,835.9,2.7,202.0,3,14,15,60,,BMQGVNUXMIRLCK-OAGWZNDDSA-N
Colchicine,CIDs00006167,colchicine,399.437,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,Tubulin,6167,"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",C22H25NO6,399.4,1.0,83.1,1,6,5,29,,IAKHMKGGTNLKSZ-INIZCTEOSA-N
Dolastatin 10,CIDs09810929,dolastatin 10,785.09092,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C,Tubulin,9810929,"(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide",C42H68N6O6S,785.1,5.8,162.0,2,9,21,55,,OFDNQWIFNXBECV-VFSYNPLYSA-N
Indibulin,CIDs00002929,indibulin,389.83434,C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)Cl)C(=O)C(=O)NC4=CC=NC=C4,C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)Cl)C(=O)C(=O)NC4=CC=NC=C4,Tubulin,2929,2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide,C22H16ClN3O2,389.8,3.9,64.0,1,3,5,28,,SOLIIYNRSAWTSQ-UHFFFAOYSA-N
E-7010,CIDs03035714,ABT-751,371.41028,COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O,COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O,Tubulin beta,3035714,N-[2-(4-hydroxyanilino)-3-pyridinyl]-4-methoxybenzenesulfonamide,C18H17N3O4S,371.4,2.8,109.0,3,7,6,26,,URCVCIZFVQDVPM-UHFFFAOYSA-N
Ombrabulin,CIDs06918405,,0.0,,COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)NC(=O)C(CO)N,Tubulin,6918405,"(2S)-2-amino-3-hydroxy-N-[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide",C21H26N2O6,402.4,2.2,112.0,3,7,9,29,,IXWNTLSTOZFSCM-YVACAVLKSA-N
Ixabepilone,CIDs06445540,ixabepilone,506.69778,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,Tubulin,6445540,"(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione",C27H42N2O5S,506.7,3.6,140.0,3,7,2,35,,FABUFPQFXZVHFB-PVYNADRNSA-N
Filanesib,CIDs44224257,ARRY-520,420.476086,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,Kinesin-like protein 1,44224257,"(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide",C20H22F2N4O2S,420.5,3.3,96.5,1,7,6,29,,LLXISKGBWFTGEI-FQEVSTJZSA-N
Litronesib,CIDs25167017,litronesib,511.70098,CCNCCS(=O)(=O)NCC1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2,CCNCCS(=O)(=O)NCC1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2,Kinesin-like protein 1,25167017,"N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide",C23H37N5O4S2,511.7,3.1,154.0,3,8,11,34,,YVAFBXLHPINSIK-QHCPKHFHSA-N
Onalespib,CIDs11955716,AT13387,409.52124,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,Heat shock protein HSP90,11955716,"(2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone",C24H31N3O3,409.5,3.1,67.3,2,5,4,30,,IFRGXKKQHBVPCQ-UHFFFAOYSA-N
Ganetespib (STA-9090),CIDs135564985,,0.0,,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,Heat shock protein HSP90,135564985,"3-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one",C20H20N4O3,364.4,3.1,90.1,3,4,3,27,,RVAQIUULWULRNW-UHFFFAOYSA-N
Retaspimycin Hydrochloride,CIDs11685945,,0.0,,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=C(C(=C2O)C1)NCC=C)O)C)OC)OC(=O)N)C)C)O)OC.Cl,Heat shock protein HSP90,11685945,"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate;hydrochloride",C31H46ClN3O8,624.2,,173.0,7,9,7,43,,OIRUWDYJGMHDHJ-AFXVCOSJSA-N
Ixazomib citrate,CIDs56844015,D10131,517.12162,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,26S proteasome,56844015,"2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid",C20H23BCl2N2O9,517.1,,168.0,4,9,11,34,,MBOMYENWWXQSNW-AWEZNQCLSA-N
Oprozomib,CIDs25067547,oprozomib,532.60918,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,26S proteasome,25067547,"N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide",C25H32N4O7S,532.6,1.1,176.0,3,9,14,37,,SWZXEVABPLUDIO-WSZYKNRRSA-N
MLN-4924,CIDs16720766,pevonedistat,443.5193,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,NEDD8 activating enzyme,16720766,"[(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate",C21H25N5O4S,443.5,1.7,141.0,3,8,6,31,,MPUQHZXIXSTTDU-QXGSTGNESA-N
Probucol,CIDs00004912,probucol,516.84162,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,ATP-binding cassette sub-family A member 1,4912,"2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol",C31H48O2S2,516.8,11.3,91.1,2,4,8,35,,FYPMFJGVHOHGLL-UHFFFAOYSA-N
Marimastat,CIDs00119031,marimastat,331.40786,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,"Matrix metalloproteinase-1, Matrix metalloproteinase 12, Matrix metalloproteinase 3, Matrix metalloproteinase 7, Matrix metalloproteinase 9, Matrix metalloproteinase-2",119031,"(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide",C15H29N3O5,331.41,0.5,128.0,5,5,8,23,,OCSMOTCMPXTDND-OUAUKWLOSA-N
CTS-1027,CIDs03342298,CTS-1027,425.8832,C1COCCC1(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C(=O)NO,C1COCCC1(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C(=O)NO,"Matrix metalloproteinase 12, Matrix metalloproteinase 3, Matrix metalloproteinase 14, Matrix metalloproteinase 9, Matrix metalloproteinase 13, Matrix metalloproteinase-2, Matrix metalloproteinase 8",3342298,4-[[4-(4-chlorophenoxy)phenyl]sulfonylmethyl]-N-hydroxyoxane-4-carboxamide,C19H20ClNO6S,425.9,2.3,110.0,2,6,6,28,,ROSNVSQTEGHUKU-UHFFFAOYSA-N
Abametapir,CIDs00015664,"5,5'-dimethyl-2,2'-bipyridine",184.23708,CC1=CN=C(C=C1)C2=NC=C(C=C2)C,CC1=CN=C(C=C1)C2=NC=C(C=C2)C,"Iron, Zinc, Metalloproteinase, Copper",15664,5-methyl-2-(5-methyl-2-pyridinyl)pyridine,C12H12N2,184.24,2.2,25.8,0,2,1,14,,PTRATZCAGVBFIQ-UHFFFAOYSA-N
Thiabendazole,CIDs00005430,thiabendazole,201.24768,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,Tubulin,5430,"4-(1H-benzimidazol-2-yl)-1,3-thiazole",C10H7N3S,201.25,2.5,69.8,1,3,1,14,,WJCNZQLZVWNLKY-UHFFFAOYSA-N
Tariquidar,CIDs00148201,tariquidar,646.73152,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,P-glycoprotein 1,148201,"N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide",C38H38N4O6,646.7,6.1,111.0,2,8,11,48,,LGGHDPFKSSRQNS-UHFFFAOYSA-N
Valspodar,CIDs05281884,valspodar,1214.62194,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,P-glycoprotein 1,5281884,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",C63H111N11O12,1214.6,7.7,276.0,4,12,15,86,,YJDYDFNKCBANTM-QCWCSKBGSA-N
HM-30181,CIDs11399764,HM-30181,688.72844,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,P-glycoprotein 1,11399764,"N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide",C38H36N6O7,688.7,5.8,139.0,1,11,11,51,,AHJUHHDDCJQACA-UHFFFAOYSA-N
Sulindac,CIDs01548887,,0.0,,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,Cyclooxygenase,1548887,2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,C20H17FO3S,356.4,3.4,73.6,1,5,4,25,,MLKXDPUZXIRXEP-MFOYZWKCSA-N
Tigecycline,CIDs54686904,tigecycline,585.64866,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,Bacterial 70S ribosome,54686904,"(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide",C29H39N5O8,585.6,1.1,206.0,7,11,7,42,,SOVUOXKZCCAWOJ-HJYUBDRYSA-N
Terameprocol,CIDs00476861,terameprocol,358.4712,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,DNA,476861,"4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene",C22H30O4,358.5,5.6,36.9,0,4,9,26,,ORQFDHFZSMXRLM-IYBDPMFKSA-N
Mitotane,CIDs00004211,mitotane,320.0412,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,"Cytochrome P450 11A1, Cytochrome P450 11B1",4211,"1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene",C14H10Cl4,320.0,6.2,0.0,0,0,3,18,,JWBOIMRXGHLCPP-UHFFFAOYSA-N
Selinexor,CIDs71481097,selinexor,443.305959,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,Exportin-1,71481097,"(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide",C17H11F6N7O,443.3,3.0,97.6,2,12,5,31,,DEVSOMFAQLZNKR-RJRFIUFISA-N
Miconazole nitrate,CIDs00068553,,0.0,,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-],Cytochrome P450 51,68553,"1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid",C18H15Cl4N3O4,479.1,,93.1,1,5,6,29,,MCCACAIVAXEFAL-UHFFFAOYSA-N
Anastrozole,CIDs00002187,anastrozole,293.36626,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Cytochrome P450 19A1,2187,"2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile",C17H19N5,293.4,2.1,78.3,0,4,4,22,,YBBLVLTVTVSKRW-UHFFFAOYSA-N
Exemestane,CIDs00060198,exemestane,296.40336,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Cytochrome P450 19A1,60198,"(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione",C20H24O2,296.4,3.1,34.1,0,2,0,22,,BFYIZQONLCFLEV-DAELLWKTSA-N
Reparixin,CIDs09838712,reparixin,283.38644,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,"Interleukin-8 receptor A, Interleukin-8 receptor B",9838712,(2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide,C14H21NO3S,283.39,2.9,71.6,1,3,5,19,,KQDRVXQXKZXMHP-LLVKDONJSA-N
Danirixin,CIDs24780598,danirixin,441.904143,CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O,CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O,Interleukin-8 receptor B,24780598,1-[4-chloro-2-hydroxy-3-[(3S)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea,C19H21ClFN3O4S,441.9,3.1,116.0,4,6,4,29,,NGYNBSHYFOFVLS-LBPRGKRZSA-N
Seviteronel,CIDs78357816,VT-464,399.339493,CC(C)C(C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O,CC(C)C(C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O,"Cytochrome P450 17A1, Androgen Receptor",78357816,"(1S)-1-[6,7-bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2H-triazol-4-yl)propan-1-ol",C18H17F4N3O3,399.3,4.7,80.3,2,9,7,28,,ZBRAJOQFSNYJMF-SFHVURJKSA-N
Olanzapine (LY-170053),CIDs135398745,,0.0,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,"D2-like dopamine receptor, Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor",135398745,"2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine",C17H20N4S,312.4,2.9,59.1,1,4,1,22,,KVWDHTXUZHCGIO-UHFFFAOYSA-N
Isoniazid,CIDs00003767,isoniazid,137.13928,C1=CN=CC=C1C(=O)NN,C1=CN=CC=C1C(=O)NN,Enoyl-[acyl-carrier-protein] reductase,3767,pyridine-4-carbohydrazide,C6H7N3O,137.14,-0.7,68.0,2,3,1,10,,QRXWMOHMRWLFEY-UHFFFAOYSA-N
Methoxsalen,CIDs00004114,8-methoxypsoralen,216.18952,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,DNA,4114,"9-methoxyfuro[3,2-g]chromen-7-one",C12H8O4,216.19,1.9,48.7,0,4,1,16,,QXKHYNVANLEOEG-UHFFFAOYSA-N
Taselisib (GDC-0032),CIDs51001932,taselisib,460.53152,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PI3-kinase class I,51001932,"2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide",C24H28N8O2,460.5,1.8,119.0,1,6,5,34,,BEUQXVWXFDOSAQ-UHFFFAOYSA-N
Ranolazine,CIDs00056959,ranolazine,427.53652,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"Sodium channel protein type V alpha subunit, Sodium channel protein type IV alpha subunit",56959,"N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide",C24H33N3O4,427.5,2.7,74.3,2,6,9,31,,XKLMZUWKNUAPSZ-UHFFFAOYSA-N
Acetaminophen,CIDs00001983,paracetamol,151.16256,CC(=O)NC1=CC=C(C=C1)O,CC(=O)NC1=CC=C(C=C1)O,"Vanilloid receptor, Anandamide amidohydrolase, Cyclooxygenase",1983,N-(4-hydroxyphenyl)acetamide,C8H9NO2,151.16,0.5,49.3,2,2,1,11,,RZVAJINKPMORJF-UHFFFAOYSA-N
Valdecoxib,CIDs00119607,valdecoxib,314.35896,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Cyclooxygenase-2,119607,"4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide",C16H14N2O3S,314.4,2.6,94.6,1,5,3,22,,LNPDTQAFDNKSHK-UHFFFAOYSA-N
Parecoxib sodium,CIDs15895902,,0.0,,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],Cyclooxygenase-2,15895902,"sodium [4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl-propanoylazanide",C19H17N2NaO4S,392.4,,86.6,0,6,5,27,,HQPVVKXJNZEAFW-UHFFFAOYSA-M
ThioTEPA,CIDs00005453,thiotepa,189.218342,C1CN1P(=S)(N2CC2)N3CC3,C1CN1P(=S)(N2CC2)N3CC3,DNA,5453,tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane,C6H12N3PS,189.22,0.5,41.1,0,4,3,11,,FOCVUCIESVLUNU-UHFFFAOYSA-N
LGK-974,CIDs46926973,LGK-974,396.4445,CC1=C(N=CC(=C1)CC(=O)NC2=NC=C(C=C2)C3=NC=CN=C3)C4=CC(=NC=C4)C,CC1=CC(=CN=C1C2=CC(=NC=C2)C)CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4,Probable protein-cysteine N-palmitoyltransferase porcupine,46926973,2-[5-methyl-6-(2-methyl-4-pyridinyl)-3-pyridinyl]-N-(5-pyrazin-2-yl-2-pyridinyl)acetamide,C23H20N6O,396.4,1.8,93.6,1,6,5,30,,XXYGTCZJJLTAGH-UHFFFAOYSA-N
BMS-833923,CIDs57662985,XL139,473.56828,CC1=C(C=C(C=C1)CNC)NC(=O)C2=CC=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5,CC1=C(C=C(C=C1)CNC)NC(=O)C2=CC=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5,Smoothened homolog,57662985,N-[2-methyl-5-(methylaminomethyl)phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide,C30H27N5O,473.6,5.7,78.9,3,5,7,36,,KLRRGBHZCJLIEL-UHFFFAOYSA-N
Glasdegib,CIDs25166913,glasdegib,374.43898,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,Smoothened homolog,25166913,"1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea",C21H22N6O,374.4,2.4,96.8,3,4,3,28,,SFNSLLSYNZWZQG-VQIMIIECSA-N
Patidegib,CIDs25027363,saridegib,504.76802,CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1,CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1,Smoothened homolog,25027363,"N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-yl]methanesulfonamide",C29H48N2O3S,504.8,4.6,75.8,2,5,2,35,,HZLFFNCLTRVYJG-WWGOJCOQSA-N
TAK-441,CIDs44187367,TAK-441,576.56415,CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4,CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4,Smoothened homolog,44187367,"6-ethyl-N-[1-(2-hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-phenacyl-3-(2,2,2-trifluoroethoxy)pyrrolo[3,2-c]pyridine-2-carboxamide",C28H31F3N4O6,576.6,2.6,121.0,2,9,9,41,,ZADWXQMNNVICKB-UHFFFAOYSA-N
Pomalidomide,CIDs00134780,pomalidomide,273.24414,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,CRL4(CRBN) E3 ubiquitin ligase,134780,"4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",C13H11N3O4,273.24,0.2,110.0,2,5,1,20,,UVSMNLNDYGZFPF-UHFFFAOYSA-N
Thalidomide,CIDs00005426,thalidomide,258.2295,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,CRL4(CRBN) E3 ubiquitin ligase,5426,"2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",C13H10N2O4,258.23,0.3,83.6,1,4,1,19,,UEJJHQNACJXSKW-UHFFFAOYSA-N
Methylrosaniline chloride,CIDs00011057,,0.0,,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],DNA,11057,"[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium chloride",C25H30ClN3,408.0,,9.5,0,3,4,29,,ZXJXZNDDNMQXFV-UHFFFAOYSA-M
Nirogacestat,CIDs46224413,PF-3084014,489.644146,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=CC(=CC(=C3C2)F)F,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,Gamma-secretase,46224413,"(2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide",C27H41F2N5O,489.6,4.8,71.0,3,6,11,35,,VFCRKLWBYMDAED-REWPJTCUSA-N
Avagacestat,CIDs46883536,avagacestat,520.884993,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,Gamma-secretase,46883536,"(2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide",C20H17ClF4N4O4S,520.9,4.0,128.0,1,11,9,34,,XEAOPVUAMONVLA-QGZVFWFLSA-N
Semagacestat,CIDs09843750,,0.0,,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,Gamma-secretase,9843750,"(2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide",C19H27N3O4,361.4,1.3,98.7,3,4,5,26,,PKXWXXPNHIWQHW-RCBQFDQVSA-N
MK-8931,CIDs51352361,Verubecestat,409.410386,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,Beta-secretase 1,51352361,"N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide",C17H17F2N5O3S,409.4,0.6,126.0,2,7,3,28,,YHYKUSGACIYRML-KRWDZBQOSA-N
PF-05175157,CIDs52934180,AGN-PC-09LZEN,405.49278,CC1=NC2=C(N1)C=C(C=C2)C(=O)N3CCC4(CC3)CC5=C(C(=O)C4)N(N=C5)C(C)C,CC1=NC2=C(N1)C=C(C=C2)C(=O)N3CCC4(CC3)CC5=C(C(=O)C4)N(N=C5)C(C)C,Acetyl-CoA carboxylase,52934180,"1'-(2-methyl-3H-benzimidazole-5-carbonyl)-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-7-one",C23H27N5O2,405.5,2.7,83.9,1,4,2,30,,BDXXSFOJPYSYOC-UHFFFAOYSA-N
Tolrestat,CIDs00053359,tolrestat,357.34747,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,Aldose reductase,53359,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid,C16H14F3NO3S,357.3,3.7,81.9,1,7,4,24,,LUBHDINQXIHVLS-UHFFFAOYSA-N
Epalrestat,CIDs01549120,,0.0,,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,Aldose reductase,1549120,"2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid",C15H13NO3S2,319.4,3.8,115.0,1,5,4,21,,CHNUOJQWGUIOLD-NFZZJPOKSA-N
PF-04457845,CIDs24771824,PF-04457845,455.43241,C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4,C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4,Anandamide amidohydrolase,24771824,N-pyridazin-3-yl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylidene]piperidine-1-carboxamide,C23H20F3N5O2,455.4,3.3,80.2,1,8,4,33,,BATCTBJIJJEPHM-UHFFFAOYSA-N
JNJ-42165279,CIDs54576693,AGN-PC-0HG8J8,410.802386,C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl,C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl,Anandamide amidohydrolase,54576693,"N-(4-chloro-3-pyridinyl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine-1-carboxamide",C18H17ClF2N4O3,410.8,2.6,66.9,1,7,3,28,,YWGYNGCRVZLMCS-UHFFFAOYSA-N
Pyrazinamide,CIDs00001046,pyrazinamide,123.1127,C1=CN=C(C=N1)C(=O)N,C1=CN=C(C=N1)C(=O)N,"Fatty acid synthase, 70S ribosome",1046,pyrazine-2-carboxamide,C5H5N3O,123.11,-0.6,68.9,1,3,1,9,,IPEHBUMCGVEMRF-UHFFFAOYSA-N
Orlistat,CIDs03034010,orlistat,495.73482,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,"Pancreatic lipase, Gastric lipase",3034010,"[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate",C29H53NO5,495.7,10.0,81.7,1,5,23,35,,AHLBNYSZXLDEJQ-FWEHEUNISA-N
Riociguat,CIDs11304743,riociguat,422.415663,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,Soluble guanylate cyclase,11304743,"methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate",C20H19FN8O2,422.4,1.6,138.0,2,9,5,31,,WXXSNCNJFUAIDG-UHFFFAOYSA-N
LY-2608204,CIDs46832368,LY2608204,559.80668,C1CCC(CC1)C2CC2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6,C1CCC(CC1)C2CC2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6,Hexokinase type IV,46832368,"trans-(1R,2S)-2-cyclohexyl-1-(4-cyclopropylsulfonylphenyl)-N-[5-(2-pyrrolidin-1-ylethylsulfanyl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide",C28H37N3O3S3,559.8,6.2,141.0,1,7,10,37,,QIIVJLHCZUTGSD-CUBQBAPOSA-N
PF-04937319,CIDs46916694,AGN-PC-080XDF,432.432,CC1=CC2=C(O1)C=C(C=C2OC3=CN=C(N=C3)C(=O)N(C)C)C(=O)NC4=NC=C(N=C4)C,CC1=CC2=C(O1)C=C(C=C2OC3=CN=C(N=C3)C(=O)N(C)C)C(=O)NC4=NC=C(N=C4)C,Hexokinase type IV,46916694,"N,N-dimethyl-5-[[2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl]oxy]pyrimidine-2-carboxamide",C22H20N6O4,432.4,1.8,123.0,1,8,5,32,,MASKQITXHVYVFL-UHFFFAOYSA-N
GSK-1292263A,CIDs24996872,GSK1292263,456.55782,CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C,CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C,Glucose-dependent insulinotropic receptor,24996872,"5-[4-[[6-(4-methylsulfonylphenyl)-3-pyridinyl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole",C23H28N4O4S,456.6,4.0,107.0,0,8,7,32,,AYJRTVVIBJSSKN-UHFFFAOYSA-N
CB-839,CIDs71577426,AGN-PC-0JHD16,571.57407,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,"Glutaminase kidney isoform, mitochondrial",71577426,"N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide",C26H24F3N7O3S,571.6,3.6,160.0,2,12,12,40,,PRAAPINBUWJLGA-UHFFFAOYSA-N
Mitapivat,CIDs59634741,AGN-PC-0D1AJ2,450.55324,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,Pyruvate kinase isozymes R/L,59634741,N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide,C24H26N4O3S,450.6,1.8,91.0,1,6,6,32,,XAYGBKHKBBXDAK-UHFFFAOYSA-N
Ataciguat,CIDs00213037,ataciguat,576.49306,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,Soluble guanylate cyclase,213037,5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-N-(4-morpholin-4-ylsulfonylphenyl)benzamide,C21H19Cl2N3O6S3,576.5,4.2,167.0,2,9,7,35,,PQHLRGARXNPFCF-UHFFFAOYSA-N
Lovastatin,CIDs00053232,lovastatin,404.53964,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,HMG-CoA reductase,53232,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate",C24H36O5,404.5,4.3,72.8,1,5,7,29,,PCZOHLXUXFIOCF-BXMDZJJMSA-N
Atorvastatin calcium,CIDs00060822,atorvastatin,1155.341726,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],HMG-CoA reductase,60822,"calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate)",C66H68CaF2N4O10,1155.3,,229.0,6,12,22,83,,FQCKMBLVYCEXJB-MNSAWQCASA-L
Pitavastatin calcium,CIDs05282451,pitavastatin,880.983646,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],HMG-CoA reductase,5282451,"calcium bis((E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)",C50H46CaF2N2O8,881.0,,187.0,4,12,14,63,,RHGYHLPFVJEAOC-FFNUKLMVSA-L
Aspirin,CIDs00002244,aspirin,180.15742,CC(=O)OC1=CC=CC=C1C(=O)O,CC(=O)OC1=CC=CC=C1C(=O)O,Cyclooxygenase,2244,2-acetyloxybenzoic acid,C9H8O4,180.16,1.2,63.6,1,4,3,13,,BSYNRYMUTXBXSQ-UHFFFAOYSA-N
Chlorothiazide,CIDs00002720,thiazide,295.72324,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,Thiazide-sensitive sodium-chloride cotransporter,2720,"6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C7H6ClN3O4S2,295.7,-0.2,135.0,2,6,1,17,,JBMKAUGHUNFTOL-UHFFFAOYSA-N
Hydrochlorothiazide,CIDs00003639,hydrochlorothiazide,297.73912,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,Thiazide-sensitive sodium-chloride cotransporter,3639,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C7H8ClN3O4S2,297.7,-0.1,135.0,3,7,1,17,,JZUFKLXOESDKRF-UHFFFAOYSA-N
Ivosidenib,CIDs71657455,SCHEMBL15122512,582.96089,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,Isocitrate dehydrogenase [NADP] cytoplasmic,71657455,"(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxopyrrolidine-2-carboxamide",C28H22ClF3N6O3,583.0,3.4,119.0,1,9,7,41,,WIJZXSAJMHAVGX-DHLKQENFSA-N
BAY-1436032,CIDs118310260,,0.0,,CC1CC(CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F,Isocitrate dehydrogenase [NADP] cytoplasmic,118310260,"3-[2-[4-(trifluoromethoxy)anilino]-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid",C26H30F3N3O3,489.5,7.2,76.4,2,8,7,35,,RNMAUIMMNAHKQR-QFBILLFUSA-N
AG-881,CIDs117817422,,0.0,,CC(C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)NC(C)C(F)(F)F,IDH1/IDH2,117817422,"6-(6-chloro-2-pyridinyl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine",C14H13ClF6N6,414.74,5.3,75.6,2,12,5,27,,QCZAWDGAVJMPTA-RNFRBKRXSA-N
Indoximod,CIDs00405012,1-methyl-D-tryptophan,218.25176,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,mTORC1,405012,(2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid,C12H14N2O2,218.25,-1.3,68.3,2,3,3,16,,ZADWXFSZEAPBJS-SNVBAGLBSA-N
Epacadostat,CIDs135564890,,0.0,,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,"Indoleamine 2,3-dioxygenase",135564890,"N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboximidamide",C11H13BrFN7O4S,438.24,0.8,176.0,5,11,8,25,,FBKMWOJEPMPVTQ-UHFFFAOYSA-N
Ibiglustat,CIDs60199242,Ibiglustat,389.486863,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,Ceramide glucosyltransferase,60199242,"[(3S)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate",C20H24FN3O2S,389.5,3.5,82.7,1,6,5,27,,YFHRCLAKZBDRHN-MRXNPFEDSA-N
Mycophenolic acid,CIDs00446541,mycophenolic acid,320.3371,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,Inosine-5'-monophosphate dehydrogenase (IMPDH),446541,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid,C17H20O6,320.3,3.2,93.1,2,6,6,23,,HPNSFSBZBAHARI-RUDMXATFSA-N
Ribavirin,CIDs00037542,ribavirin,244.20468,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,"Hepatitis C virus NS5B RNA-dependent RNA polymerase, RNA, Inosine-5'-monophosphate dehydrogenase 1",37542,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide",C8H12N4O5,244.2,-1.8,144.0,4,7,3,17,,IWUCXVSUMQZMFG-AFCXAGJDSA-N
Mizoribine,CIDs00104762,mizoribine,259.21602,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,"GMP synthase [glutamine-hydrolyzing], Inosine-5'-monophosphate dehydrogenase (IMPDH)",104762,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide",C9H13N3O6,259.22,-1.9,151.0,5,7,3,18,,HZQDCMWJEBCWBR-UUOKFMHZSA-N
Mycophenolate mofetil,CIDs05281078,mycophenolate mofetil,433.49474,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)OCCN3CCOCC3)O,Inosine-5'-monophosphate dehydrogenase (IMPDH),5281078,2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate,C23H31NO7,433.5,3.2,94.5,1,8,10,31,,RTGDFNSFWBGLEC-SYZQJQIISA-N
AVN944,CIDs09918559,AVN944,477.51238,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,Inosine-5'-monophosphate dehydrogenase (IMPDH),9918559,"[(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate",C25H27N5O5,477.5,3.1,139.0,3,7,10,35,,GYCPCOJTCINIFZ-OXJNMPFZSA-N
Clotrimazole,CIDs00002812,clotrimazole,344.83678,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,Cytochrome P450 51,2812,1-[(2-chlorophenyl)-diphenylmethyl]imidazole,C22H17ClN2,344.8,5.0,17.8,0,1,4,25,,VNFPBHJOKIVQEB-UHFFFAOYSA-N
Voriconazole,CIDs00071616,voriconazole,349.31047,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,Cytochrome P450 51,71616,"(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol",C16H14F3N5O,349.31,1.5,76.7,1,8,5,25,,BCEHBSKCWLPMDN-MGPLVRAMSA-N
Posaconazole,CIDs00468595,posaconazole,700.777386,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,Cytochrome P450 51,468595,"4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one",C37H42F2N8O4,700.8,4.6,112.0,1,11,12,51,,RAGOYPUPXAKGKH-XAKZXMRKSA-N
Sivelestat,CIDs00107706,sivelestat,434.46288,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,Leukocyte elastase,107706,"2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid",C20H22N2O7S,434.5,3.0,147.0,3,8,9,30,,BTGNGJJLZOIYID-UHFFFAOYSA-N
Zafirlukast,CIDs00005717,zafirlukast,575.67522,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,Cysteinyl leukotriene receptor 1,5717,cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate,C31H33N3O6S,575.7,5.5,124.0,2,6,9,41,,YEEZWCHGZNKEEK-UHFFFAOYSA-N
Pranlukast hydrate,CIDs00004887,pranlukast,481.50262,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,Cysteinyl leukotriene receptor 1,4887,N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide,C27H23N5O4,481.5,4.2,119.0,2,7,9,36,,NBQKINXMPLXUET-UHFFFAOYSA-N
Anacetrapib,CIDs11556427,anacetrapib,637.508432,CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,Cholesteryl ester transfer protein,11556427,"(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one",C30H25F10NO3,637.5,8.8,38.8,0,13,6,44,,MZZLGJHLQGUVPN-HAWMADMCSA-N
Torcetrapib,CIDs00159325,torcetrapib,600.473329,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,Cholesteryl ester transfer protein,159325,"ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate",C26H25F9N2O4,600.5,7.0,59.1,0,13,7,41,,CMSGWTNRGKRWGS-NQIIRXRSSA-N
Evacetrapib (LY2484595),CIDs49836058,evacetrapib,638.646959,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,Cholesteryl ester transfer protein,49836058,"4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid",C31H36F6N6O2,638.6,7.7,87.4,1,13,7,45,,IHIUGIVXARLYHP-UXNJHFGPSA-N
Melatonin,CIDs00000896,melatonin,232.27834,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,Melatonin receptor,896,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,C13H16N2O2,232.28,0.8,54.1,2,2,4,17,,DRLFMBDRBRZALE-UHFFFAOYSA-N
GKT-137831,CIDs58496428,GKT137831,394.85416,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,"NADPH oxidase 1, NADPH oxidase 4",58496428,"2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6-dione",C21H19ClN4O2,394.9,3.2,55.9,1,4,3,28,,RGYQPQARIQKJKH-UHFFFAOYSA-N
Levetiracetam,CIDs05284583,levetiracetam,170.20896,CCC(C(=O)N)N1CCCC1=O,CCC(C(=O)N)N1CCCC1=O,"Synaptic vesicle glycoprotein 2A, Voltage-gated N-type calcium channel alpha-1B subunit",5284583,(2S)-2-(2-oxopyrrolidin-1-yl)butanamide,C8H14N2O2,170.21,-0.3,63.4,1,2,3,12,,HPHUVLMMVZITSG-LURJTMIESA-N
Omaveloxolone,CIDs71811910,Nrf1-activator-1,554.710866,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,Nuclear factor erythroid 2-related factor 2,71811910,"N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide",C33H44F2N2O3,554.7,6.7,87.0,1,6,2,40,,RJCWBNBKOKFWNY-IDPLTSGASA-N
Lemborexant,CIDs56944144,Lemborexant,410.416606,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,"Orexin receptor 1, Orexin receptor 2",56944144,"cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide",C22H20F2N4O2,410.4,3.2,77.0,1,7,6,30,,MUGXRYIUWFITCP-PGRDOPGGSA-N
Gemfibrozil,CIDs00003463,gemfibrozil,250.33338,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Peroxisome proliferator-activated receptor alpha,3463,"5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid",C15H22O3,250.33,3.8,46.5,1,3,6,18,,HEMJJKBWTPKOJG-UHFFFAOYSA-N
Ciprofibrate,CIDs00002763,ciprofibrate,289.15446,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,Peroxisome proliferator-activated receptor alpha,2763,"2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid",C13H14Cl2O3,289.15,3.4,46.5,1,3,4,18,,KPSRODZRAIWAKH-UHFFFAOYSA-N
Clofibrate,CIDs00002796,clofibrate,242.6987,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,Peroxisome proliferator-activated receptor alpha,2796,ethyl 2-(4-chlorophenoxy)-2-methylpropanoate,C12H15ClO3,242.7,3.3,35.5,0,3,5,16,,KNHUKKLJHYUCFP-UHFFFAOYSA-N
Fenofibrate,CIDs00003339,fenofibrate,360.83134,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Peroxisome proliferator-activated receptor alpha,3339,propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate,C20H21ClO4,360.8,5.2,52.6,0,4,7,25,,YMTINGFKWWXKFG-UHFFFAOYSA-N
Elafibranor,CIDs09864881,2J3H5C81A5,384.48856,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,"Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor delta",9864881,"2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid",C22H24O4S,384.5,5.1,88.9,1,5,7,27,,AFLFKFHDSCQHOL-IZZDOVSWSA-N
Pemafibrate,CIDs11526038,17VGG92R23,490.5476,CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,Peroxisome proliferator-activated receptor alpha,11526038,"(2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid",C28H30N2O6,490.5,6.2,94.3,1,8,13,36,,ZHKNLJLMDFQVHJ-RUZDIDTESA-N
Pradigastat,CIDs53387035,,0.0,,C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F,Diacylglycerol O-acyltransferase 1,53387035,2-[4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexyl]acetic acid,C25H24F3N3O2,455.5,5.7,75.1,2,8,6,33,,GXALXAKNHIROPE-UHFFFAOYSA-N
Tiagabine hydrochloride,CIDs00091274,,0.0,,CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl,GABA transporter 1,91274,"(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride",C20H26ClNO2S2,412.0,,97.0,2,5,6,26,,YUKARLAABCGMCN-PKLMIRHRSA-N
GSK-2256294A,CIDs59448236,L33EX3XR0T,447.45677,CC1=NC(=NC(=N1)NC)NC2CCCC(C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F,CC1=NC(=NC(=N1)NC2CCCC(C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F)NC,Epoxide hydratase,59448236,"cis-(1R,3S)-N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]cyclohexane-1-carboxamide",C21H24F3N7O,447.5,3.7,116.0,3,10,6,32,,LQHDJQIMETZMPH-ZBFHGGJFSA-N
Cinaciguat,CIDs09808022,cinaciguat,565.69856,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,Soluble guanylate cyclase,9808022,4-[[4-carboxybutyl-[2-[2-[[4-(2-phenylethyl)phenyl]methoxy]phenyl]ethyl]amino]methyl]benzoic acid,C36H39NO5,565.7,4.9,87.1,2,6,17,42,,WPYWMXNXEZFMAK-UHFFFAOYSA-N
Tetrabenazine,CIDs00006018,tetrabenazine,317.42258,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,Synaptic vesicular amine transporter,6018,"9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one",C19H27NO3,317.4,2.9,38.8,0,4,4,23,,MKJIEFSOBYUXJB-UHFFFAOYSA-N
PX-12,CIDs00219104,1-methylpropyl 2-imidazolyl disulfide,188.31358,CCC(C)SSC1=NC=CN1,CCC(C)SSC1=NC=CN1,Thioredoxin,219104,2-(butan-2-yldisulfanyl)-1H-imidazole,C7H12N2S2,188.3,2.3,79.3,1,3,4,11,,BPBPYQWMFCTCNG-UHFFFAOYSA-N
Deferasirox,CIDs00214348,,0.0,,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,Iron,214348,"4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid",C21H15N3O4,373.4,3.8,108.0,3,6,4,28,,BOFQWVMAQOTZIW-UHFFFAOYSA-N
Penicillamine,CIDs00005852,D-penicillamine,149.21134,CC(C)(C(C(=O)O)N)S,CC(C)(C(C(=O)O)N)S,Copper,5852,(2S)-2-amino-3-methyl-3-sulfanylbutanoic acid,C5H11NO2S,149.21,-1.8,64.3,3,4,2,9,,VVNCNSJFMMFHPL-VKHMYHEASA-N
Molidustat,CIDs59603622,molidustat,314.30266,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,"Egl nine homolog 1, Hypoxia-inducible factor prolyl hydroxylase 1, Egl nine homolog 3",59603622,2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one,C13H14N8O2,314.3,-0.2,101.0,1,8,3,23,,IJMBOKOTALXLKS-UHFFFAOYSA-N
Roxadustat,CIDs11256664,FG-4592,352.34074,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,Hypoxia-inducible factor prolyl hydroxylase,11256664,2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid,C19H16N2O5,352.3,3.4,109.0,3,6,5,26,,YOZBGTLTNGAVFU-UHFFFAOYSA-N
Daprodustat,CIDs91617630,Daprodustat,393.43418,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,Hypoxia-inducible factor prolyl hydroxylase,91617630,"2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid",C19H27N3O6,393.4,2.5,124.0,2,6,5,28,,RUEYEZADQJCKGV-UHFFFAOYSA-N
Vadadustat,CIDs23634441,AGN-PC-0HAO1I,306.70114,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,"Egl nine homolog 1, Hypoxia-inducible factor prolyl hydroxylase 1, Egl nine homolog 3",23634441,2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid,C14H11ClN2O4,306.7,2.5,99.5,3,5,4,21,,JGRXMPYUTJLTKT-UHFFFAOYSA-N
Dyphylline,CIDs00003182,diprophylline,254.24256,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,"Phosphodiesterase 4, Phosphodiesterase 3A",3182,"7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione",C10H14N4O4,254.24,-1.8,98.9,2,5,3,18,,KSCFJBIXMNOVSH-UHFFFAOYSA-N
Allopurinol,CIDs135401907,,0.0,,C1=NNC2=C1C(=O)NC=N2,Xanthine dehydrogenase,135401907,"1,5-dihydropyrazolo[5,4-d]pyrimidin-4-one",C5H4N4O,136.11,-0.7,70.1,2,3,0,10,,OFCNXPDARWKPPY-UHFFFAOYSA-N
Febuxostat,CIDs00134018,febuxostat,316.37484,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,Xanthine dehydrogenase,134018,"2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid",C16H16N2O3S,316.4,3.9,111.0,1,6,5,22,,BQSJTQLCZDPROO-UHFFFAOYSA-N
Deferoxamine mesylate,CIDs00062881,,0.0,,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O,Iron,62881,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid,C26H52N6O11S,656.8,,269.0,7,12,23,44,,IDDIJAWJANBQLJ-UHFFFAOYSA-N
Vidofludimus,CIDs09820008,Vidofludimus,355.359623,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,Dihydroorotate dehydrogenase,9820008,2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid,C20H18FNO4,355.4,3.4,75.6,2,5,5,26,,XPRDUGXOWVXZLL-UHFFFAOYSA-N
Brequinar,CIDs00057030,brequinar,375.367506,CC1=C(N=C2C=CC(=CC2=C1C(=O)O)F)C3=CC=C(C=C3)C4=CC=CC=C4F,CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O,Dihydroorotate dehydrogenase,57030,6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid,C23H15F2NO2,375.4,5.6,50.2,1,5,3,28,,PHEZJEYUWHETKO-UHFFFAOYSA-N
Sulfadoxine,CIDs00017134,sulfadoxine,310.32896,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,Dihydropteroate synthetase,17134,"4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide",C12H14N4O4S,310.33,0.7,125.0,2,8,5,21,,PJSFRIWCGOHTNF-UHFFFAOYSA-N
Gimeracil,CIDs54679224,,0.0,,C1=C(C(=CNC1=O)Cl)O,Dihydropyrimidine dehydrogenase,54679224,5-chloro-4-hydroxy-1H-pyridin-2-one,C5H4ClNO2,145.54,-0.1,49.3,2,2,0,9,,ZPLQIPFOCGIIHV-UHFFFAOYSA-N
Linagliptin,CIDs10096344,linagliptin,472.54222,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Dipeptidyl peptidase IV,10096344,"8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione",C25H28N8O2,472.5,1.9,113.0,1,7,4,35,,LTXREWYXXSTFRX-QGZVFWFLSA-N
APR-246,CIDs52918385,PRIMA-1MET,199.24688,COCC1(C(=O)C2CCN1CC2)CO,COCC1(C(=O)C2CCN1CC2)CO,Cellular tumor antigen p53,52918385,2-(hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one,C10H17NO3,199.25,-0.1,49.8,1,4,3,14,,BGBNULCRKBVAKL-UHFFFAOYSA-N
Elagolix,CIDs11250647,elagolix,631.589716,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,Gonadotropin-releasing hormone receptor,11250647,"4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid",C32H30F5N3O5,631.6,2.6,99.2,2,11,12,45,,HEAUOKZIVMZVQL-VWLOTQADSA-N
Relugolix,CIDs10348973,TAK-385,623.630386,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,Gonadotropin-releasing hormone receptor,10348973,"1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea",C29H27F2N7O5S,623.6,3.2,157.0,2,11,9,44,,AOMXMOCNKJTRQP-UHFFFAOYSA-N
Dronedarone hydrochloride,CIDs00219025,,0.0,,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,"Inward rectifier potassium channel 2, Voltage-gated L-type calcium channel, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel alpha subunit",219025,N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide;hydrochloride,C31H45ClN2O5S,593.2,,97.2,2,7,18,40,,DWKVCQXJYURSIQ-UHFFFAOYSA-N
Epinephrine,CIDs00005816,,0.0,,CNCC(C1=CC(=C(C=C1)O)O)O,Adrenergic receptor,5816,"4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",C9H13NO3,183.2,-1.4,72.7,4,4,3,13,,UCTWMZQNUQWSLP-VIFPVBQESA-N
Phenylephrine hydrochloride,CIDs05284443,,0.0,,CNCC(C1=CC(=CC=C1)O)O.Cl,Adrenergic receptor alpha-1,5284443,3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride,C9H14ClNO2,203.66,,52.5,4,3,3,13,,OCYSGIYOVXAGKQ-FVGYRXGTSA-N
Naftopidil,CIDs00004418,naftopidil,392.49072,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,Alpha-1d adrenergic receptor,4418,1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol,C24H28N2O3,392.5,4.1,45.2,1,5,7,29,,HRRBJVNMSRJFHQ-UHFFFAOYSA-N
Oxymetazoline hydrochloride,CIDs00066259,,0.0,,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl,Adrenergic receptor alpha,66259,"6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol;hydrochloride",C16H25ClN2O,296.83,,44.6,3,2,3,20,,BEEDODBODQVSIM-UHFFFAOYSA-N
Tizanidine hydrochloride,CIDs00114869,,0.0,,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,Adrenergic receptor alpha-2,114869,"5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride",C9H9Cl2N5S,290.17,,90.4,3,4,2,17,,ZWUKMNZJRDGCTQ-UHFFFAOYSA-N
Phentolamine mesilate,CIDs00091430,,0.0,,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,Adrenergic receptor alpha,91430,"3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid",C18H23N3O4S,377.5,,111.0,3,6,4,26,,OGIYDFVHFQEFKQ-UHFFFAOYSA-N
Miglitol,CIDs00441314,miglitol,207.22428,C1C(C(C(C(N1CCO)CO)O)O)O,C1C(C(C(C(N1CCO)CO)O)O)O,"Maltase-glucoamylase, Lysosomal alpha-glucosidase",441314,"(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol",C8H17NO5,207.22,-2.6,104.0,5,6,3,14,,IBAQFPQHRJAVAV-ULAWRXDQSA-N
Avacopan,CIDs49841217,SCHEMBL2567144,581.643513,CC1=C(C(=CC=C1)F)C(=O)N2CCCC(C2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,CC1=C(C(=CC=C1)F)C(=O)N2CCCC(C2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,C5a anaphylatoxin chemotactic receptor,49841217,"(2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide",C33H35F4N3O2,581.6,7.2,61.4,2,7,6,42,,PUKBOVABABRILL-YZNIXAGQSA-N
Ampanel,CIDs00164509,talampanel,337.37246,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,"Glutamate receptor ionotropic, AMPA 1, Glutamate receptor ionotropic, AMPA 2",164509,"1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone",C19H19N3O3,337.4,2.7,77.2,1,5,1,25,,JACAAXNEHGBPOQ-LLVKDONJSA-N
Etrasimod,CIDs44623998,SCHEMBL1919311,457.48475,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,Sphingosine 1-phosphate receptor Edg-1,44623998,"2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid",C26H26F3NO3,457.5,6.4,62.3,2,6,6,33,,MVGWUTBTXDYMND-QGZVFWFLSA-N
MK-0557,CIDs11491176,MK-0557,406.409663,C1CC2(CCC1C(=O)NC3=NN(C=C3)C4=CC=CC=C4F)C5=C(C=CN=C5)C(=O)O2,C1CC2(CCC1C(=O)NC3=NN(C=C3)C4=CC=CC=C4F)C5=C(C=CN=C5)C(=O)O2,Neuropeptide Y receptor type 5,11491176,"N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide",C22H19FN4O3,406.4,2.6,86.1,1,6,3,30,,RMYZIRFUCOMQRH-UHFFFAOYSA-N
Sertraline hydrochloride,CIDs00063009,sertraline,342.69052,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,Serotonin transporter,63009,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride",C17H18Cl3N,342.7,,12.0,2,1,2,21,,BLFQGGGGFNSJKA-XHXSRVRCSA-N
Varespladib,CIDs00155815,varespladib,380.3939,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,Phospholipase A2 group IIA,155815,2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid,C21H20N2O5,380.4,2.8,112.0,2,5,8,28,,BHLXTPHDSZUFHR-UHFFFAOYSA-N
Darolutamide (ODM-201),CIDs67171867,SCHEMBL1814935,398.84616,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,Androgen Receptor,67171867,N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide,C19H19ClN6O2,398.8,1.8,120.0,3,5,6,28,,BLIJXOOIHRSQRB-PXYINDEMSA-N
Orteronel,CIDs09796590,orteronel,307.34648,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,Cytochrome P450 17A1,9796590,"6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide",C18H17N3O2,307.3,1.3,67.2,2,3,2,23,,OZPFIJIOIVJZMN-SFHVURJKSA-N
Testosterone cypionate,CIDs00441404,testosterone cypionate,412.6047,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C,Androgen Receptor,441404,"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate",C27H40O3,412.6,6.4,43.4,0,3,5,30,,HPFVBGJFAYZEBE-ZLQWOROUSA-N
Cyproterone acetate,CIDs00009880,cyproterone acetate,416.93766,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C,"Glucocorticoid receptor, Androgen Receptor, Progesterone receptor",9880,"[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate",C24H29ClO4,416.9,3.6,60.4,0,4,3,29,,UWFYSQMTEOIJJG-FDTZYFLXSA-N
Finasteride,CIDs00057363,finasteride,372.54414,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,Steroid 5-alpha-reductase 2,57363,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide",C23H36N2O2,372.5,3.0,58.2,2,2,2,27,,DBEPLOCGEIEOCV-WSBQPABSSA-N
17 alpha-propionate,CIDs11750009,cortexolone 17alpha-propionate,402.52376,CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO,CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO,Androgen Receptor,11750009,"[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate",C24H34O5,402.5,3.9,80.7,1,5,5,29,,GPNHMOZDMYNCPO-PDUMRIMRSA-N
Flutamide,CIDs00003397,flutamide,276.21185,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,Androgen Receptor,3397,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,C11H11F3N2O3,276.21,3.3,74.9,1,6,2,19,,MKXKFYHWDHIYRV-UHFFFAOYSA-N
Nilutamide,CIDs00004493,nilutamide,317.22071,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,Androgen Receptor,4493,"5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione",C12H10F3N3O4,317.22,2.0,95.2,1,7,1,22,,XWXYUMMDTVBTOU-UHFFFAOYSA-N
Apalutamide,CIDs24872560,ARN-509,477.434713,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C4)C(F)(F)F)C#N)F,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,Androgen Receptor,24872560,"4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide",C21H15F4N5O2S,477.4,3.0,121.0,1,9,3,33,,HJBWBFZLDZWPHF-UHFFFAOYSA-N
AZD-3514,CIDs46893585,AZD3514,519.56249,CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4,CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4,Androgen Receptor,46893585,"1-[4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazin-1-yl]ethanone",C25H32F3N7O2,519.6,1.7,79.1,0,9,6,37,,JMEYDSHPKCSIJC-UHFFFAOYSA-N
Prinaberel,CIDs00656954,,0.0,,C=CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC(=C(C=C3)O)F,Estrogen receptor beta,656954,"7-ethenyl-2-(3-fluoro-4-hydroxyphenyl)-1,3-benzoxazol-5-ol",C15H10FNO3,271.24,3.6,66.5,2,5,2,20,,MQIMZDXIAHJKQP-UHFFFAOYSA-N
Ostarine,CIDs11326715,enobosarm,389.32797,CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Androgen Receptor,11326715,(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide,C19H14F3N3O3,389.3,2.7,106.0,2,8,5,28,,JNGVJMBLXIUVRD-SFHVURJKSA-N
Galeterone,CIDs11188409,galeterone,388.54508,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,"Cytochrome P450 17A1, Androgen Receptor",11188409,"(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol",C26H32N2O,388.5,5.2,38.1,1,2,1,29,,PAFKTGFSEFKSQG-PAASFTFBSA-N
Brilanestrant,CIDs56941241,SCHEMBL767215,446.900603,CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl,CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl,Estrogen receptor alpha,56941241,(E)-3-[4-[(E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-enyl]phenyl]prop-2-enoic acid,C26H20ClFN2O2,446.9,7.4,66.0,2,4,6,32,,BURHGPHDEVGCEZ-KJGLQBJMSA-N
Toremifene citrate,CIDs03005572,toremifene,598.08314,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Estrogen receptor,3005572,"2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid",C32H36ClNO8,598.1,,145.0,4,9,14,42,,IWEQQRMGNVVKQW-OQKDUQJOSA-N
Elacestrant,CIDs23642301,SCHEMBL229431,458.63492,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,Estrogen receptor alpha,23642301,"(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol",C30H38N2O2,458.6,6.3,44.7,2,4,10,34,,SIFNOOUKXBRGGB-AREMUKBSSA-N
Acolbifene,CIDs00155435,acolbifene,457.56074,CC1=C(C(OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O,CC1=C(C(OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O,Estrogen receptor,155435,(2S)-3-(4-hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-7-ol,C29H31NO4,457.6,5.2,62.2,2,5,6,34,,DUYNJNWVGIWJRI-LJAQVGFWSA-N
Ospemifene,CIDs03036505,ospemifene,378.89122,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,Estrogen receptor,3036505,"2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol",C24H23ClO2,378.9,6.5,29.5,1,2,8,27,,LUMKNAVTFCDUIE-VHXPQNKSSA-N
Estetrol,CIDs00027125,estetrol,304.38076,CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O,Estrogen receptor,27125,"(8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol",C18H24O4,304.4,1.5,80.9,4,4,0,22,,AJIPIJNNOJSSQC-NYLIRDPKSA-N
Dienestrol,CIDs00667476,dienestrol,266.33432,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,Estrogen receptor alpha,667476,"4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol",C18H18O2,266.3,5.4,40.5,2,2,3,20,,NFDFQCUYFHCNBW-SCGPFSFSSA-N
Diethylstilbestrol,CIDs00448537,estrogen,268.3502,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,Estrogen receptor alpha,448537,4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,C18H20O2,268.3,5.1,40.5,2,2,4,20,,RGLYKWWBQGJZGM-ISLYRVAYSA-N
Ethinylestradiol,CIDs00005991,ethynylestradiol,296.40336,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha,5991,"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C20H24O2,296.4,3.7,40.5,2,2,1,22,,BFPYWIDHMRZLRN-SLHNCBLASA-N
Estradiol,CIDs00005757,estradiol,272.38196,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha,5757,"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C18H24O2,272.4,4.0,40.5,2,2,0,20,,VOXZDWNPVJITMN-ZBRFXRBCSA-N
Mestranol,CIDs00006291,mestranol,310.42994,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,Estrogen receptor alpha,6291,"(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol",C21H26O2,310.4,4.0,29.5,1,2,2,23,,IMSSROKUHAOUJS-MJCUULBUSA-N
Estriol,CIDs00005756,estriol,288.38136,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,Estrogen receptor,5756,"(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol",C18H24O3,288.4,2.5,60.7,3,3,0,21,,PROQIPRRNZUXQM-ZXXIGWHRSA-N
Erteberel,CIDs10286159,SERBA-1,282.33372,C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O,C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O,Estrogen receptor beta,10286159,"(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",C18H18O3,282.3,4.0,49.7,2,3,1,21,,XIESSJVMWNJCGZ-VKJFTORMSA-N
Trilostane,CIDs00656583,trilostane,329.43328,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II,656583,"(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile",C20H27NO3,329.4,2.9,76.8,2,4,0,24,,KVJXBPDAXMEYOA-CXANFOAXSA-N
Fulvestrant,CIDs00104741,fulvestrant,606.770796,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Estrogen receptor,104741,"(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",C32H47F5O3S,606.8,9.2,76.7,2,9,14,41,,VWUXBMIQPBEWFH-WCCTWKNTSA-N
Chenodeoxycholic acid,CIDs00010133,cDCs,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Bile acid receptor FXR,10133,"(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C24H40O4,392.6,4.9,77.8,3,4,4,28,,RUDATBOHQWOJDD-BSWAIDMHSA-N
Zoledronic acid monohydrate,CIDs00121586,,0.0,,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O,Farnesyl diphosphate synthase,121586,(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;hydrate,C5H12N2O8P2,290.11,,154.0,6,9,4,17,,FUXFIVRTGHOMSO-UHFFFAOYSA-N
Lonafarnib,CIDs00148195,lonafarnib,638.82164,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,Protein farnesyltransferase,148195,"4-[2-[4-[(2R)-6,15-dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide",C27H31Br2ClN4O2,638.8,4.8,79.5,1,3,3,36,,DHMTURDWPRKSOA-RUZDIDTESA-N
Ramelteon,CIDs00208902,ramelteon,259.34344,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,Melatonin receptor,208902,"N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide",C16H21NO2,259.34,2.7,38.3,1,2,4,19,,YLXDSYKOBKBWJQ-LBPRGKRZSA-N
Alvimopan,CIDs05488548,,0.0,,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,Mu opioid receptor,5488548,"2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid",C25H32N2O4,424.5,1.7,89.9,3,5,8,31,,UPNUIXSCZBYVBB-JVFUWBCBSA-N
Loperamide hydrochloride,CIDs00071420,,0.0,,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,Mu opioid receptor,71420,"4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide;hydrochloride",C29H34Cl2N2O2,513.5,,43.8,2,3,7,35,,PGYPOBZJRVSMDS-UHFFFAOYSA-N
Naltrexone hydrochloride,CIDs05485201,,0.0,,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl,Opioid receptors; mu/kappa/delta,5485201,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride",C20H24ClNO4,377.9,,70.0,3,5,2,26,,RHBRMCOKKKZVRY-ITLPAZOVSA-N
Gallamine triethiodide,CIDs00006172,,0.0,,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],Muscle-type nicotinic acetylcholine receptor,6172,"2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium triiodide",C30H60I3N3O3,891.5,,27.7,0,6,21,39,,REEUVFCVXKWOFE-UHFFFAOYSA-K
Amiodarone hydrochloride,CIDs00441325,,0.0,,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,HERG,441325,"(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone;hydrochloride",C25H30ClI2NO3,681.8,,42.7,1,4,11,32,,ITPDYQOUSLNIHG-UHFFFAOYSA-N
Bethanechol chloride,CIDs00011548,,0.0,,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2",11548,2-carbamoyloxypropyl(trimethyl)azanium chloride,C7H17ClN2O2,196.67,,52.3,1,3,4,12,,XXRMYXBSBOVVBH-UHFFFAOYSA-N
Ticlopidine hydrochloride,CIDs00065335,,0.0,,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl,Purinergic receptor P2Y12,65335,"5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride",C14H15Cl2NS,300.2,,31.5,1,2,2,18,,MTKNGOHFNXIVOS-UHFFFAOYSA-N
Clopidogrel bisulfate,CIDs00115366,,0.0,,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,Purinergic receptor P2Y12,115366,"methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid",C16H18ClNO6S2,419.9,,141.0,2,8,4,26,,FDEODCTUSIWGLK-RSAXXLAASA-N
Rifaximin,CIDs06436173,rifaximin,785.87854,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Bacterial DNA-directed RNA polymerase,6436173,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate",C43H51N3O11,785.9,6.9,198.0,5,12,3,57,,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
Imiquimod,CIDs00057469,imiquimod,240.30364,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,Toll-like receptor 7,57469,"1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine",C14H16N4,240.3,2.6,56.7,1,3,2,18,,DOUYETYNHWVLEO-UHFFFAOYSA-N
Resiquimod,CIDs00159603,resiquimod,314.38218,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,"Toll-like receptor 7, Toll-like receptor 8",159603,"1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol",C17H22N4O2,314.4,1.3,86.2,2,5,5,23,,BXNMTOQRYBFHNZ-UHFFFAOYSA-N
Vesatolimod,CIDs46241268,GS-9620,410.5126,CCCCOC1=NC2=C(C(=N1)N)NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,Toll-like receptor 7,46241268,"4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one",C22H30N6O2,410.5,2.7,96.6,2,7,8,30,,VFOKSTCIRGDTBR-UHFFFAOYSA-N
Motolimod,CIDs16049404,vtx-2337,458.59516,CCCN(CCC)C(=O)C1=CC2=C(C=C(C=C2)C3=CC=C(C=C3)C(=O)N4CCCC4)N=C(C1)N,CCCN(CCC)C(=O)C1=CC2=C(C=C(C=C2)C3=CC=C(C=C3)C(=O)N4CCCC4)N=C(C1)N,Toll-like receptor 8,16049404,"2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide",C28H34N4O2,458.6,3.8,79.0,1,3,7,34,,QSPOQCXMGPDIHI-UHFFFAOYSA-N
Resatorvid,CIDs11703255,resatorvid,361.816183,CCOC(=O)C1=CCCCC1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl,CCOC(=O)C1=CCCCC1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl,Toll-like receptor 4,11703255,ethyl (6R)-6-[(2-chloro-4-fluorophenyl)sulfamoyl]cyclohexene-1-carboxylate,C15H17ClFNO4S,361.8,3.0,80.9,1,6,6,23,,LEEIJTHMHDMWLJ-CQSZACIVSA-N
SB-705498,CIDs09910486,sb-705498,429.23435,C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F,C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F,Vanilloid receptor,9910486,1-(2-bromophenyl)-3-[(3R)-1-[5-(trifluoromethyl)-2-pyridinyl]pyrrolidin-3-yl]urea,C17H16BrF3N4O,429.2,3.8,57.3,2,6,3,26,,JYILLRHXRVTRSH-GFCCVEGCSA-N
Propofol,CIDs00004943,propofol,178.27072,CC(C)C1=C(C(=CC=C1)C(C)C)O,CC(C)C1=C(C(=CC=C1)C(C)C)O,GABA-A receptor; anion channel,4943,"2,6-di(propan-2-yl)phenol",C12H18O,178.27,3.8,20.2,1,1,2,13,,OLBCVFGFOZPWHH-UHFFFAOYSA-N
Istradefylline,CIDs05311037,istradefylline,384.42896,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,Adenosine A2a receptor,5311037,"8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione",C20H24N4O4,384.4,2.5,76.9,0,5,6,28,,IQVRBWUUXZMOPW-PKNBQFBNSA-N
CVT-6883,CIDs11270783,CVT-6883,446.42565,CCCN1C(=O)C2=C(N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F)N(C1=O)CC,CCCN1C(=O)C2=C(N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F)N(C1=O)CC,Adenosine A2b receptor,11270783,"3-ethyl-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]pyrazol-4-yl]-7H-purine-2,6-dione",C21H21F3N6O2,446.4,4.2,87.1,1,7,6,32,,KOYXXLLNCXWUNF-UHFFFAOYSA-N
Preladenant,CIDs10117987,preladenant,503.55626,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,Adenosine A2a receptor,10117987,"4-(furan-2-yl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine",C25H29N9O3,503.6,1.9,125.0,1,10,9,37,,DTYWJKSSUANMHD-UHFFFAOYSA-N
CPI-444,CIDs44537963,SCHEMBL536782,407.42584,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,Adenosine A2a receptor,44537963,"7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]-2-pyridinyl]methyl]triazolo[4,5-d]pyrimidin-5-amine",C20H21N7O3,407.4,0.8,127.0,1,9,6,30,,KURQKNMKCGYWRJ-HNNXBMFYSA-N
Namodenoson,CIDs03035850,Cl-IB-MECA,544.73079,CNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC4=CC(=CC=C4)I)Cl)O)O,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,Adenosine A3 receptor,3035850,"(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide",C18H18ClIN6O4,544.7,1.9,134.0,4,8,5,30,,IPSYPUKKXMNCNQ-PFHKOEEOSA-N
Adenosine,CIDs00060961,adenosine,267.24132,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,Adenosine receptor,60961,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C10H13N5O4,267.24,-1.1,140.0,4,8,2,19,,OIRDTQYFTABQOQ-KQYNXXCUSA-N
Theophyllamine,CIDs00009433,aminophylline,420.42636,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,"Phosphodiesterase 4, Adenosine receptor, Phosphodiesterase 3",9433,"bis(1,3-dimethyl-7H-purine-2,6-dione);ethane-1,2-diamine",C16H24N10O4,420.43,,191.0,4,8,1,30,,FQPFAHBPWDRTLU-UHFFFAOYSA-N
Phenoxybenzamine hydrochloride,CIDs05284441,,0.0,,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,Adrenergic receptor alpha,5284441,N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine;hydrochloride,C18H23Cl2NO,340.3,,12.5,1,2,8,22,,VBCPVIWPDJVHAN-UHFFFAOYSA-N
Fluticasone furoate,CIDs09854489,fluticasone furoate,538.57577,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,Glucocorticoid receptor,9854489,"[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate",C27H29F3O6S,538.6,4.8,119.0,1,10,6,37,,XTULMSXFIHGYFS-VLSRWLAYSA-N
Ciclesonide,CIDs06918155,ciclesonide,540.68756,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,Glucocorticoid receptor,6918155,"[2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate",C32H44O7,540.7,5.3,99.1,1,7,6,39,,LUKZNWIVRBCLON-GXOBDPJESA-N
Cortisone acetate,CIDs00005745,cortisone acetate,402.4807,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,Glucocorticoid receptor,5745,"[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",C23H30O6,402.5,2.1,97.7,1,6,4,29,,ITRJWOMZKQRYTA-RFZYENFJSA-N
Fluocinolone acetonide,CIDs00006215,fluocinolone acetonide,452.488206,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C,Glucocorticoid receptor,6215,"(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C24H30F2O6,452.5,2.5,93.1,2,8,2,32,,FEBLZLNTKCEFIT-VSXGLTOVSA-N
Prednisolone acetate,CIDs00005834,prednisolone acetate,402.4807,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,Glucocorticoid receptor,5834,"[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",C23H30O6,402.5,2.4,101.0,2,6,4,29,,LRJOMUJRLNCICJ-JZYPGELDSA-N
Fluocinonide,CIDs00009642,fluocinonide,494.524886,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,Glucocorticoid receptor,9642,"[2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate",C26H32F2O7,494.5,3.2,99.1,1,9,4,35,,WJOHZNCJWYWUJD-IUGZLZTKSA-N
Methylprednisolone,CIDs00006741,methylprednisolone,374.4706,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Glucocorticoid receptor,6741,"(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C22H30O5,374.5,1.9,94.8,3,5,2,27,,VHRSUDSXCMQTMA-PJHHCJLFSA-N
Triamcinolone acetonide,CIDs00006436,triamcinolone acetonide,434.497743,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,Glucocorticoid receptor,6436,"(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C24H31FO6,434.5,2.5,93.1,2,7,2,31,,YNDXUCZADRHECN-JNQJZLCISA-N
Prednisone,CIDs00005865,prednisone,358.42814,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Glucocorticoid receptor,5865,"(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione",C21H26O5,358.4,1.5,91.7,2,5,2,26,,XOFYZVNMUHMLCC-ZPOLXVRWSA-N
Betamethasone dipropionate,CIDs00021800,betamethasone dipropionate,504.587583,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,Glucocorticoid receptor,21800,"[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate",C28H37FO7,504.6,3.6,107.0,1,8,8,36,,CIWBQSYVNNPZIQ-XYWKZLDCSA-N
Budesonide,CIDs05281004,budesonide,430.53386,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Glucocorticoid receptor,5281004,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C25H34O6,430.5,2.5,93.1,2,6,4,31,,VOVIALXJUBGFJZ-KWVAZRHASA-N
BETAMETHASONE,CIDs00009782,betamethasone,392.461063,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Glucocorticoid receptor,9782,"(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C22H29FO5,392.5,1.9,94.8,3,6,2,28,,UREBDLICKHMUKA-DVTGEIKXSA-N
Hyodeoxycholic acid,CIDs05283820,hyodeoxycholic acid,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,"LXR-beta, LXR-alpha",5283820,"(4R)-4-[(3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C24H40O4,392.6,4.9,77.8,3,4,4,28,,DGABKXLVXPYZII-SIBKNCMHSA-N
Prednisolone,CIDs00005755,prednisolone,360.44402,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Glucocorticoid receptor,5755,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",C21H28O5,360.4,1.6,94.8,3,5,2,26,,OIGNJSKKLXVSLS-VWUMJDOOSA-N
Meprednisone,CIDs05284587,meprednisone,372.45472,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,Glucocorticoid receptor,5284587,"(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione",C22H28O5,372.5,1.9,91.7,2,5,2,27,,PIDANAQULIKBQS-RNUIGHNZSA-N
Betamethasone valerate,CIDs00016533,Betnovate,476.577483,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,Glucocorticoid receptor,16533,"[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate",C27H37FO6,476.6,3.6,101.0,2,7,7,34,,SNHRLVCMMWUAJD-SUYDQAKGSA-N
Clobetasol propionate,CIDs00032798,clobetasol propionate,466.969983,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,Glucocorticoid receptor,32798,"[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",C25H32ClFO5,467.0,3.8,80.7,1,6,5,32,,CBGUOGMQLZIXBE-XGQKBEPLSA-N
FLUNISOLIDE,CIDs00082153,flunisolide,434.497743,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,Glucocorticoid receptor,82153,"(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C24H31FO6,434.5,2.5,93.1,2,7,2,31,,XSFJVAJPIHIPKU-XWCQMRHXSA-N
Loteprednol etabonate,CIDs00444025,loteprednol etabonate,466.95174,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,Glucocorticoid receptor,444025,"chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate",C24H31ClO7,466.9,3.9,99.1,1,7,7,32,,DMKSVUSAATWOCU-HROMYWEYSA-N
Fluticasone propionate,CIDs00444036,fluticasone propionate,500.57085,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,Glucocorticoid receptor,444036,"[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",C25H31F3O5S,500.6,4.0,106.0,1,9,6,34,,WMWTYOKRWGGJOA-CENSZEJFSA-N
Mometasone furoate,CIDs00441336,mometasone furoate,521.4295,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,Glucocorticoid receptor,441336,"[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate",C27H30Cl2O6,521.4,3.9,93.8,1,6,5,35,,WOFMFGQZHJDGCX-ZULDAHANSA-N
Deflazacort,CIDs00189821,deflazacort,441.51674,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,Glucocorticoid receptor,189821,"[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate",C25H31NO6,441.5,2.0,102.0,1,7,4,32,,FBHSPRKOSMHSIF-GRMWVWQJSA-N
Desonide,CIDs05311066,desonide,416.50728,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,Glucocorticoid receptor,5311066,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",C24H32O6,416.5,2.7,93.1,2,6,2,30,,WBGKWQHBNHJJPZ-LECWWXJVSA-N
Medroxyprogesterone acetate,CIDs00006279,progestins,386.52436,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Progesterone receptor,6279,"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C24H34O4,386.5,4.1,60.4,0,4,3,28,,PSGAAPLEWMOORI-PEINSRQWSA-N
Megestrol acetate,CIDs00011683,megestrol acetate,384.50848,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Progesterone receptor,11683,"[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",C24H32O4,384.5,3.1,60.4,0,4,3,28,,RQZAXGRLVPAYTJ-GQFGMJRRSA-N
Progesterone,CIDs00005994,progesterone,314.4617,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,Progesterone receptor,5994,"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C21H30O2,314.5,3.9,34.1,0,2,1,23,,RJKFOVLPORLFTN-LEKSSAKUSA-N
Levonorgestrel,CIDs00013109,levonorgestrel,312.44582,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor,13109,"(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",C21H28O2,312.4,3.3,37.3,1,2,2,23,,WWYNJERNGUHSAO-XUDSTZEESA-N
Gestodene,CIDs03033968,gestodene,310.42994,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor,3033968,"(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one",C21H26O2,310.4,2.9,37.3,1,2,2,23,,SIGSPDASOTUPFS-XUDSTZEESA-N
Digoxin,CIDs02724385,digoxin,780.93846,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Sodium/potassium-transporting ATPase,2724385,"3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C41H64O14,780.9,1.3,203.0,6,14,7,55,,LTMHDMANZUZIPE-PUGKRICDSA-N
Ursodiol,CIDs00031401,UDCA,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Bile acid receptor FXR,31401,"(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C24H40O4,392.6,4.9,77.8,3,4,4,28,,RUDATBOHQWOJDD-UZVSRGJWSA-N
Dutasteride,CIDs06918296,dutasteride,528.529719,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,Steroid 5-alpha-reductase,6918296,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide",C27H30F6N2O2,528.5,5.4,58.2,2,8,2,37,,JWJOTENAMICLJG-QWBYCMEYSA-N
Estrone,CIDs00005870,estrone,270.36608,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha,5870,"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",C18H22O2,270.4,3.1,37.3,1,2,0,20,,DNXHEGUUPJUMQT-CBZIJGRNSA-N
Nandrolone phenylpropionate,CIDs00229455,NTPP,406.55706,CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35,CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35,Androgen Receptor,229455,"[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate",C27H34O3,406.6,5.1,43.4,0,3,5,30,,UBWXUGDQUBIEIZ-QNTYDACNSA-N
Pancuronium bromide,CIDs00027350,pancuronium,732.6699,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],Muscle-type nicotinic acetylcholine receptor,27350,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide",C35H60Br2N2O4,732.7,,52.6,0,6,6,43,,NPIJXCQZLFKBMV-YTGGZNJNSA-L
Rocuronium bromide,CIDs00441351,,0.0,,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],Muscle-type nicotinic acetylcholine receptor,441351,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide",C32H53BrN2O4,609.7,,59.0,1,6,6,39,,OYTJKRAYGYRUJK-FMCCZJBLSA-M
Vecuronium bromide,CIDs00039764,vecuronium,637.73138,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],Muscle-type nicotinic acetylcholine receptor,39764,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromide",C34H57BrN2O4,637.7,,55.8,0,6,6,41,,VEPSYABRBFXYIB-PWXDFCLTSA-M
Drospirenone,CIDs00068873,drospirenone,366.4932,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,"Progesterone receptor, Mineralocorticoid receptor",68873,"(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione",C24H30O3,366.5,3.5,43.4,0,3,0,27,,METQSPRSQINEEU-HXCATZOESA-N
Oxandrolone,CIDs00005878,oxandrolone,306.4397,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Androgen Receptor,5878,"(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one",C19H30O3,306.4,3.7,46.5,1,3,0,22,,QSLJIVKCVHQPLV-PEMPUTJUSA-N
Stanozolol,CIDs00025249,stanozolol,328.49158,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,Androgen Receptor,25249,"(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol",C21H32N2O,328.5,4.5,48.9,2,2,0,24,,LKAJKIOFIWVMDJ-IYRCEVNGSA-N
Etoricoxib,CIDs00123619,etoricoxib,358.8419,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,Cyclooxygenase-2,123619,5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine,C18H15ClN2O2S,358.8,3.3,68.3,0,4,3,24,,MNJVRJDLRVPLFE-UHFFFAOYSA-N
Piroxicam,CIDs54676228,,0.0,,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,Cyclooxygenase,54676228,"4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide",C15H13N3O4S,331.3,3.1,108.0,2,6,2,23,,QYSPLQLAKJAUJT-UHFFFAOYSA-N
Naproxen sodium,CIDs23681059,,0.0,,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+],Cyclooxygenase,23681059,sodium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate,C14H13NaO3,252.24,,49.4,0,3,3,18,,CDBRNDSHEYLDJV-FVGYRXGTSA-M
Meloxicam,CIDs54677470,,0.0,,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,Cyclooxygenase-2,54677470,"4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide",C14H13N3O4S2,351.4,3.0,136.0,2,7,2,23,,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
Diclofenac sodium,CIDs05018304,,0.0,,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],Cyclooxygenase,5018304,"sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate",C14H10Cl2NNaO2,318.1,,52.2,1,3,4,20,,KPHWPUGNDIVLNH-UHFFFAOYSA-M
Rofecoxib,CIDs00005090,rofecoxib,314.35566,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Cyclooxygenase-2,5090,3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one,C17H14O4S,314.4,2.3,68.8,0,4,3,22,,RZJQGNCSTQAWON-UHFFFAOYSA-N
Alprostadil,CIDs05280723,prostaglandin E1,354.48096,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,"Prostanoid EP1 receptor, Prostanoid EP2 receptor",5280723,"7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid",C20H34O5,354.5,3.2,94.8,3,5,13,25,,GMVPRGQOIOIIMI-DWKJAMRDSA-N
Prostaglandin E2,CIDs05280360,prostaglandin E2,352.46508,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,Prostaglandin E2 receptor,5280360,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",C20H32O5,352.5,2.8,94.8,3,5,12,25,,XEYBRNLFEZDVAW-ARSRFYASSA-N
Bimatoprost,CIDs05311027,bimatoprost,415.56558,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Prostanoid FP receptor,5311027,"(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide",C25H37NO4,415.6,2.8,89.8,4,4,12,30,,AQOKCDNYWBIDND-FTOWTWDKSA-N
Ramatroban,CIDs00123879,ramatroban,416.465843,C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O,C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O,"Thromboxane A2 receptor, G protein-coupled receptor 44",123879,"3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid",C21H21FN2O4S,416.5,2.9,96.8,2,6,6,29,,LDXDSHIEDAPSSA-OAHLLOKOSA-N
Laropiprant,CIDs09867642,laropiprant,435.896263,CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F,Prostanoid DP receptor,9867642,"2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid",C21H19ClFNO4S,435.9,3.5,84.8,1,5,5,29,,NXFFJDQHYLNEJK-CYBMUJFWSA-N
Indomethacin,CIDs00003715,indomethacin,357.78764,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Cyclooxygenase,3715,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,C19H16ClNO4,357.8,4.3,68.5,1,4,4,25,,CGIGDMFJXJATDK-UHFFFAOYSA-N
Streptomycin (sulfate),CIDs00019648,streptomycin,1457.38356,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Bacterial 70S ribosome,19648,"bis(2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine);sulfuric acid",C42H84N14O36S3,1457.4,,922.0,30,42,18,95,,QTENRWWVYAAPBI-YCRXJPFRSA-N
Tetracycline hydrochloride,CIDs54704426,,0.0,,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,Bacterial 70S ribosome,54704426,"(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride",C22H25ClN2O8,480.9,,182.0,7,9,2,33,,YCIHPQHVWDULOY-FMZCEJRJSA-N
Tobramycin,CIDs00036294,tobramycin,467.51448,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,70S ribosome,36294,"(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol",C18H37N5O9,467.5,-6.2,268.0,10,14,6,32,,NLVFBUXFDBBNBW-PBSUHMDJSA-N
Nitisinone,CIDs00115355,NTBC,329.22811,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],4-hydroxyphenylpyruvate dioxygenase,115355,"2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione",C14H10F3NO5,329.23,2.3,97.0,0,8,2,23,,OUBCNLGXQFSTLU-UHFFFAOYSA-N
Azithromycin,CIDs00447043,azithromycin,748.98448,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Bacterial 70S ribosome,447043,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one",C38H72N2O12,749.0,4.0,180.0,5,14,7,52,,MQTOSJVFKKJCRP-BICOPXKESA-N
Linezolid,CIDs00441401,linezolid,337.346103,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Bacterial 70S ribosome,441401,"N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide",C16H20FN3O4,337.35,0.7,71.1,1,6,4,24,,TYZROVQLWOKYKF-ZDUSSCGKSA-N
Masoprocol,CIDs00071398,nordihydroguaiaretic acid,302.36488,CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O,CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O,"Insulin-like growth factor I receptor, Receptor protein-tyrosine kinase erbB-2",71398,"4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol",C18H22O4,302.4,4.3,80.9,4,4,5,22,,HCZKYJDFEPMADG-TXEJJXNPSA-N
Tacrine hydrochloride,CIDs02723754,,0.0,,C1CCC2=NC3=CC=CC=C3C(=C2C1)N.Cl,Cholinesterases; ACHE & BCHE,2723754,"1,2,3,4-tetrahydroacridin-9-amine;hydrochloride",C13H15ClN2,234.72,,38.9,2,2,0,16,,ZUFVXZVXEJHHBN-UHFFFAOYSA-N
Acitretin,CIDs05284513,acitretin,326.42934,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Retinoid receptor,5284513,"(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid",C21H26O3,326.4,6.1,46.5,1,3,6,24,,IHUNBGSDBOWDMA-AQFIFDHZSA-N
Isotretinoin,CIDs05282379,isotretinoin,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoic acid receptor,5282379,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",C20H28O2,300.4,6.3,37.3,1,2,5,22,,SHGAZHPCJJPHSC-XFYACQKRSA-N
Tazarotene,CIDs00005381,tazarotene,351.46194,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,Retinoic acid receptor,5381,"ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate",C21H21NO2S,351.5,4.9,64.5,0,4,5,25,,OGQICQVSFDPSEI-UHFFFAOYSA-N
Tamibarotene,CIDs00108143,tamibarotene,351.4388,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,"Retinoic acid receptor alpha, Retinoic acid receptor beta",108143,"4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid",C22H25NO3,351.4,5.4,66.4,2,3,3,26,,MUTNCGKQJGXKEM-UHFFFAOYSA-N
Tretinoin,CIDs00444795,retinoic acid,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoic acid receptor,444795,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",C20H28O2,300.4,6.3,37.3,1,2,5,22,,SHGAZHPCJJPHSC-YCNIQYBTSA-N
Bexarotene,CIDs00082146,bexarotene,348.47792,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,Retinoid X receptor,82146,"4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid",C24H28O2,348.5,7.6,37.3,1,2,3,26,,NAVMQTYZDKMPEU-UHFFFAOYSA-N
AGN-194204,CIDs09863341,AGN-194204,352.50968,CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,Retinoid X receptor,9863341,"(2E,4E)-3-methyl-5-[(1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]penta-2,4-dienoic acid",C24H32O2,352.5,7.3,37.3,1,2,4,26,,BOOOLEGQBVUTKC-NVQSDHBMSA-N
Adapalene,CIDs00060164,adapalene,412.52012,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,Retinoic acid receptor,60164,6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid,C28H28O3,412.5,7.7,46.5,1,3,4,31,,LZCDAPDGXCYOEH-UHFFFAOYSA-N
Calcitriol,CIDs05280453,calcitriol,416.63646,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor,5280453,"trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C27H44O3,416.6,5.1,60.7,3,3,6,30,,GMRQFYUYWCNGIN-NKMMMXOESA-N
Paricalcitol-D6 (ABT-358),CIDs05281104,paricalcitol,416.63646,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,Vitamin D receptor,5281104,"trans-(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol",C27H44O3,416.6,5.0,60.7,3,3,5,30,,BPKAHTKRCLCHEA-UBFJEZKGSA-N
Calcitriol (Ro-21-5535),CIDs05280453,calcitriol,416.63646,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor,5280453,"trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C27H44O3,416.6,5.1,60.7,3,3,6,30,,GMRQFYUYWCNGIN-NKMMMXOESA-N
Warfarin sodium,CIDs16204922,,0.0,,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+],Vitamin k epoxide reductase complex subunit 1 isoform 1,16204922,sodium 2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate,C19H15NaO4,330.3,,66.4,0,4,4,24,,KYITYFHKDODNCQ-UHFFFAOYSA-M
Cilostazol,CIDs00002754,cilostazol,369.46068,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,Phosphodiesterase 3A,2754,"6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one",C20H27N5O2,369.5,3.1,81.9,1,5,7,27,,RRGUKTPIGVIEKM-UHFFFAOYSA-N
AN-2728,CIDs44591583,AN-2728,251.0451,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,Phosphodiesterase 4,44591583,"4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile",C14H10BNO3,251.05,,62.5,1,4,2,19,,USZAGAREISWJDP-UHFFFAOYSA-N
Roflumilast,CIDs00449193,roflumilast,403.207466,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,Phosphodiesterase 4,449193,"3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide",C17H14Cl2F2N2O3,403.2,4.6,60.5,1,6,7,26,,MNDBXUUTURYVHR-UHFFFAOYSA-N
GSK-256066,CIDs09827968,GSK256066,518.58414,CC1=C2C(=CC(=C1)S(=O)(=O)C3=CC=CC(=C3)C(=O)N(C)C)C(=C(C=N2)C(=O)N)NC4=CC(=CC=C4)OC,CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)C,Phosphodiesterase 4,9827968,6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide,C27H26N4O5S,518.6,3.8,140.0,2,7,7,37,,JFHROPTYMMSOLG-UHFFFAOYSA-N
Rolipram,CIDs00005092,rolipram,275.34284,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,Phosphodiesterase 4,5092,4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one,C16H21NO3,275.34,2.2,47.6,1,3,4,20,,HJORMJIFDVBMOB-UHFFFAOYSA-N
MP-10,CIDs11581936,MP-10,392.4525,CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5,CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5,Phosphodiesterase 10A,11581936,2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline,C25H20N4O,392.5,4.2,52.8,0,4,5,30,,AZEXWHKOMMASPA-UHFFFAOYSA-N
Dipyridamole,CIDs00003108,dipyridamole,504.6256,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,"Equilibrative nucleoside transporter 1, 3',5'-cyclic phosphodiesterase",3108,"2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol",C24H40N8O4,504.6,0.7,145.0,4,12,12,36,,IZEKFCXSFNUWAM-UHFFFAOYSA-N
Tadalafil,CIDs00110635,tadalafil,389.40396,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Phosphodiesterase 5A,110635,"(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione",C22H19N3O4,389.4,2.3,74.9,1,4,1,29,,WOXKDUGGOYFFRN-IIBYNOLFSA-N
Ezutromid,CIDs25109292,SMTC1100,337.3923,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,Utrophin,25109292,"5-ethylsulfonyl-2-naphthalen-2-yl-1,3-benzoxazole",C19H15NO3S,337.4,4.3,68.6,0,4,3,24,,KSGCNXAZROJSNW-UHFFFAOYSA-N
Trichlormethiazide,CIDs00005560,trichlormethiazide,380.65582,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,Thiazide-sensitive sodium-chloride cotransporter,5560,"6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C8H8Cl3N3O4S2,380.7,0.6,135.0,3,7,2,20,,LMJSLTNSBFUCMU-UHFFFAOYSA-N
Rifampicin,CIDs135398735,,0.0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,Bacterial DNA-directed RNA polymerase,135398735,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate",C43H58N4O12,822.9,4.9,220.0,6,15,5,59,,JQXXHWHPUNPDRT-WLSIYKJHSA-N
Rifapentine,CIDs135403821,,0.0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,Bacterial DNA-directed RNA polymerase,135403821,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate",C47H64N4O12,877.0,6.7,220.0,6,15,6,63,,WDZCUPBHRAEYDL-GZAUEHORSA-N
Mavacamten,CIDs117761397,,0.0,,CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2,Cardiac myosin,117761397,"6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione",C15H19N3O2,273.33,2.1,61.4,2,3,4,20,,RLCLASQCAPXVLM-NSHDSACASA-N
Caffeine,CIDs00002519,caffeine,194.1906,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,Adenosine receptor,2519,"1,3,7-trimethylpurine-2,6-dione",C8H10N4O2,194.19,-0.1,58.4,0,3,0,14,,RYYVLZVUVIJVGH-UHFFFAOYSA-N
Lumacaftor,CIDs16678941,lumacaftor,452.406926,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,Cystic fibrosis transmembrane conductance regulator,16678941,"3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methyl-2-pyridinyl]benzoic acid",C24H18F2N2O5,452.4,4.4,97.8,2,8,5,33,,UFSKUSARDNFIRC-UHFFFAOYSA-N
PTC-124,CIDs11219835,ataluren,284.241963,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,80S Ribosome,11219835,"3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid",C15H9FN2O3,284.24,3.1,76.2,1,6,3,21,,OOUGLTULBSNHNF-UHFFFAOYSA-N
Ethionamide,CIDs02761171,ethionamide,166.2434,CCC1=NC=CC(=C1)C(=S)N,CCC1=NC=CC(=C1)C(=S)N,Enoyl-[acyl-carrier-protein] reductase,2761171,2-ethylpyridine-4-carbothioamide,C8H10N2S,166.25,1.1,71.0,1,2,2,11,,AEOCXXJPGCBFJA-UHFFFAOYSA-N
Cefoperazone (sodium salt),CIDs23663974,,0.0,,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],Bacterial penicillin-binding protein,23663974,"sodium (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C25H26N9NaO8S2,667.7,,274.0,3,13,9,45,,NCFTXMQPRQZFMZ-WERGMSTESA-M
Tolcapone,CIDs04659569,tolcapone,273.24084,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Catechol O-methyltransferase,4659569,"(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone",C14H11NO5,273.24,3.3,103.0,2,5,2,20,,MIQPIUSUKVNLNT-UHFFFAOYSA-N
Proglumide,CIDs00004922,proglumide,334.41004,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,Cholecystokinin receptor,4922,4-benzamido-5-(dipropylamino)-5-oxopentanoic acid,C18H26N2O4,334.4,2.4,86.7,2,4,10,24,,DGMKFQYCZXERLX-UHFFFAOYSA-N
MK-3207,CIDs25019940,MK-3207,557.590466,C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4,C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4,Calcitonin gene-related peptide type 1 receptor,25019940,"2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide",C31H29F2N5O3,557.6,2.8,103.0,3,7,4,41,,AZAANWYREOQRFB-SETSBSEESA-N
Gabapentin,CIDs00003446,gabapentin,171.23678,C1CCC(CC1)(CC(=O)O)CN,C1CCC(CC1)(CC(=O)O)CN,Voltage-gated calcium channel,3446,2-[1-(aminomethyl)cyclohexyl]acetic acid,C9H17NO2,171.24,-1.1,63.3,2,3,3,12,,UGJMXCAKCUNAIE-UHFFFAOYSA-N
Cinacalcet hydrochloride,CIDs00156418,cinacalcet,393.87293,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,Calcium sensing receptor,156418,N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;hydrochloride,C22H23ClF3N,393.9,,12.0,2,4,6,27,,QANQWUQOEJZMLL-PKLMIRHRSA-N
Rimonabant,CIDs00104850,,0.0,,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,Cannabinoid CB1 receptor,104850,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide",C22H21Cl3N4O,463.8,6.5,50.2,1,3,4,30,,JZCPYUJPEARBJL-UHFFFAOYSA-N
Otenabant,CIDs10052040,otenabant,510.4183,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N,Cannabinoid CB1 receptor,10052040,1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide,C25H25Cl2N7O,510.4,4.3,102.0,2,6,6,35,,UNAZAADNBYXMIV-UHFFFAOYSA-N
842166X,CIDs10253143,GW 842166X,449.25439,C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl,C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl,Cannabinoid CB2 receptor,10253143,"2-(2,4-dichloroanilino)-N-(oxan-4-ylmethyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide",C18H17Cl2F3N4O2,449.3,4.1,76.1,2,8,5,29,,TWQYWUXBZHPIIV-UHFFFAOYSA-N
Cannabidiol,CIDs00644019,cannabidiol (CBD,314.4617,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,Cannabinoid CB1 receptor,644019,"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol",C21H30O2,314.5,6.5,40.5,2,2,6,23,,QHMBSVQNZZTUGM-ZWKOTPCHSA-N
Doripenem,CIDs00073303,doripenem,420.50426,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,Bacterial penicillin-binding protein,73303,"(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C15H24N4O6S2,420.5,-3.4,196.0,5,10,7,27,,AVAACINZEOAHHE-VFZPANTDSA-N
Diclofenamide,CIDs00003038,dichlorphenamide,305.15884,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,"Carbonic anhydrase XII, Carbonic anhydrase II, Carbonic anhydrase I, Carbonic anhydrase IV",3038,"4,5-dichlorobenzene-1,3-disulfonamide",C6H6Cl2N2O4S2,305.2,0.3,137.0,2,6,2,16,,GJQPMPFPNINLKP-UHFFFAOYSA-N
Dorzolamide hydrochloride,CIDs06918132,,0.0,,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,Carbonic anhydrase II,6918132,"(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride",C10H17ClN2O4S3,360.9,,151.0,3,7,3,20,,OSRUSFPMRGDLAG-QMGYSKNISA-N
Sulfanilamide,CIDs00005333,sulfonamide,172.20492,C1=CC(=CC=C1N)S(=O)(=O)N,C1=CC(=CC=C1N)S(=O)(=O)N,Bacterial dihydropteroate synthase,5333,4-aminobenzenesulfonamide,C6H8N2O2S,172.21,-0.6,94.6,2,4,1,11,,FDDDEECHVMSUSB-UHFFFAOYSA-N
Irosustat (STX-64),CIDs05287541,irosustat,309.3376,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,Steryl-sulfatase,5287541,"(6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta[c]chromen-3-yl) sulfamate",C14H15NO5S,309.34,2.3,104.0,1,6,2,21,,DSLPMJSGSBLWRE-UHFFFAOYSA-N
Indapamide,CIDs00003702,indapamide,365.83454,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Thiazide-sensitive sodium-chloride cotransporter,3702,"4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide",C16H16ClN3O3S,365.8,2.9,101.0,2,5,3,24,,NDDAHWYSQHTHNT-UHFFFAOYSA-N
Metolazone,CIDs00004170,metolazone,365.83454,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Thiazide-sensitive sodium-chloride cotransporter,4170,"7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide",C16H16ClN3O3S,365.8,4.1,101.0,2,5,2,24,,AQCHWTWZEMGIFD-UHFFFAOYSA-N
Omecamtiv mecarbil,CIDs11689883,omecamtiv mecarbil,401.434663,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,Cardiac myosin,11689883,methyl 4-[[2-fluoro-3-[(6-methyl-3-pyridinyl)carbamoylamino]phenyl]methyl]piperazine-1-carboxylate,C20H24FN5O3,401.4,1.4,86.8,2,6,5,29,,RFUBTTPMWSKEIW-UHFFFAOYSA-N
Telotristat Etiprate (LX 1606 Hippurate),CIDs25253377,telotristat etiprate,754.15461,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,Tryptophan 5-hydroxylase,25253377,"2-benzamidoacetic acid;ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate",C36H35ClF3N7O6,754.2,,198.0,4,14,13,53,,XSFPZBUIBYMVEA-CELUQASASA-N
Aripiprazole,CIDs00060795,aripiprazole,448.38538,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,"Serotonin 1a (5-HT1a) receptor, Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor",60795,"7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one",C23H27Cl2N3O2,448.4,4.6,44.8,1,4,7,30,,CEUORZQYGODEFX-UHFFFAOYSA-N
Brintellix,CIDs56843850,,0.0,,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,"Serotonin 3a (5-HT3a) receptor, Serotonin 1a (5-HT1a) receptor, Serotonin transporter",56843850,"1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine;hydrobromide",C18H23BrN2S,379.4,,40.6,2,3,3,22,,VNGRUFUIHGGOOM-UHFFFAOYSA-N
Cyclobenzaprine hydrochloride,CIDs00022576,,0.0,,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl,"Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor",22576,"N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride",C20H22ClN,311.8,,3.2,1,1,3,22,,VXEAYBOGHINOKW-UHFFFAOYSA-N
Mirtazapine,CIDs00004205,mirtazapine,265.35286,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"Adrenergic receptor alpha-2, Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor",4205,"5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene",C17H19N3,265.35,3.3,19.4,0,3,0,20,,RONZAEMNMFQXRA-UHFFFAOYSA-N
Agomelatine,CIDs00082148,agomelatine,243.30098,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,"Serotonin 2c (5-HT2c) receptor, Melatonin receptor",82148,N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide,C15H17NO2,243.3,2.7,38.3,1,2,4,18,,YJYPHIXNFHFHND-UHFFFAOYSA-N
Prucalopride,CIDs03052762,prucalopride,367.87034,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,Serotonin 4 (5-HT4) receptor,3052762,"4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide",C18H26ClN3O3,367.9,2.0,76.8,2,5,6,25,,ZPMNHBXQOOVQJL-UHFFFAOYSA-N
Tegaserod maleate,CIDs135413539,,0.0,,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC.C(=CC(=O)O)C(=O)O,Serotonin 4 (5-HT4) receptor,135413539,(Z)-but-2-enedioic acid;1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine,C20H27N5O5,417.5,,162.0,5,7,10,30,,CPDDZSSEAVLMRY-FEQFWAPWSA-N
Balsalazide disodium,CIDs135413496,,0.0,,C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)[O-])C(=O)O.[Na+].[Na+],"Cyclooxygenase, Peroxisome proliferator-activated receptor gamma, Arachidonate 5-lipoxygenase",135413496,disodium;3-[[4-[(3-carboxy-4-oxidophenyl)diazenyl]benzoyl]amino]propanoate,C17H13N3Na2O6,401.28,,154.0,2,8,6,28,,CKMOQBVBEGCJGW-UHFFFAOYSA-L
Sulfamethizole,CIDs00005328,sulfamethizole,270.3313,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase,5328,"4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide",C9H10N4O2S2,270.3,0.5,135.0,2,7,3,17,,VACCAVUAMIDAGB-UHFFFAOYSA-N
Clindamycin HCl,CIDs16051951,,0.0,,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl,Bacterial 70S ribosome,16051951,"(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride",C18H34Cl2N2O5S,461.4,,128.0,5,7,7,28,,AUODDLQVRAJAJM-XJQDNNTCSA-N
Prulifloxacin,CIDs00065947,prulifloxacin,461.463403,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,"Bacterial DNA gyrase, Topoisomerase IV",65947,"6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid",C21H20FN3O6S,461.5,1.0,125.0,1,11,4,32,,PWNMXPDKBYZCOO-UHFFFAOYSA-N
Pefloxacin,CIDs00051081,pefloxacin,333.357403,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,"Bacterial DNA gyrase, Topoisomerase IV",51081,1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,C17H20FN3O3,333.36,0.3,64.1,1,7,3,24,,FHFYDNQZQSQIAI-UHFFFAOYSA-N
Clindamycin palmitate,CIDs16052038,clindamycin palmitate,699.85276,CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl,CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl,Bacterial 70S ribosome,16052038,"[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride",C34H64Cl2N2O6S,699.9,,134.0,4,8,23,45,,GTNDZRUWKHDICY-DJHAJVGHSA-N
Ofloxacin,CIDs00004583,ofloxacin,361.367503,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Bacterial DNA gyrase,4583,"7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid",C18H20FN3O4,361.4,-0.4,73.3,1,8,2,26,,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
Primidone,CIDs00004909,primidone,218.25176,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,"GABA-A receptor; anion channel, Sodium channel alpha subunit",4909,"5-ethyl-5-phenyl-1,3-diazinane-4,6-dione",C12H14N2O2,218.25,0.9,58.2,2,2,2,16,,DQMZLTXERSFNPB-UHFFFAOYSA-N
Econazole nitrate,CIDs00068589,,0.0,,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],Cytochrome P450 51,68589,"1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid",C18H16Cl3N3O4,444.7,,93.1,1,5,6,28,,DDXORDQKGIZAME-UHFFFAOYSA-N
Fluconazole,CIDs00003365,fluconazole,306.270786,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,Cytochrome P450 51,3365,"2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol",C13H12F2N6O,306.27,0.4,81.7,1,7,5,22,,RFHAOTPXVQNOHP-UHFFFAOYSA-N
Tioconazole,CIDs00005482,tioconazole,387.71122,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,Cytochrome P450 51,5482,"1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole",C16H13Cl3N2OS,387.7,5.3,55.3,0,3,6,23,,QXHHHPZILQDDPS-UHFFFAOYSA-N
Butoconazole nitrate,CIDs00047471,butoconazole,474.78852,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],Cytochrome P450 51,47471,"1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid",C19H18Cl3N3O3S,474.8,,109.0,1,5,7,29,,ZHPWRQIPPNZNML-UHFFFAOYSA-N
Natamycin,CIDs05284447,Cl-12625,665.72518,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,Ergosterol,5284447,"(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid",C33H47NO13,665.7,-1.3,231.0,7,14,3,47,,NCXMLFZGDNKEPB-FFPOYIOWSA-N
Vidarabine,CIDs00021704,vidarabine,267.24132,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,Human herpesvirus 1 DNA polymerase,21704,"(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C10H13N5O4,267.24,-1.1,140.0,4,8,2,19,,OIRDTQYFTABQOQ-UHTZMRCNSA-N
Docosanol,CIDs00012620,docosanol,326.60004,CCCCCCCCCCCCCCCCCCCCCCO,CCCCCCCCCCCCCCCCCCCCCCO,Envelope glycoprotein,12620,docosan-1-ol,C22H46O,326.6,10.5,20.2,1,1,20,23,,NOPFSRXAKWQILS-UHFFFAOYSA-N
Idoxuridine,CIDs00005905,IUdR,354.09851,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,DNA,5905,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione",C9H11IN2O5,354.1,-1.0,99.1,3,5,2,17,,XQFRJNBWHJMXHO-RRKCRQDMSA-N
Arbidol,CIDs00131411,,0.0,,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,Hemagglutinin,131411,ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate,C22H25BrN2O3S,477.4,4.4,80.0,1,5,8,29,,KCFYEAOKVJSACF-UHFFFAOYSA-N
Artemether,CIDs00068911,artemether,298.37464,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,Ferriprotoporphyrin IX,68911,"(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane",C16H26O5,298.37,3.1,46.2,0,5,1,21,,SXYIRMFQILZOAM-HVNFFKDJSA-N
Lumefantrine,CIDs06437380,lumefantrine,528.94018,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)C(=CC4=CC=C(C=C4)Cl)C2=CC(=C1)Cl)O,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,Ferriprotoporphyrin IX,6437380,"2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol",C30H32Cl3NO,528.9,8.7,23.5,1,2,10,35,,DYLGFOYVTXJFJP-MYYYXRDXSA-N
Piperaquine,CIDs00122262,piperaquine,535.51058,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl,Ferriprotoporphyrin IX,122262,7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline,C29H32Cl2N6,535.5,5.6,38.7,0,6,6,37,,UCRHFBCYFMIWHC-UHFFFAOYSA-N
Praziquantel,CIDs00004891,praziquantel,312.40606,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,"Voltage-activated calcium channel beta 1 subunit, Voltage-activated calcium channel beta 2 subunit",4891,"2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one",C19H24N2O2,312.4,2.7,40.6,0,2,1,23,,FSVJFNAIGNNGKK-UHFFFAOYSA-N
Fenbendazole,CIDs00003334,fenbendazole,299.34762,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,Tubulin beta chain,3334,methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate,C15H13N3O2S,299.3,3.6,92.3,2,4,4,21,,HDDSHPAODJUKPD-UHFFFAOYSA-N
Oxfendazole,CIDs00040854,oxfendazole,315.34702,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,Tubulin,40854,methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate,C15H13N3O3S,315.3,2.3,103.0,2,5,4,22,,BEZZFPOZAYTVHN-UHFFFAOYSA-N
Nitazoxanide,CIDs00041684,nitazoxanide,307.28196,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],Pyruvate:ferredoxin oxidoreductase,41684,"[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate",C12H9N3O5S,307.28,2.0,142.0,1,7,4,21,,YQNQNVDNTFHQSW-UHFFFAOYSA-N
Secnidazole,CIDs00071815,secnidazole,185.18054,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],CC1=NC=C(N1CC(C)O)[N+](=O)[O-],DNA,71815,1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol,C7H11N3O3,185.18,0.2,83.9,1,4,2,13,,KPQZUUQMTUIKBP-UHFFFAOYSA-N
Propylthiouracil,CIDs00657298,propylthiouracil (PTU,170.2321,CCCC1=CC(=O)NC(=S)N1,CCCC1=CC(=O)NC(=S)N1,"Thyroid peroxidase, Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI)",657298,6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,C7H10N2OS,170.23,0.8,73.2,2,2,2,11,,KNAHARQHSZJURB-UHFFFAOYSA-N
Famciclovir,CIDs00003324,famciclovir,321.33176,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,Human herpesvirus 1 DNA polymerase,3324,[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,C14H19N5O4,321.33,0.0,122.0,1,8,9,23,,GGXKWVWZWMLJEH-UHFFFAOYSA-N
Benserazide,CIDs00002327,benserazide,257.2432,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,DOPA decarboxylase,2327,"2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide",C10H15N3O5,257.24,-1.3,148.0,7,7,5,18,,BNQDCRGUHNALGH-UHFFFAOYSA-N
Methyldopa,CIDs00038853,,0.0,,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,Adrenergic receptor alpha-2,38853,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid",C10H13NO4,211.21,-1.9,104.0,4,5,3,15,,CJCSPKMFHVPWAR-JTQLQIEISA-N
Amisulpride,CIDs00002159,amisulpride,369.47898,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,"Dopamine receptors; D2 & D3, Serotonin (5-HT) receptor",2159,4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide,C17H27N3O4S,369.5,1.5,110.0,2,6,7,25,,NTJOBXMMWNYJFB-UHFFFAOYSA-N
Clozapine,CIDs135398737,,0.0,,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor",135398737,"3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine",C18H19ClN4,326.8,3.1,30.9,1,3,1,23,,QZUDBNBUXVUHMW-UHFFFAOYSA-N
Levodopa,CIDs00006047,levodopa,197.18794,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Dopamine D3 receptor,6047,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid",C9H11NO4,197.19,-2.7,104.0,4,5,3,14,,WTDRDQBEARUVNC-LURJTMIESA-N
Amantadine hydrochloride,CIDs00064150,,0.0,,C1C2CC3CC1CC(C2)(C3)N.Cl,"Matrix protein 2, Glutamate [NMDA] receptor",64150,adamantan-1-amine;hydrochloride,C10H18ClN,187.71,,26.0,2,1,0,12,,WOLHOYHSEKDWQH-UHFFFAOYSA-N
Domperidone,CIDs00003151,domperidone,425.91126,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,Dopamine D2 receptor,3151,6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one,C22H24ClN5O2,425.9,3.9,67.9,2,3,5,30,,FGXWKSZFVQUSTL-UHFFFAOYSA-N
Bupropion hydrochloride,CIDs00062884,,0.0,,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl,"Norepinephrine transporter, Dopamine transporter",62884,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride,C13H19Cl2NO,276.2,,29.1,2,2,4,17,,HEYVINCGKDONRU-UHFFFAOYSA-N
Salbutamol sulfate,CIDs00002083,salbutamol,239.31074,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Beta-2 adrenergic receptor,2083,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,C13H21NO3,239.31,0.3,72.7,4,4,5,17,,NDAUXUAQIAJITI-UHFFFAOYSA-N
Isoprenaline hydrochloride,CIDs00005807,,0.0,,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,Adrenergic receptor beta,5807,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;hydrochloride",C11H18ClNO3,247.72,,72.7,5,4,4,16,,IROWCYIEJAOFOW-UHFFFAOYSA-N
Lubiprostone,CIDs00157920,lubiprostone,390.461886,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,Chloride channel protein 2,157920,"7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid",C20H32F2O5,390.5,4.0,83.8,2,7,11,27,,WGFOBBZOWHGYQH-MXHNKVEKSA-N
Rivaroxaban,CIDs09875401,rivaroxaban,435.88132,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,Coagulation factor X,9875401,"5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide",C19H18ClN3O5S,435.9,2.5,116.0,1,6,5,29,,KGFYHTZWPPHNLQ-AWEZNQCLSA-N
Apixaban,CIDs10182969,apixaban,459.4971,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,Coagulation factor X,10182969,"1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide",C25H25N5O4,459.5,2.2,111.0,1,5,5,34,,QNZCBYKSOIHPEH-UHFFFAOYSA-N
PCI-27483,CIDs135425273,,0.0,,C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)NC(CC(=O)O)C(=O)O,Coagulation factor VII,135425273,(2S)-2-[[2-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-4-hydroxy-5-(2-hydroxy-5-sulfamoylphenyl)phenyl]acetyl]amino]butanedioic acid,C26H24N6O9S,596.6,-0.1,291.0,9,12,10,42,,WDJHHCAKBRKCLW-IBGZPJMESA-N
Balicatib,CIDs10201696,balicatib,411.54042,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N,Cathepsin K,10201696,N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide,C23H33N5O2,411.5,2.8,88.5,2,5,7,30,,LLCRBOWRJOUJAE-UHFFFAOYSA-N
ADL-5859,CIDs11417954,ADL-5859,392.49072,CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=C2C(=CC=C4)O,CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC(=C42)O,Delta opioid receptor,11417954,"N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide",C24H28N2O3,392.5,3.2,61.8,2,4,4,29,,OPIKUXLJQFYMSC-UHFFFAOYSA-N
Ambrisentan,CIDs06918493,ambrisentan,378.42108,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,"Endothelin receptor, ET-A/ET-B",6918493,"(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid",C22H22N2O4,378.4,3.8,81.5,1,6,7,28,,OUJTZYPIHDYQMC-LJQANCHMSA-N
Sitaxentan,CIDs00216235,sitaxsentan,454.9045,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"Endothelin receptor, ET-A/ET-B",216235,"N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide",C18H15ClN2O6S2,454.9,3.7,144.0,1,9,6,29,,PHWXUGHIIBDVKD-UHFFFAOYSA-N
Macitentan,CIDs16004692,macitentan,588.2729,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Endothelin receptor, ET-A/ET-B",16004692,5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine,C19H20Br2N6O4S,588.3,3.7,137.0,2,10,11,32,,JGCMEBMXRHSZKX-UHFFFAOYSA-N
GLPG-0974,CIDs57520598,SCHEMBL11298599,484.995,CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl,CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl,Free fatty acid receptor 2,57520598,4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid,C25H25ClN2O4S,485.0,4.3,106.0,1,5,8,33,,MPMKMQHJHDHPBE-RUZDIDTESA-N
Flumazenil,CIDs00003373,flumazenil,303.288363,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,GABA-A receptor; anion channel,3373,"ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",C15H14FN3O3,303.29,1.0,64.4,0,5,3,22,,OFBIFZUFASYYRE-UHFFFAOYSA-N
Felbamate,CIDs00003331,felbamate,238.23986,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Glutamate [NMDA] receptor,3331,(3-carbamoyloxy-2-phenylpropyl) carbamate,C11H14N2O4,238.24,0.6,105.0,2,4,7,17,,WKGXYQFOCVYPAC-UHFFFAOYSA-N
TD-139,CIDs73774610,TD139,648.635006,C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O,C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O,Galectin-3,73774610,"(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol",C28H30F2N6O8S,648.6,0.2,227.0,6,15,8,45,,YGIDGBAHDZEYMT-MQFIMZJJSA-N
Adomeglivant,CIDs91933867,,0.0,,CC1=CC(=CC(=C1C2=CC=C(C=C2)C(C)(C)C)C)OC(CCC(F)(F)F)C3=CC=C(C=C3)C(=O)NCCC(=O)O,Glucagon receptor,91933867,"3-[[4-[(1S)-1-[4-(4-tert-butylphenyl)-3,5-dimethylphenoxy]-4,4,4-trifluorobutyl]benzoyl]amino]propanoic acid",C32H36F3NO4,555.6,8.1,75.6,2,7,11,40,,FASLTMSUPQDLIB-MHZLTWQESA-N
Lansoprazole,CIDs00003883,lansoprazole,369.36147,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Potassium-transporting ATPase,3883,"2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole",C16H14F3N3O2S,369.4,2.8,87.1,1,8,5,25,,MJIHNNLFOKEZEW-UHFFFAOYSA-N
Esomeprazole Sodium,CIDs00004594,omeprazole,345.41606,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,Potassium-transporting ATPase,4594,"6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole",C17H19N3O3S,345.4,2.2,96.3,1,6,5,24,,SUBDBMMJDZJVOS-UHFFFAOYSA-N
Telaprevir (VX-950),CIDs03010818,telaprevir,679.84932,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,"Hepatitis C virus serine protease, NS3/NS4A",3010818,"(3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide",C36H53N7O6,679.8,4.2,180.0,4,8,14,49,,BBAWEDCPNXPBQM-GDEBMMAJSA-N
Daclatasvir dihydrochloride,CIDs25154713,daclatasvir,811.79688,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl,Nonstructural protein 5A,25154713,methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;dihydrochloride,C40H52Cl2N8O6,811.8,,175.0,6,8,13,56,,BVZLLUDATICXCI-JMSCDMLISA-N
Danoprevir,CIDs11285588,X7550,731.831243,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,"Hepatitis C virus serine protease, NS3/NS4A",11285588,"[(1S,4R,6S,7Z,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",C35H46FN5O9S,731.8,3.3,189.0,3,10,8,51,,ZVTDLPBHTSMEJZ-JSZLBQEHSA-N
Cyproheptadine hydrochloride,CIDs00013770,,0.0,,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,Histamine H1 receptor,13770,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride",C21H22ClN,323.9,,3.2,1,1,0,23,,ZPMVNZLARAEGHB-UHFFFAOYSA-N
Diphenhydramine hydrochloride,CIDs00008980,,0.0,,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,Histamine H1 receptor,8980,"2-benzhydryloxy-N,N-dimethylethanamine;hydrochloride",C17H22ClNO,291.8,,12.5,1,2,6,20,,PCHPORCSPXIHLZ-UHFFFAOYSA-N
Nelfinavir,CIDs00064142,nelfinavir,663.88806,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease,64142,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid",C33H49N3O7S2,663.9,,190.0,5,9,10,45,,NQHXCOAXSHGTIA-SKXNDZRYSA-N
Elvitegravir,CIDs05277135,elvitegravir,447.883823,CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,Human immunodeficiency virus type 1 integrase,5277135,6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid,C23H23ClFNO5,447.9,5.3,87.1,2,7,7,31,,JUZYLCPPVHEVSV-LJQANCHMSA-N
Rilmenidine,CIDs00068712,rilmenidine,180.24684,C1CC1C(C2CC2)NC3=NCCO3,C1CC1C(C2CC2)NC3=NCCO3,Nischarin,68712,"N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine",C10H16N2O,180.25,1.2,33.6,1,2,4,13,,CQXADFVORZEARL-UHFFFAOYSA-N
Cyclosporine A,CIDs05284373,ciclosporin A,1202.61124,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Cyclophilin A,5284373,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",C62H111N11O12,1202.6,7.5,279.0,5,12,15,85,,PMATZTZNYRCHOR-CGLBZJNRSA-N
Repaglinide,CIDs00065981,repaglinide,452.58574,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,"Sulfonylurea receptor 1, Kir6.2",65981,2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid,C27H36N2O4,452.6,5.2,78.9,2,5,10,33,,FAEKWTJYAYMJKF-QHCPKHFHSA-N
Nateglinide,CIDs05311309,nateglinide,317.42258,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,"Sulfonylurea receptor 1, Kir6.2",5311309,(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid,C19H27NO3,317.4,3.2,66.4,2,3,6,23,,OELFLUMRDSZNSF-OFLPRAFFSA-N
TAK-875,CIDs24857286,fasiglifam,524.62518,CC1=CC(=CC(=C1C2=CC(=CC=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,Free fatty acid receptor 1,24857286,"2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid",C29H32O7S,524.6,4.7,108.0,1,7,11,37,,BZCALJIHZVNMGJ-HSZRJFAPSA-N
RUC-4,CIDs71668132,AGN-PC-0JILBQ,386.43152,C1CN(CCN1)C2=CC(=O)N3C(=N2)SC(=N3)C4=CC(=CN=C4)NC(=O)CN,C1CN(CCN1)C2=CC(=O)N3C(=N2)SC(=N3)C4=CC(=CN=C4)NC(=O)CN,Integrin alpha-IIb/beta-3,71668132,"2-amino-N-[5-(5-oxo-7-piperazin-1-yl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)-3-pyridinyl]acetamide",C16H18N8O2S,386.4,-1.2,154.0,3,9,4,27,,LTVKZVGAALCRFW-UHFFFAOYSA-N
Cilengitide,CIDs00176873,cilengitide,588.6559,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,"Integrin alpha-V/beta-3, Integrin alpha-V/beta-5",176873,"2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid",C27H40N8O7,588.7,-1.0,238.0,7,8,9,42,,AMLYAMJWYAIXIA-VWNVYAMZSA-N
ATN-161,CIDs09960285,ATN-161,597.6445,CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N,CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N,"Integrin alpha-5/beta-1, Integrin alpha-V/beta-3",9960285,(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-acetylpyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-sulfanylpropanoyl]amino]butanediamide,C23H35N9O8S,597.6,-4.7,273.0,9,10,15,41,,MMHDBUJXLOFTLC-WOYTXXSLSA-N
PF-06650833,CIDs118414016,,0.0,,CCC1C(NC(=O)C1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N,Interleukin-1 receptor-associated kinase 4,118414016,"1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide",C18H20FN3O4,361.4,2.0,104.0,2,6,6,26,,JKDGKIBAOAFRPJ-ZBINZKHDSA-N
Minoxidil,CIDs00004201,minoxidil,209.2483,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,"Sulfonylurea receptor 2, Kir6.2",4201,3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine,C9H15N5O,209.25,1.2,88.9,3,3,1,15,,ZIMGGGWCDYVHOY-UHFFFAOYSA-N
Levosimendan,CIDs03033825,levosimendan,280.28468,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,"Troponin, cardiac muscle, Phosphodiesterase 3",3033825,"2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile",C14H12N6O,280.28,2.3,113.0,2,6,3,21,,WHXMKTBCFHIYNQ-SECBINFHSA-N
Glipizide,CIDs00003478,glipizide,445.53518,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,"Sulfonylurea receptor 1, Kir6.2",3478,N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide,C21H27N5O4S,445.5,1.9,139.0,3,6,7,31,,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
Glimepiride,CIDs00003476,glimepiride,490.61556,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,"Sulfonylurea receptor 1, Kir6.2",3476,4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide,C24H34N4O5S,490.6,3.9,133.0,3,5,7,34,,WIGIZIANZCJQQY-UHFFFAOYSA-N
Gliclazide,CIDs00003475,gliclazide,323.41054,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,"Sulfonylurea receptor 1, Kir6.2",3475,"1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea",C15H21N3O3S,323.4,1.5,86.9,2,4,3,22,,BOVGTQGAOIONJV-UHFFFAOYSA-N
Ibutilide fumarate,CIDs05281065,,0.0,,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,HERG,5281065,(E)-but-2-enedioic acid;bis(N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide),C44H76N4O10S2,885.2,,231.0,6,14,30,60,,PCIOHQNIRPWFMV-WXXKFALUSA-N
Dofetilide,CIDs00071329,dofetilide,441.56478,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,HERG,71329,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide,C19H27N3O5S2,441.6,1.8,122.0,2,8,11,29,,IXTMWRCNAAVVAI-UHFFFAOYSA-N
Retigabine,CIDs00121892,retigabine,303.331423,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,KCNQ (Kv7) potassium channel,121892,ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate,C16H18FN3O2,303.33,2.8,76.4,3,5,6,22,,PCOBBVZJEWWZFR-UHFFFAOYSA-N
Telithromycin,CIDs03002190,telithromycin,812.0037,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Bacterial 70S ribosome,3002190,"(1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone",C43H65N5O10,812.0,4.2,172.0,1,13,11,58,,LJVAJPDWBABPEJ-PNUFFHFMSA-N
Daptomycin,CIDs16134395,daptomycin,1620.67064,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,Cell membrane,16134395,"(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid",C72H101N17O26,1620.7,-5.1,702.0,22,28,35,115,,DOAKLVKFURWEDJ-RWDRXURGSA-N
Bumetanide,CIDs00002471,bumetanide,364.4161,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Sodium-(potassium)-chloride cotransporter 2,2471,3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid,C17H20N2O5S,364.4,2.8,127.0,3,7,8,25,,MAEIEVLCKWDQJH-UHFFFAOYSA-N
Pregabalin,CIDs05486971,pregabalin,159.22608,CC(C)CC(CC(=O)O)CN,CC(C)CC(CC(=O)O)CN,Voltage-gated calcium channel,5486971,(3S)-3-(aminomethyl)-5-methylhexanoic acid,C8H17NO2,159.23,-1.6,63.3,2,3,5,11,,AYXYPKUFHZROOJ-ZETCQYMHSA-N
Diltiazem hydrochloride,CIDs00062920,,0.0,,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,Voltage-gated L-type calcium channel,62920,"[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride",C22H27ClN2O4S,451.0,,84.4,1,6,7,30,,HDRXZJPWHTXQRI-BHDTVMLSSA-N
BMS-986020,CIDs49792850,SCHEMBL344742,482.52714,CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O,CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O,Lysophosphatidic acid receptor Edg-2,49792850,"1-[4-[4-[3-methyl-4-[[(1R)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]cyclopropane-1-carboxylic acid",C29H26N2O5,482.5,5.3,102.0,2,6,8,36,,GQBRZBHEPUQRPL-LJQANCHMSA-N
Amiselimod hydrochloride,CIDs67418070,,0.0,,CCCCCCCOC1=C(C=C(C=C1)CCC(CO)(CO)N)C(F)(F)F.Cl,Sphingosine 1-phosphate receptor,67418070,"2-amino-2-[2-[4-heptoxy-3-(trifluoromethyl)phenyl]ethyl]propane-1,3-diol;hydrochloride",C19H31ClF3NO3,413.9,,75.7,4,7,12,27,,GEDVJGOVRLHFQG-UHFFFAOYSA-N
BAF-312,CIDs44599207,siponimod,516.59501,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,Sphingosine 1-phosphate receptor Edg-1,44599207,1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid,C29H35F3N2O3,516.6,4.8,62.1,1,8,9,37,,KIHYPELVXPAIDH-HNSNBQBZSA-N
Amphotericin B,CIDs05280965,amphotericin B,924.07902,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Ergosterol,5280965,"(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid",C47H73NO17,924.1,0.0,320.0,12,18,3,65,,APKFDSVGJQXUKY-INPOYWNPSA-N
Selegiline hydrochloride,CIDs00026758,,0.0,,CC(CC1=CC=CC=C1)N(C)CC#C.Cl,Monoamine oxidase B,26758,(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride,C13H18ClN,223.74,,3.2,1,1,4,15,,IYETZZCWLLUHIJ-UTONKHPSSA-N
Rasagiline mesylate,CIDs03052775,rasagiline,267.34398,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,Monoamine oxidase B,3052775,"methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine",C13H17NO3S,267.35,,74.8,2,4,2,18,,JDBJJCWRXSVHOQ-UTONKHPSSA-N
Amlexanox,CIDs00002161,amlexanox,298.29336,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,Phosphodiesterase 4,2161,"2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid",C16H14N2O4,298.29,3.1,103.0,2,6,2,22,,SGRYPYWGNKJSDL-UHFFFAOYSA-N
LY-2140023,CIDs25195354,pomaglumetad methionil,366.41052,CSCCC(C(=O)NC1(CS(=O)(=O)C2C1C2C(=O)O)C(=O)O)N,CSCCC(C(=O)NC1(CS(=O)(=O)C2C1C2C(=O)O)C(=O)O)N,"Metabotropic glutamate receptor 3, Metabotropic glutamate receptor 2",25195354,"(1R,4S,5S,6S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2lambda6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid",C12H18N2O7S2,366.4,-4.4,198.0,4,9,7,23,,VOYCNOJFAJAILW-CAMHOICYSA-N
Eplerenone,CIDs00443872,eplerenone,414.4914,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,Mineralocorticoid receptor,443872,"methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate",C24H30O6,414.5,1.4,82.2,0,6,2,30,,JUKPWJGBANNWMW-VWBFHTRKSA-N
Racecadotril,CIDs00107751,racecadotril,385.47662,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,Neprilysin,107751,benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate,C21H23NO4S,385.5,3.3,97.8,1,5,11,27,,ODUOJXZPIYUATO-UHFFFAOYSA-N
Oseltamivir phosphate,CIDs00078000,,0.0,,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,Neuraminidase,78000,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid",C16H31N2O8P,410.4,,168.0,5,9,8,27,,PGZUMBJQJWIWGJ-ONAKXNSWSA-N
Cisatracurium besylate,CIDs00062886,cisatracurium,1243.47918,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],Muscle-type nicotinic acetylcholine receptor,62886,"benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate",C65H82N2O18S2,1243.5,,258.0,0,18,26,87,,XXZSQOVSEBAPGS-DONVQRBFSA-L
Dopamine hydrochloride,CIDs00065340,,0.0,,C1=CC(=C(C=C1CCN)O)O.Cl,Beta-1 adrenergic receptor,65340,"4-(2-aminoethyl)benzene-1,2-diol;hydrochloride",C8H12ClNO2,189.64,,66.5,4,3,2,12,,CTENFNNZBMHDDG-UHFFFAOYSA-N
AZD9668,CIDs46861623,,0.0,,CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,Leukocyte elastase,46861623,6-methyl-5-(2-methylpyrazol-3-yl)-N-[(5-methylsulfonyl-2-pyridinyl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide,C25H22F3N5O4S,545.5,2.5,123.0,1,9,6,38,,QNQZWEGMKJBHEM-UHFFFAOYSA-N
Fluphenazine hydrochloride,CIDs00067356,,0.0,,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl,Dopamine D2 receptor,67356,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride,C22H28Cl2F3N3OS,510.4,,55.3,3,8,6,32,,MBHNWCYEGXQEIT-UHFFFAOYSA-N
L-tetramisol,CIDs00027944,,0.0,,C1CSC2=NC(CN21)C3=CC=CC=C3.Cl,Nicotinic acetylcholine receptor alpha subunit,27944,"(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride",C11H13ClN2S,240.75,,40.9,1,2,1,15,,LAZPBGZRMVRFKY-HNCPQSOCSA-N
Memantine hydrochloride,CIDs00181458,,0.0,,CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl,Glutamate [NMDA] receptor,181458,"3,5-dimethyladamantan-1-amine;hydrochloride",C12H22ClN,215.76,,26.0,2,1,0,14,,LDDHMLJTFXJGPI-UHFFFAOYSA-N
Lacosamide,CIDs00219078,lacosamide,250.29362,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,Sodium channel alpha subunit,219078,(2R)-2-acetamido-N-benzyl-3-methoxypropanamide,C13H18N2O3,250.29,0.3,67.4,2,3,6,18,,VPPJLAIAVCUEMN-GFCCVEGCSA-N
D-Cycloserine,CIDs00006234,cycloserine,102.09194,C1C(C(=O)NO1)N,C1C(C(=O)NO1)N,"D-alanylalanine synthetase, Alanine racemase",6234,"(4R)-4-amino-1,2-oxazolidin-3-one",C3H6N2O2,102.09,-1.5,64.4,2,3,0,7,,DYDCUQKUCUHJBH-UWTATZPHSA-N
ACAMPROSATE CALCIUM,CIDs00155434,,0.0,,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],"Glutamate [NMDA] receptor, GABA-A receptor; anion channel",155434,calcium bis(3-acetamidopropane-1-sulfonate),C10H20CaN2O8S2,400.5,,189.0,2,8,6,23,,BUVGWDNTAWHSKI-UHFFFAOYSA-L
Cebranopadol,CIDs11848225,cebranopadol,378.482383,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,"Nociceptin receptor, Opioid receptors; mu/kappa/delta",11848225,"6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine",C24H27FN2O,378.5,4.3,28.3,1,3,2,28,,CSMVOZKEWSOFER-UHFFFAOYSA-N
Ketoprofen,CIDs00003825,ketoprofen,254.28056,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Cyclooxygenase,3825,2-(3-benzoylphenyl)propanoic acid,C16H14O3,254.28,3.1,54.4,1,3,4,19,,DKYWVDODHFEZIM-UHFFFAOYSA-N
Flurbiprofen,CIDs00003394,flurbiprofen,244.260923,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,Cyclooxygenase,3394,2-(3-fluoro-4-phenylphenyl)propanoic acid,C15H13FO2,244.26,4.2,37.3,1,3,3,18,,SYTBZMRGLBWNTM-UHFFFAOYSA-N
Lornoxicam,CIDs54690031,lornoxicam,371.8192,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,Cyclooxygenase,54690031,"6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide",C13H10ClN3O4S2,371.8,2.1,136.0,2,7,2,23,,WLHQHAUOOXYABV-UHFFFAOYSA-N
Reserpine,CIDs00005770,reserpine,608.6787,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,Synaptic vesicular amine transporter,5770,"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate",C33H40N2O9,608.7,4.0,118.0,1,10,10,44,,QEVHRUUCFGRFIF-MDEJGZGSSA-N
Trioxsalen,CIDs00005585,antipsoriatic,228.24328,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,DNA,5585,"2,5,9-trimethylfuro[3,2-g]chromen-7-one",C14H12O3,228.24,3.0,39.4,0,3,0,17,,FMHHVULEAZTJMA-UHFFFAOYSA-N
Fomepizole,CIDs00003406,4-methylpyrazole,82.10384,CC1=CNN=C1,CC1=CNN=C1,Alcohol dehydrogenase class I,3406,4-methyl-1H-pyrazole,C4H6N2,82.1,1.4,28.7,1,1,0,6,,RIKMMFOAQPJVMX-UHFFFAOYSA-N
Disulfiram,CIDs00003117,disulfiram,296.5392,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(CC)C(=S)SSC(=S)N(CC)CC,Aldehyde dehydrogenase,3117,"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate",C10H20N2S4,296.5,3.9,121.0,0,4,7,16,,AUZONCFQVSMFAP-UHFFFAOYSA-N
Tranexamic Acid,CIDs00005526,tranexamic acid,157.2102,C1CC(CCC1CN)C(=O)O,C1CC(CCC1CN)C(=O)O,Plasminogen,5526,4-(aminomethyl)cyclohexane-1-carboxylic acid,C8H15NO2,157.21,-2.0,63.3,2,3,2,11,,GYDJEQRTZSCIOI-UHFFFAOYSA-N
Aminocaproic acid,CIDs00000564,EACA,131.17292,C(CCC(=O)O)CCN,C(CCC(=O)O)CCN,"Tissue-type plasminogen activator, Plasminogen",564,6-aminohexanoic acid,C6H13NO2,131.17,-3.0,63.3,2,3,5,9,,SLXKOJJOQWFEFD-UHFFFAOYSA-N
Propafenone hydrochloride,CIDs00036708,,0.0,,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl,"Beta-1 adrenergic receptor, Sodium channel alpha subunit, Beta-2 adrenergic receptor",36708,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride,C21H28ClNO3,377.9,,58.6,3,4,11,26,,XWIHRGFIPXWGEF-UHFFFAOYSA-N
Pentamidine isethionate,CIDs00008813,diamidine,592.68274,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,"DNA, Kinetoplast DNA",8813,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;bis(2-hydroxyethanesulfonic acid),C23H36N4O10S2,592.7,,284.0,8,12,14,39,,YBVNFKZSMZGRAD-UHFFFAOYSA-N
Lomefloxacin hydrochloride,CIDs00068624,,0.0,,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl,Bacterial DNA gyrase,68624,"1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrochloride",C17H20ClF2N3O3,387.8,,72.9,3,8,3,26,,KXEBLAPZMOQCKO-UHFFFAOYSA-N
Efaproxiral,CIDs00122335,efaproxiral,341.40092,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C,Hemoglobin HbA,122335,"2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoic acid",C20H23NO4,341.4,3.6,75.6,2,4,6,25,,BNFRJXLZYUTIII-UHFFFAOYSA-N
Aliskiren hemifumarate,CIDs06918427,,0.0,,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O,Renin,6918427,"bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid",C64H110N6O16,1219.6,,367.0,10,18,40,86,,KLRSDBSKUSSCGU-KRQUFFFQSA-N
Lamivudine,CIDs00060825,lamivudine,229.25624,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,"DNA, DNA polymerase/reverse transcriptase, Human immunodeficiency virus type 1 reverse transcriptase",60825,"4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one",C8H11N3O3S,229.26,-0.9,113.0,2,4,2,15,,JTEGQNOMFQHVDC-NKWVEPMBSA-N
Lurbinectedin,CIDs57327016,lurbinectedin,784.87386,CC1=C(C(=C2C3C4C5C6=C(C(N4C(C(N3C)CC2=C1)O)COC(=O)C7(CS5)C8=C(CCN7)C9=C(N8)C=CC(=C9)OC)C1=C(C(=C6OC(=O)C)C)OCO1)O)OC,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,DNA,57327016,"[(1R,2R,3R,11S,12S,14R,26R)-5,12-dihydroxy-6,6'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-22-yl] acetate",C41H44N4O10S,784.9,3.9,190.0,4,14,4,56,,YDDMIZRDDREKEP-HWTBNCOESA-N
Favipiravir,CIDs00492405,favipiravir,157.102563,C1=C(N=C(C(=O)N1)C(=O)N)F,C1=C(N=C(C(=O)N1)C(=O)N)F,RNA-directed RNA polymerase,492405,5-fluoro-2-oxo-1H-pyrazine-3-carboxamide,C5H4FN3O2,157.1,-0.6,84.6,2,4,1,11,,ZCGNOVWYSGBHAU-UHFFFAOYSA-N
Sofosbuvir,CIDs45375808,sofosbuvir,529.452525,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,Hepatitis C virus NS5B RNA-dependent RNA polymerase,45375808,"propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",C22H29FN3O9P,529.5,1.0,153.0,3,11,11,36,,TTZHDVOVKQGIBA-IQWMDFIBSA-N
Nesbuvir,CIDs11561383,nesbuvir,446.491823,CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F,CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F,Hepatitis C virus NS5B RNA-dependent RNA polymerase,11561383,5-cyclopropyl-2-(4-fluorophenyl)-6-[2-hydroxyethyl(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide,C22H23FN2O5S,446.5,2.7,108.0,2,7,7,31,,WTDWVLJJJOTABN-UHFFFAOYSA-N
Clomipramine hydrochloride,CIDs00068539,,0.0,,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,Serotonin transporter,68539,"3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride",C19H24Cl2N2,351.3,,6.5,1,2,4,23,,WIMWMKZEIBHDTH-UHFFFAOYSA-N
Lamotrigine,CIDs00003878,lamotrigine,256.09138,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Sodium channel alpha subunit,3878,"6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine",C9H7Cl2N5,256.09,1.4,90.7,2,5,1,16,,PYZRQGJRPPTADH-UHFFFAOYSA-N
Flecainide acetate,CIDs00041022,,0.0,,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,Sodium channel protein type V alpha subunit,41022,"acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide",C19H24F6N2O5,474.4,,96.9,3,12,7,32,,RKXNZRPQSOPPRN-UHFFFAOYSA-N
Dabigatran,CIDs00216210,dabigatran,471.5111,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,Thrombin,216210,3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid,C25H25N7O3,471.5,1.7,150.0,4,7,9,35,,YBSJFWOBGCMAKL-UHFFFAOYSA-N
E5555,CIDs10459564,atopaxar,527.627523,CCOC1=C(C(=C2C(=C1)CN(C2=N)CC(=O)C3=CC(=C(C(=C3)N4CCOCC4)OC)C(C)(C)C)F)OCC,CCOC1=C(C(=C2C(=C1)CN(C2=N)CC(=O)C3=CC(=C(C(=C3)N4CCOCC4)OC)C(C)(C)C)F)OCC,Proteinase-activated receptor 1,10459564,"1-(3-tert-butyl-4-methoxy-5-morpholin-4-ylphenyl)-2-(5,6-diethoxy-4-fluoro-3-imino-1H-isoindol-2-yl)ethanone",C29H38FN3O5,527.6,4.6,84.3,1,8,10,38,,QWKAUGRRIXBIPO-UHFFFAOYSA-N
Eltrombopag olamine,CIDs135449331,,0.0,,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,Thrombopoietin receptor,135449331,"bis(2-aminoethanol);3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid",C29H36N6O6,564.6,,207.0,7,11,7,41,,DJMJHIKGMVJYCW-UHFFFAOYSA-N
Taltirelin,CIDs00114750,taltirelin,405.40842,CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N,CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N,Thyrotropin-releasing hormone receptor,114750,"(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide",C17H23N7O5,405.4,-3.0,171.0,4,6,6,29,,LQZAIAZUDWIVPM-SRVKXCTJSA-N
Monobenzone,CIDs00007638,monobenzone,200.23318,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,Tyrosinase,7638,4-phenylmethoxyphenol,C13H12O2,200.23,3.4,29.5,1,2,3,15,,VYQNWZOUAUKGHI-UHFFFAOYSA-N
Ibandronate sodium hydrate,CIDs23663991,,0.0,,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+],Farnesyl diphosphate synthase,23663991,sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate,C9H24NNaO8P2,359.23,,142.0,5,9,9,21,,VBDRTGFACFYFCT-UHFFFAOYSA-M
Conivaptan hydrochloride,CIDs00216322,,0.0,,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,"Vasopressin V1a receptor, Vasopressin V2 receptor",216322,"N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride",C32H27ClN4O2,535.0,,78.1,3,3,4,39,,BTYHAFSDANBVMJ-UHFFFAOYSA-N
Tolvaptan,CIDs00216237,tolvaptan,448.9413,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,Vasopressin V2 receptor,216237,"N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide",C26H25ClN2O3,448.9,4.8,69.6,2,3,3,32,,GYHCTFXIZSNGJT-UHFFFAOYSA-N
Ethosuximide,CIDs00003291,ethosuximide,141.16774,CCC1(CC(=O)NC1=O)C,CCC1(CC(=O)NC1=O)C,Voltage-gated T-type calcium channel,3291,"3-ethyl-3-methylpyrrolidine-2,5-dione",C7H11NO2,141.17,0.4,46.2,1,2,1,10,,HAPOVYFOVVWLRS-UHFFFAOYSA-N
Marizomib / Salinosporamide A,CIDs11347535,salinosporamide A,313.7766,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,20S proteasome,11347535,"(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione",C15H20ClNO4,313.77,1.8,75.6,2,4,4,21,,NGWSFRIPKNWYAO-SHTIJGAHSA-N
Chloro-IB-MECA,CIDs03035850,Cl-IB-MECA,544.73079,CNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC4=CC(=CC=C4)I)Cl)O)O,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,Adenosine A3 receptor,3035850,"(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide",C18H18ClIN6O4,544.7,1.9,134.0,4,8,5,30,,IPSYPUKKXMNCNQ-PFHKOEEOSA-N
Prochlorperazine dimaleate,CIDs00004917,prochlorperazine,373.94266,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dopamine D2 receptor,4917,2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine,C20H24ClN3S,373.9,4.9,35.0,0,4,4,25,,WIKYUJGCLQQFNW-UHFFFAOYSA-N
9-cis-Retinoic acid,CIDs00449171,alitretinoin,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoid receptor,449171,"(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",C20H28O2,300.4,6.3,37.3,1,2,5,22,,SHGAZHPCJJPHSC-ZVCIMWCZSA-N
Amodiaquin dihydrochloride dihydrate,CIDs00064646,,0.0,,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O.O.O.Cl.Cl,Ferriprotoporphyrin IX,64646,4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrate;dihydrochloride,C20H28Cl3N3O3,464.8,,50.4,6,6,6,29,,YVNAYSHNIILOJS-UHFFFAOYSA-N
ARRY-520,CIDs44224257,ARRY-520,420.476086,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,Kinesin-like protein 1,44224257,"(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide",C20H22F2N4O2S,420.5,3.3,96.5,1,7,6,29,,LLXISKGBWFTGEI-FQEVSTJZSA-N
XL-647,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Receptor protein-tyrosine kinase erbB-2, Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4",10458325,"7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",C24H25Cl2FN4O2,491.4,5.8,59.5,1,7,6,33,,HVXKQKFEHMGHSL-GOOCMWNKSA-N
Loratadine,CIDs00003957,loratadine,382.88322,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Histamine H1 receptor,3957,"ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate",C22H23ClN2O2,382.9,5.2,42.4,0,3,2,27,,JCCNYMKQOSZNPW-UHFFFAOYSA-N
Clemastine fumarate,CIDs05281069,,0.0,,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,Histamine H1 receptor,5281069,(E)-but-2-enedioic acid;(2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine,C25H30ClNO5,460.0,,87.1,2,6,8,32,,PMGQWSIVQFOFOQ-YKVZVUFRSA-N
Mizolastine,CIDs00065906,mizolastine,432.493303,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,Histamine H1 receptor,65906,2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one,C24H25FN6O,432.5,3.2,65.8,1,5,5,32,,PVLJETXTTWAYEW-UHFFFAOYSA-N
Azelastine hydrochloride,CIDs00054360,,0.0,,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,Histamine H1 receptor,54360,4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride,C22H25Cl2N3O,418.4,,35.9,1,3,3,28,,YEJAJYAHJQIWNU-UHFFFAOYSA-N
Lafutidine,CIDs05282136,lafutidine,431.54836,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,Histamine H2 receptor,5282136,2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[[4-(piperidin-1-ylmethyl)-2-pyridinyl]oxy]but-2-enyl]acetamide,C22H29N3O4S,431.6,1.4,104.0,1,7,11,30,,KMZQAVXSMUKBPD-DJWKRKHSSA-N
Famotidine,CIDs05702160,famotidine,337.4454,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Histamine H2 receptor,5702160,"3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide",C8H15N7O2S3,337.5,-0.6,238.0,4,8,7,20,,XUFQPHANEAPEMJ-UHFFFAOYSA-N
Testosterone,CIDs00006013,testosterone,288.42442,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,Androgen Receptor,6013,"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C19H28O2,288.4,3.3,37.3,1,2,0,21,,MUMGGOZAMZWBJJ-DYKIIFRCSA-N
Testosterone propionate,CIDs00005995,testosterone propionate,344.48768,CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,Androgen Receptor,5995,"[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate",C22H32O3,344.5,4.4,43.4,0,3,3,25,,PDMMFKSKQVNJMI-BLQWBTBKSA-N
Eprosartan mesylate,CIDs05282474,,0.0,,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O,Type-1 angiotensin II receptor,5282474,4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid,C24H28N2O7S2,520.6,,183.0,3,9,10,35,,DJSLTDBPKHORNY-XMMWENQYSA-N
Esomeprazole magnesium,CIDs00130564,,0.0,,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],Potassium-transporting ATPase,130564,"magnesium bis(5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide)",C34H36MgN6O6S2,713.1,,163.0,0,14,10,49,,KWORUUGOSLYAGD-UHFFFAOYSA-N
RABEPRAZOLE SODIUM,CIDs14720269,,0.0,,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+],Potassium-transporting ATPase,14720269,sodium 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ide,C18H20N3NaO3S,381.4,,81.5,0,7,8,26,,KRCQSTCYZUOBHN-UHFFFAOYSA-N
Oxcarbazepine,CIDs00034312,oxcarbazepine,252.26798,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Sodium channel alpha subunit,34312,5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide,C15H12N2O2,252.27,1.7,63.4,1,2,0,19,,CTRLABGOLIVAIY-UHFFFAOYSA-N
Safinamide mesilate,CIDs03038502,,0.0,,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,Monoamine oxidase B,3038502,(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide;methanesulfonic acid,C18H23FN2O5S,398.5,,127.0,3,7,7,27,,YKOCHIUQOBQIAC-YDALLXLXSA-N
Isradipine,CIDs00003784,isradipine,371.38714,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,Voltage-gated L-type calcium channel,3784,"3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",C19H21N3O5,371.4,4.3,104.0,1,8,6,27,,HMJIYCCIJYRONP-UHFFFAOYSA-N
Sumatriptan succinate,CIDs00059772,,0.0,,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor",59772,butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,C18H27N3O6S,413.5,,148.0,4,8,9,28,,PORMUFZNYQJOEI-UHFFFAOYSA-N
Naratriptan hydrochloride,CIDs00060875,,0.0,,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor",60875,N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;hydrochloride,C17H26ClN3O2S,371.9,,73.6,3,4,5,24,,AWEZYKMQFAUBTD-UHFFFAOYSA-N
Rizatriptan benzoate,CIDs00077997,rizatriptan benzoate,391.4662,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor",77997,"benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine",C22H25N5O2,391.5,,87.0,2,5,6,29,,JPRXYLQNJJVCMZ-UHFFFAOYSA-N
Zolmitriptan,CIDs00060857,zolmitriptan,287.35684,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor",60857,"(4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one",C16H21N3O2,287.36,2.2,57.4,2,3,5,21,,ULSDMUVEXKOYBU-ZDUSSCGKSA-N
Citalopram hydrobromide,CIDs00077995,,0.0,,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br,Serotonin transporter,77995,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide,C20H22BrFN2O,405.3,,36.3,1,4,5,25,,WIHMBLDNRMIGDW-UHFFFAOYSA-N
Venlafaxine hydrochloride,CIDs00062923,,0.0,,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,"Serotonin transporter, Norepinephrine transporter",62923,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride,C17H28ClNO2,313.9,,32.7,2,3,5,21,,QYRYFNHXARDNFZ-UHFFFAOYSA-N
Ondansetron,CIDs00004595,ondansetron,293.36296,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Serotonin 3a (5-HT3a) receptor,4595,"9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one",C18H19N3O,293.4,2.3,39.8,0,2,2,22,,FELGMEQIXOGIFQ-UHFFFAOYSA-N
Tropisetron,CIDs00656665,,0.0,,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,Serotonin 3 (5-HT3) receptor,656665,"[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate",C17H20N2O2,284.35,3.8,45.3,1,3,3,21,,ZNRGQMMCGHDTEI-FUNVUKJBSA-N
Amoxapine,CIDs00002170,amoxapine,313.78144,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Serotonin transporter, Dopamine receptor, Norepinephrine transporter",2170,"8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine",C17H16ClN3O,313.8,2.6,36.9,1,3,1,22,,QWGDMFLQWFTERH-UHFFFAOYSA-N
Nepafenac,CIDs00151075,nepafenac,254.28386,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,Cyclooxygenase,151075,2-(2-amino-3-benzoylphenyl)acetamide,C15H14N2O2,254.28,1.9,86.2,2,3,4,19,,QEFAQIPZVLVERP-UHFFFAOYSA-N
Etodolac,CIDs00003308,etodolac,287.35354,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Cyclooxygenase-2,3308,"2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid",C17H21NO3,287.35,2.8,62.3,2,3,4,21,,NNYBQONXHNTVIJ-UHFFFAOYSA-N
Acemetacin,CIDs00001981,acemetacin,415.82372,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,Cyclooxygenase,1981,2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid,C21H18ClNO6,415.8,4.2,94.8,1,6,7,29,,FSQKKOOTNAMONP-UHFFFAOYSA-N
Zalcitabine,CIDs00024066,zalcitabine,211.21782,C1CC(OC1CO)N2C=CC(=NC2=O)N,C1CC(OC1CO)N2C=CC(=NC2=O)N,Human immunodeficiency virus type 1 reverse transcriptase,24066,"4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",C9H13N3O3,211.22,-1.3,88.2,2,3,2,15,,WREGKURFCTUGRC-POYBYMJQSA-N
Stavudine,CIDs00018283,stavudine,224.21328,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Human immunodeficiency virus type 1 reverse transcriptase,18283,"1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione",C10H12N2O4,224.21,-0.8,78.9,2,4,2,16,,XNKLLVCARDGLGL-JGVFFNPUSA-N
Emtricitabine,CIDs00060877,emtricitabine,247.246703,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Human immunodeficiency virus type 1 reverse transcriptase,60877,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one",C8H10FN3O3S,247.25,-0.6,113.0,2,5,2,16,,XQSPYNMVSIKCOC-NTSWFWBYSA-N
Clevudine,CIDs00073115,clevudine,260.219023,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,Protein P,73115,"1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",C10H13FN2O5,260.22,-0.9,99.1,3,6,2,18,,GBBJCSTXCAQSSJ-XQXXSGGOSA-N
"2',3'-Dideoxyinosine",CIDs135398739,,0.0,,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,Human immunodeficiency virus type 1 reverse transcriptase,135398739,"9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",C10H12N4O3,236.23,-1.2,88.7,2,5,2,17,,BXZVVICBKDXVGW-NKWVEPMBSA-N
Nevirapine,CIDs00004463,nevirapine,266.29786,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Human immunodeficiency virus type 1 reverse transcriptase,4463,"2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one",C15H14N4O,266.3,2.0,58.1,1,4,1,20,,NQDJXKOVJZTUJA-UHFFFAOYSA-N
Zidovudine,CIDs00035370,zidovudine,267.24132,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Human immunodeficiency virus type 1 reverse transcriptase,35370,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",C10H13N5O4,267.24,0.0,93.2,2,6,3,19,,HBOMLICNUCNMMY-XLPZGREQSA-N
Pimecrolimus,CIDs06509979,pimecrolimus,810.45312,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,FK506-binding protein 1A,6509979,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone",C43H68ClNO11,810.4,3.8,158.0,2,11,6,56,,KASDHRXLYQOAKZ-XDSKOBMDSA-N
Clarithromycin,CIDs00084029,clarithromycin,747.95336,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Bacterial 70S ribosome,84029,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",C38H69NO13,748.0,3.2,183.0,4,14,8,52,,AGOYDEPGAOXOCK-KCBOHYOISA-N
Streptomycin sulfate,CIDs00019648,streptomycin,1457.38356,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Bacterial 70S ribosome,19648,"bis(2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine);sulfuric acid",C42H84N14O36S3,1457.4,,922.0,30,42,18,95,,QTENRWWVYAAPBI-YCRXJPFRSA-N
Meropenem,CIDs00441130,,0.0,,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,Bacterial penicillin-binding protein,441130,"(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid",C17H25N3O5S,383.5,-2.4,135.0,3,7,5,26,,DMJNNHOOLUXYBV-PQTSNVLCSA-N
Tebipenem pivoxil,CIDs09892071,TBPM-PI,497.62804,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,Bacterial penicillin-binding protein,9892071,"2,2-dimethylpropanoyloxymethyl (4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate",C22H31N3O6S2,497.6,2.3,159.0,1,9,10,33,,SNUDIPVBUUXCDG-QHSBEEBCSA-N
Chloramphenicol palmitate,CIDs00443382,chloramphenicol palmitate,561.53818,CCCCCCCCCCCCCCCC(=O)OCC(C(C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,CCCCCCCCCCCCCCCC(=O)OCC(C(C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,Bacterial 70S ribosome,443382,"[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoate",C27H42Cl2N2O6,561.5,9.0,121.0,2,6,21,37,,PXKHGMGELZGJQE-ILBGXUMGSA-N
Sulfapyridine,CIDs00005336,sulfapyridine,249.28894,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase,5336,4-amino-N-pyridin-2-ylbenzenesulfonamide,C11H11N3O2S,249.29,0.0,93.5,2,5,3,17,,GECHUMIMRBOMGK-UHFFFAOYSA-N
Sulfameter,CIDs00005326,Supramid,280.30298,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase,5326,4-amino-N-(5-methoxypyrimidin-2-yl)benzenesulfonamide,C11H12N4O3S,280.31,0.4,116.0,2,7,4,19,,GPTONYMQFTZPKC-UHFFFAOYSA-N
Sulfaphenazole,CIDs00005335,sulfaphenazole,314.36226,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,Bacterial dihydropteroate synthase,5335,4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide,C15H14N4O2S,314.4,1.5,98.4,2,5,4,22,,QWCJHSGMANYXCW-UHFFFAOYSA-N
Sulfafurazole,CIDs00005344,sulfisoxazole,267.30422,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase,5344,"4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide",C11H13N3O3S,267.31,1.0,107.0,2,6,3,18,,NHUHCSRWZMLRLA-UHFFFAOYSA-N
Sulfamethoxazole,CIDs00005329,sulfamethoxazole,253.27764,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase,5329,"4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",C10H11N3O3S,253.28,0.9,107.0,2,6,3,17,,JLKIGFTWXXRPMT-UHFFFAOYSA-N
Sulphadimethoxine,CIDs00005323,sulfadimethoxine,310.32896,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,Bacterial dihydropteroate synthase,5323,"4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide",C12H14N4O4S,310.33,1.6,125.0,2,8,5,21,,ZZORFUFYDOWNEF-UHFFFAOYSA-N
Nitrofurazone,CIDs05447130,nitrofurazone,198.13624,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,DNA,5447130,[(E)-(5-nitrofuran-2-yl)methylideneamino]urea,C6H6N4O4,198.14,0.2,126.0,2,5,2,14,,IAIWVQXQOWNYOU-FPYGCLRLSA-N
Chloramphenicol,CIDs00005959,chloramphenicol,323.12938,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Bacterial 70S ribosome,5959,"2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide",C11H12Cl2N2O5,323.13,1.1,115.0,3,5,5,20,,WIIZWVCIJKGZOK-RKDXNWHRSA-N
Silver sulfadiazine,CIDs00441244,,0.0,,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],Bacterial dihydropteroate synthase,441244,silver (4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide,C10H9AgN4O2S,357.14,,95.3,1,6,3,18,,UEJSSZHHYBHCEL-UHFFFAOYSA-N
Metronidazole,CIDs00004173,metronidazole,171.15396,CC1=NC=C(N1CCO)[N+](=O)[O-],CC1=NC=C(N1CCO)[N+](=O)[O-],DNA,4173,2-(2-methyl-5-nitroimidazol-1-yl)ethanol,C6H9N3O3,171.15,0.0,83.9,1,4,2,12,,VAOCPAMSLUNLGC-UHFFFAOYSA-N
Aztreonam,CIDs05742832,aztreonam,435.43278,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,Bacterial penicillin-binding protein,5742832,"2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid",C13H17N5O8S2,435.4,0.3,238.0,4,12,7,28,,WZPBZJONDBGPKJ-VEHQQRBSSA-N
Enoxacin,CIDs00003229,enoxacin,320.318883,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,"Topoisomerase IV, DNA gyrase",3229,"1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid",C15H17FN4O3,320.32,-0.2,85.8,2,8,3,23,,IDYZIJYBMGIQMJ-UHFFFAOYSA-N
Nalidixic acid,CIDs00004421,nalidixic acid,232.23528,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,Bacterial DNA gyrase,4421,"1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid",C12H12N2O3,232.23,1.4,70.5,1,5,2,17,,MHWLWQUZZRMNGJ-UHFFFAOYSA-N
Cephradine,CIDs00038103,cephradine,349.40476,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,Bacterial penicillin-binding protein,38103,"(6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C16H19N3O4S,349.4,0.4,138.0,3,6,4,24,,RDLPVSKMFDYCOR-UEKVPHQBSA-N
Cefdinir,CIDs06915944,cefdinir,395.41352,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,Bacterial penicillin-binding protein,6915944,"(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C14H13N5O5S2,395.4,0.0,212.0,4,10,5,26,,RTXOFQZKPXMALH-GHXIOONMSA-N
Cefoperazone sodium,CIDs23663974,,0.0,,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],Bacterial penicillin-binding protein,23663974,"sodium (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C25H26N9NaO8S2,667.7,,274.0,3,13,9,45,,NCFTXMQPRQZFMZ-WERGMSTESA-M
Cefditoren pivoxil,CIDs06437877,cefditoren pivoxil,620.72082,CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C,CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C,Bacterial penicillin-binding protein,6437877,"2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",C25H28N6O7S3,620.7,4.7,257.0,2,14,12,41,,AFZFFLVORLEPPO-UVYJNCLZSA-N
Cefprozil monohydrate,CIDs06436628,,0.0,,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,Bacterial penicillin-binding protein,6436628,"(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate",C18H21N3O6S,407.4,,159.0,5,8,5,28,,ALYUMNAHLSSTOU-CIRGZYLNSA-N
Indiplon,CIDs06450813,indiplon,376.43164,CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4,CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4,GABA receptor alpha-1 subunit,6450813,"N-methyl-N-[3-[3-(thiophene-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide",C20H16N4O2S,376.4,2.3,95.8,0,5,4,27,,CBIAWPMZSFFRGN-UHFFFAOYSA-N
Eszopiclone,CIDs00969472,eszopiclone,388.80828,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,GABA-A receptor; anion channel,969472,"[(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate",C17H17ClN6O3,388.8,0.5,91.8,0,7,3,27,,GBBSUAFBMRNDJC-INIZCTEOSA-N
Arbutin,CIDs00440936,arbutin,272.25124,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,Tyrosinase,440936,"(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol",C12H16O7,272.25,-0.7,120.0,5,7,3,19,,BJRNKVDFDLYUGJ-RMPHRYRLSA-N
Indinavir sulfate,CIDs05462355,,0.0,,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5.OS(=O)(=O)O,Human immunodeficiency virus type 1 protease,5462355,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide;sulfuric acid",C36H49N5O8S,711.9,,201.0,6,11,12,50,,NUBQKPWHXMGDLP-BDEHJDMKSA-N
Ritonavir,CIDs00392622,ritonavir,720.94422,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,"Cytochrome P450 3A, Human immunodeficiency virus type 1 protease",392622,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",C37H48N6O5S2,720.9,6.0,202.0,4,9,18,50,,NCDNCNXCDXHOMX-XGKFQTDJSA-N
Lopinavir,CIDs00092727,lopinavir,628.80082,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Human immunodeficiency virus type 1 protease,92727,"(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",C37H48N4O5,628.8,5.9,120.0,4,5,15,46,,KJHKTHWMRKYKJE-SUGCFTRWSA-N
Atazanavir sulfate,CIDs00158550,,0.0,,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,Human immunodeficiency virus type 1 protease,158550,"methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acid",C38H54N6O11S,802.9,,254.0,7,13,18,56,,DQSGVVGOPRWTKI-QVFAWCHISA-N
Darunavir,CIDs00213039,darunavir,547.66358,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Human immunodeficiency virus type 1 protease,213039,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate",C27H37N3O7S,547.7,2.9,149.0,3,9,12,38,,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
Amprenavir,CIDs00065016,amprenavir,505.6269,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,Human immunodeficiency virus type 1 protease,65016,"[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate",C25H35N3O6S,505.6,2.9,140.0,3,8,12,35,,YMARZQAQMVYCKC-OEMFJLHTSA-N
Viracept,CIDs00064142,nelfinavir,663.88806,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease,64142,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid",C33H49N3O7S2,663.9,,190.0,5,9,10,45,,NQHXCOAXSHGTIA-SKXNDZRYSA-N
BMS-707035,CIDs54682040,HIV integrase inhibitor,410.419963,CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O,CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O,Integrase,54682040,"2-(1,1-dioxothiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide",C17H19FN4O5S,410.4,1.0,128.0,2,7,4,28,,VNIWZCGZPBJWBI-UHFFFAOYSA-N
Terbinafine hydrochloride,CIDs05282481,,0.0,,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl,Squalene monooxygenase,5282481,"(E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine;hydrochloride",C21H26ClN,327.9,,3.2,1,1,5,23,,BWMISRWJRUSYEX-SZKNIZGXSA-N
Liranaftate,CIDs00003936,liranaftate,328.4286,CN(C1=NC(=CC=C1)OC)C(=S)OC2=CC3=C(CCCC3)C=C2,CN(C1=NC(=CC=C1)OC)C(=S)OC2=CC3=C(CCCC3)C=C2,Squalene monooxygenase,3936,"O-(5,6,7,8-tetrahydronaphthalen-2-yl) N-(6-methoxy-2-pyridinyl)-N-methylcarbamothioate",C18H20N2O2S,328.4,4.9,66.7,0,4,4,23,,VPHPQNGOVQYUMG-UHFFFAOYSA-N
Furosemide,CIDs00003440,furosemide,330.74414,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Sodium-(potassium)-chloride cotransporter 2,3440,4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid,C12H11ClN2O5S,330.74,2.0,131.0,3,7,5,21,,ZZUFCTLCJUWOSV-UHFFFAOYSA-N
Torasemide,CIDs00041781,torasemide,348.42,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Sodium-(potassium)-chloride cotransporter 2,41781,1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea,C16H20N4O3S,348.4,2.7,109.0,3,5,5,24,,NGBFQHCMQULJNZ-UHFFFAOYSA-N
Betaxolol hydrochloride,CIDs00107952,,0.0,,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,Beta-1 adrenergic receptor,107952,1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride,C18H30ClNO3,343.9,,50.7,3,4,11,23,,CHDPSNLJFOQTRK-UHFFFAOYSA-N
Carvedilol,CIDs00002585,carvedilol,406.47424,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,"Adrenergic receptor alpha-1, Adrenergic receptor beta",2585,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,C24H26N2O4,406.5,4.2,75.7,3,5,10,30,,OGHNVEJMJSYVRP-UHFFFAOYSA-N
Doxazosin mesylate,CIDs00062978,,0.0,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,Adrenergic receptor alpha-1,62978,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid",C24H29N5O8S,547.6,,175.0,2,12,4,38,,VJECBOKJABCYMF-UHFFFAOYSA-N
Alfuzosin hydrochloride,CIDs00071764,,0.0,,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,Adrenergic receptor alpha-1,71764,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide;hydrochloride",C19H28ClN5O4,425.9,,112.0,3,8,8,29,,YTNKWDJILNVLGX-UHFFFAOYSA-N
Tamsulosin hydrochloride,CIDs05362376,,0.0,,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl,Adrenergic receptor alpha-1,5362376,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride,C20H29ClN2O5S,445.0,,108.0,3,7,11,29,,ZZIZZTHXZRDOFM-XFULWGLBSA-N
Silodosin,CIDs05312125,silodosin,495.53449,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,Alpha-1a adrenergic receptor,5312125,"1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide",C25H32F3N3O4,495.5,3.6,97.1,3,9,13,35,,PNCPYILNMDWPEY-QGZVFWFLSA-N
Trazodone hydrochloride,CIDs00062935,,0.0,,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl,"Serotonin transporter, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor",62935,"2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride",C19H23Cl2N5O,408.3,,42.4,1,4,5,27,,OHHDIOKRWWOXMT-UHFFFAOYSA-N
Clonidine,CIDs00002803,clonidine,230.09386,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Adrenergic receptor alpha-2,2803,"N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine",C9H9Cl2N3,230.09,1.6,36.4,2,1,2,14,,GJSURZIOUXUGAL-UHFFFAOYSA-N
17-Methyltestosterone,CIDs00006010,17alpha-methyltestosterone,302.451,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,Androgen Receptor,6010,"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C20H30O2,302.5,3.4,37.3,1,2,0,22,,GCKMFJBGXUYNAG-HLXURNFRSA-N
Trospium chloride,CIDs05284631,trospium,427.9636,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2",5284631,"[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate chloride",C25H30ClNO3,428.0,,46.5,1,4,5,30,,RVCSYOQWLPPAOA-DHWZJIOFSA-M
Oxybutynin chloride,CIDs00091505,,0.0,,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2",91505,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride,C22H32ClNO3,393.9,,49.8,2,4,8,27,,SWIJYDAEGSIQPZ-UHFFFAOYSA-N
Orphenadrine hydrochloride,CIDs00009568,,0.0,,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.Cl,"Norepinephrine transporter, Sodium channel alpha subunit, Glutamate [NMDA] receptor, Histamine H1 receptor",9568,"N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;hydrochloride",C18H24ClNO,305.8,,12.5,1,2,6,21,,UQZKYYIKWZOKKD-UHFFFAOYSA-N
Fesoterodine fumarate,CIDs09849808,,0.0,,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O,"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2",9849808,(E)-but-2-enedioic acid;[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,C30H41NO7,527.6,,124.0,3,8,13,38,,MWHXMIASLKXGBU-RNCYCKTQSA-N
AP-761,CIDs45270144,Actimis,501.50085,CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O,CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O,G protein-coupled receptor 44,45270144,"2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid",C25H26F3N5O3,501.5,4.3,98.7,2,10,8,36,,XEOSTBFUCNZKGS-UHFFFAOYSA-N
Travoprost,CIDs05282226,travoprost,500.54771,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,Prostanoid FP receptor,5282226,"propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate",C26H35F3O6,500.5,4.1,96.2,3,9,13,35,,MKPLKVHSHYCHOC-AHTXBMBWSA-N
Methocarbamol,CIDs00004107,methocarbamol,241.2405,COC1=CC=CC=C1OCC(COC(=O)N)O,COC1=CC=CC=C1OCC(COC(=O)N)O,Carbonic anhydrase I,4107,[2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate,C11H15NO5,241.24,0.6,91.0,2,5,7,17,,GNXFOGHNGIVQEH-UHFFFAOYSA-N
Ziprasidone hydrochloride,CIDs00060853,ziprasidone,467.41186,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor",60853,"5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride",C21H24Cl2N4O2S,467.4,,77.7,3,6,4,30,,ZCBZSCBNOOIHFP-UHFFFAOYSA-N
Telotristat etiprate,CIDs25253377,telotristat etiprate,754.15461,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,Tryptophan 5-hydroxylase,25253377,"2-benzamidoacetic acid;ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate",C36H35ClF3N7O6,754.2,,198.0,4,14,13,53,,XSFPZBUIBYMVEA-CELUQASASA-N
Iloperidone,CIDs00071360,iloperidone,426.480583,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor",71360,"1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone",C24H27FN2O4,426.5,4.1,64.8,0,7,8,31,,XMXHEBAFVSFQEX-UHFFFAOYSA-N
Risperidone???,CIDs00005073,risperidone,410.484483,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor",5073,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one",C23H27FN4O2,410.5,2.7,61.9,0,6,4,30,,RAPZEAPATHNIPO-UHFFFAOYSA-N
Haloperidol,CIDs00003559,haloperidol,375.864223,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,"Serotonin 2a (5-HT2a) receptor, D2-like dopamine receptor",3559,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,C21H23ClFNO2,375.9,3.2,40.5,1,4,6,26,,LNEPOXFFQSENCJ-UHFFFAOYSA-N
Levosulpiride,CIDs00688272,levosulpiride,341.42582,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,"Dopamine D2 receptor, Serotonin 4 (5-HT4) receptor",688272,N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide,C15H23N3O4S,341.4,0.6,110.0,2,6,6,23,,BGRJTUBHPOOWDU-NSHDSACASA-N
Olanzapine,CIDs135398745,,0.0,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,"D2-like dopamine receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor",135398745,"2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine",C17H20N4S,312.4,2.9,59.1,1,4,1,22,,KVWDHTXUZHCGIO-UHFFFAOYSA-N
Duloxetine hydrochloride,CIDs00060834,duloxetine,333.8755,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,"Serotonin transporter, Norepinephrine transporter",60834,(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride,C18H20ClNOS,333.9,,49.5,2,3,6,22,,BFFSMCNJSOPUAY-LMOVPXPDSA-N
Galantamine hydrobromide,CIDs00121587,,0.0,,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br,Acetylcholinesterase,121587,"(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide",C17H22BrNO3,368.3,,41.9,2,4,1,22,,QORVDGQLPPAFRS-XPSHAMGMSA-N
Zanamivir,CIDs00060855,zanamivir,332.3098,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,Neuraminidase,60855,"(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid",C12H20N4O7,332.31,-3.2,201.0,7,8,6,23,,ARAIBEBZBOPLMB-UFGQHTETSA-N
AVN-944,CIDs09918559,AVN944,477.51238,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,Inosine-5'-monophosphate dehydrogenase (IMPDH),9918559,"[(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate",C25H27N5O5,477.5,3.1,139.0,3,7,10,35,,GYCPCOJTCINIFZ-OXJNMPFZSA-N
Danusertib (PHA-739358),CIDs11442891,danusertib,474.5548,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,Serine/threonine-protein kinase Aurora,11442891,"N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide",C26H30N6O3,474.6,1.8,93.8,2,6,6,35,,XKFTZKGMDDZMJI-HSZRJFAPSA-N
Fluspirilene,CIDs00003396,fluspirilene,475.572746,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,Dopamine D2 receptor,3396,"8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one",C29H31F2N3O,475.6,5.6,35.6,1,5,7,35,,QOYHHIBFXOOADH-UHFFFAOYSA-N
Zonisamide,CIDs00005734,zonisamide,212.22572,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,Sodium channel alpha subunit,5734,"1,2-benzoxazol-3-ylmethanesulfonamide",C8H8N2O3S,212.23,0.2,94.6,1,5,2,14,,UBQNRHZMVUUOMG-UHFFFAOYSA-N
Azelnidipine,CIDs00065948,azelnidipine,582.64626,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,Voltage-gated L-type calcium channel,65948,"3-O-(1-benzhydrylazetidin-3-yl) 5-O-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate",C33H34N4O6,582.6,6.0,140.0,2,9,10,43,,ZKFQEACEUNWPMT-UHFFFAOYSA-N
Lacidipine,CIDs05311217,lacidipine,455.54332,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,Voltage-gated L-type calcium channel,5311217,"diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate",C26H33NO6,455.5,4.5,90.9,1,7,11,33,,GKQPCPXONLDCMU-CCEZHUSRSA-N
Alfacalcidol,CIDs05282181,alfacalcidol,400.63706,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor,5282181,"trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C27H44O2,400.6,6.8,40.5,2,2,6,29,,OFHCOWSQAMBJIW-AVJTYSNKSA-N
Topiramate,CIDs05284627,topiramate,339.36204,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,"Carbonic anhydrase IV, Glutamate receptor ionotropic kainate, GABA-A receptor; anion channel, Carbonic anhydrase II, Glutamate receptor ionotropic AMPA, Sodium channel alpha subunit",5284627,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate",C12H21NO8S,339.36,-0.8,124.0,1,9,3,22,,KJADKKWYZYXHBB-XBWDGYHZSA-N
Halofantrine hydrochloride,CIDs00037392,halofantrine,536.88465,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl,Ferriprotoporphyrin IX,37392,"3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride",C26H31Cl3F3NO,536.9,,23.5,2,5,10,34,,WANGFTDWOFGECH-UHFFFAOYSA-N
NITD609,CIDs44469321,NITD609,390.238363,CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,P-type ATPase,44469321,"(3R,3'S)-5,7'-dichloro-6'-fluoro-3'-methylspiro[1H-indole-3,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one",C19H14Cl2FN3O,390.2,3.9,56.9,3,3,0,26,,CKLPLPZSUQEDRT-WPCRTTGESA-N
Fosmidomycin,CIDs00000572,fosmidomycin,183.099662,C(CN(C=O)O)CP(=O)(O)O,C(CN(C=O)O)CP(=O)(O)O,"1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic",572,3-[formyl(hydroxy)amino]propylphosphonic acid,C4H10NO5P,183.1,-2.2,98.1,3,5,4,11,,GJXWDTUCERCKIX-UHFFFAOYSA-N
Miconazole,CIDs00004189,miconazole,416.12856,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Cytochrome P450 51,4189,"1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole",C18H14Cl4N2O,416.1,5.3,27.1,0,2,6,25,,BYBLEWFAAKGYCD-UHFFFAOYSA-N
Etonogestrel,CIDs06917715,etonogestrel,324.45652,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor,6917715,"(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",C22H28O2,324.5,3.3,37.3,1,2,2,24,,GCKFUYQCUCGESZ-BPIQYHPVSA-N
TRIMETHOPRIM,CIDs00005578,trimethoprim,290.31772,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Bacterial dihydrofolate reductase,5578,"5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine",C14H18N4O3,290.32,0.9,106.0,2,7,5,21,,IEDVJHCEMCRBQM-UHFFFAOYSA-N
Tavaborole / AN2690,CIDs11499245,tavaborole,151.930743,B1(C2=C(CO1)C=C(C=C2)F)O,B1(C2=C(CO1)C=C(C=C2)F)O,Leucine-tRNA ligase,11499245,"5-fluoro-1-hydroxy-3H-2,1-benzoxaborole",C7H6BFO2,151.93,,29.5,1,3,0,11,,LFQDNHWZDQTITF-UHFFFAOYSA-N
RIFAMPIN,CIDs135398735,,0.0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,Bacterial DNA-directed RNA polymerase,135398735,"[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate",C43H58N4O12,822.9,4.9,220.0,6,15,5,59,,JQXXHWHPUNPDRT-WLSIYKJHSA-N
TRICLOSAN,CIDs00005564,triclosan,289.54178,C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,Bacterial enoyl-[acyl-carrier-protein] reductase,5564,"5-chloro-2-(2,4-dichlorophenoxy)phenol",C12H7Cl3O2,289.5,5.0,29.5,1,2,2,17,,XEFQLINVKFYRCS-UHFFFAOYSA-N
Mibefradil dihydrochloride,CIDs00060662,mibefradil,568.550603,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,Voltage-gated T-type calcium channel,60662,"[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate;dihydrochloride",C29H40Cl2FN3O3,568.5,,67.5,3,6,12,38,,MTJLQTFHJIHXIX-GDUXWEAWSA-N
Hexylcaine hydrochloride,CIDs00102426,,0.0,,CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2.Cl,Sodium channel alpha subunit,102426,1-(cyclohexylamino)propan-2-yl benzoate;hydrochloride,C16H24ClNO2,297.82,,38.3,2,3,6,20,,MTFCPNHRBINLRQ-UHFFFAOYSA-N
Methdilazine hydrochloride,CIDs00014676,methdilazine,332.89074,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl,Histamine H1 receptor,14676,10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine;hydrochloride,C18H21ClN2S,332.9,,31.8,1,3,2,22,,IEISBKIVLDXSMZ-UHFFFAOYSA-N
DESIPRAMINE HYDROCHLORIDE,CIDs00065327,,0.0,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl,Norepinephrine transporter,65327,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine;hydrochloride",C18H23ClN2,302.8,,15.3,2,2,4,21,,XAEWZDYWZHIUCT-UHFFFAOYSA-N
Tocainide hydrochloride,CIDs00108173,,0.0,,CC1=C(C(=CC=C1)C)NC(=O)C(C)N.Cl,Sodium channel alpha subunit,108173,"2-amino-N-(2,6-dimethylphenyl)propanamide;hydrochloride",C11H17ClN2O,228.72,,55.1,3,2,2,15,,AMZACPWEJDQXGW-UHFFFAOYSA-N
Dydrogesterone,CIDs00009051,dydrogesterone,312.44582,CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,Progesterone receptor,9051,"(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one",C21H28O2,312.4,3.8,34.1,0,2,1,23,,JGMOKGBVKVMRFX-HQZYFCCVSA-N
Buprenorphine hydrochloride,CIDs09848989,U- 952,504.10108,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl,"Mu opioid receptor, Kappa opioid receptor",9848989,"(1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol;hydrochloride",C29H42ClNO4,504.1,,62.2,3,5,5,35,,UAIXRPCCYXNJMQ-HPRIMLMLSA-N
Naltrexone,CIDs05360515,naltrexone,341.40092,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,Opioid receptors; mu/kappa/delta,5360515,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",C20H23NO4,341.4,1.9,70.0,2,5,2,25,,DQCKKXVULJGBQN-XFWGSAIBSA-N
Saquinavir mesylate,CIDs00060934,saquinavir,766.94646,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease,60934,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid",C39H54N6O8S,766.9,,230.0,6,10,13,54,,IRHXGOXEBNJUSN-YOXDLBRISA-N
cyclosporin A,CIDs05284373,ciclosporin A,1202.61124,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Cyclophilin A,5284373,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",C62H111N11O12,1202.6,7.5,279.0,5,12,15,85,,PMATZTZNYRCHOR-CGLBZJNRSA-N
Mitomycine,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA,5746,"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",C15H18N4O5,334.33,-0.4,147.0,3,8,4,24,,NWIBSHFKIJFRCO-WUDYKRTCSA-N
ibrutinib,CIDs24821094,ibrutinib,440.49706,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,Tyrosine-protein kinase BTK,24821094,"1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one",C25H24N6O2,440.5,3.6,99.2,1,6,5,33,,XYFPWWZEPKGCCK-GOSISDBHSA-N
Thioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"Inosine-5'-monophosphate dehydrogenase (IMPDH), DNA",2723601,"2-amino-3,7-dihydropurine-6-thione",C5H5N5S,167.19,-0.1,111.0,3,2,0,11,,WYWHKKSPHMUBEB-UHFFFAOYSA-N
Uracil mustard,CIDs00006194,uracil mustard,252.09784,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,DNA,6194,"5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione",C8H11Cl2N3O2,252.09,0.5,61.4,2,3,5,15,,IDPUKCWIGUEADI-UHFFFAOYSA-N
Dexrazoxane,CIDs00071384,dexrazoxane,268.26914,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,"DNA topoisomerase II, Iron",71384,"4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione",C11H16N4O4,268.27,-1.4,98.8,2,6,3,19,,BMKDZUISNHGIBY-ZETCQYMHSA-N
Sunitinib (free base),CIDs05329102,sunitinib,398.473783,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor beta, Platelet-derived growth factor receptor alpha, Vascular endothelial growth factor receptor 1, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor 3, Macrophage colony stimulating factor receptor",5329102,"N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide",C22H27FN4O2,398.5,2.6,77.2,3,4,7,29,,WINHZLLDWRZWRT-ATVHPVEESA-N
Vorinostat,CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 6, Histone deacetylase 3, Histone deacetylase 1, Histone deacetylase 2",5311,N'-hydroxy-N-phenyloctanediamide,C14H20N2O3,264.32,1.9,78.4,3,3,8,19,,WAEXFXRVDQXREF-UHFFFAOYSA-N
Azacitidine,CIDs00009444,5-azacytidine,244.20468,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,"RNA, DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA",9444,"4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",C8H12N4O5,244.2,-2.2,141.0,4,5,2,17,,NMUSYJAQQFHJEW-KVTDHHQDSA-N
Gemcitabine hydrochloride,CIDs00060749,gemcitabine,299.659086,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon)",60749,"4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride",C9H12ClF2N3O4,299.66,,108.0,4,6,2,19,,OKKDEIYWILRZIA-OSZBKLCCSA-N
Imatinib mesylate,CIDs00123596,,0.0,,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,"Stem cell growth factor receptor, Bcr/Abl fusion protein, Tyrosine-protein kinase ABL, Platelet-derived growth factor receptor beta",123596,methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,C30H35N7O4S,589.7,,149.0,3,10,7,42,,YLMAHDNUQAMNNX-UHFFFAOYSA-N
Tamoxifen citrate,CIDs02733525,tamoxifen,563.63808,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Estrogen receptor alpha,2733525,"2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid",C32H37NO8,563.6,,145.0,4,9,13,41,,FQZYTYWMLGAPFJ-OQKDUQJOSA-N
Sorafenib tosylate,CIDs00406563,,0.0,,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,"Serine/threonine-protein kinase B-raf, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Serine/threonine-protein kinase RAF, Vascular endothelial growth factor receptor, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3",406563,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid,C28H24ClF3N4O6S,637.0,,155.0,4,10,6,43,,IVDHYUQIDRJSTI-UHFFFAOYSA-N
bendamustine hydrochloride,CIDs00077082,,0.0,,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,DNA,77082,4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;hydrochloride,C16H22Cl3N3O2,394.7,,58.4,2,4,9,24,,ZHSKUOZOLHMKEA-UHFFFAOYSA-N
Aminolevulinic acid hydrochloride,CIDs00123608,,0.0,,C(CC(=O)O)C(=O)CN.Cl,DNA,123608,5-amino-4-oxopentanoic acid;hydrochloride,C5H10ClNO3,167.59,,80.4,3,4,4,10,,ZLHFONARZHCSET-UHFFFAOYSA-N
Pipobroman,CIDs00004842,pipobroman,356.05424,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,DNA,4842,3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one,C10H16Br2N2O2,356.05,0.4,40.6,0,2,4,16,,NJBFOOCLYDNZJN-UHFFFAOYSA-N
Mitomycin,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA,5746,"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",C15H18N4O5,334.33,-0.4,147.0,3,8,4,24,,NWIBSHFKIJFRCO-WUDYKRTCSA-N
Ifosfamide,CIDs00003690,ifosfamide,261.085962,C1CN(P(=O)(OC1)NCCCl)CCCl,C1CN(P(=O)(OC1)NCCCl)CCCl,DNA,3690,"N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C7H15Cl2N2O2P,261.08,0.9,41.6,1,4,5,14,,HOMGKSMUEGBAAB-UHFFFAOYSA-N
Dactinomycin,CIDs00457193,Lyovac Cosmegen,1255.41704,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,DNA,457193,"2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",C62H86N12O16,1255.4,3.8,356.0,5,18,8,90,,RJURFGZVJUQBHK-IIXSONLDSA-N
Mechlorethamine hydrochloride,CIDs00005935,,0.0,,CN(CCCl)CCCl.Cl,DNA,5935,2-chloro-N-(2-chloroethyl)-N-methylethanamine;hydrochloride,C5H12Cl3N,192.5,,3.2,1,1,4,9,,QZIQJVCYUQZDIR-UHFFFAOYSA-N
PF562271,CIDs11713159,PF-562271,507.48881,CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C,CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C,Focal adhesion kinase 1,11713159,"N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]-2-pyridinyl]methanesulfonamide",C21H20F3N7O3S,507.5,2.0,138.0,3,12,7,35,,MZDKLVOWGIOKTN-UHFFFAOYSA-N
I-BET,CIDs46943432,I-BET762,423.89538,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,Bromodomain and extra-terminal motif (BET),46943432,"2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide",C22H22ClN5O2,423.9,2.9,81.4,1,5,5,30,,AAAQFGUYHFJNHI-SFHVURJKSA-N
ABT-888,CIDs11960529,veliparib,244.29234,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"PARP 1, 2 and 3",11960529,2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide,C13H16N4O,244.29,0.5,83.8,3,3,2,18,,JNAHVYVRKWKWKQ-CYBMUJFWSA-N
PD325901,CIDs09826528,PD 0325901,482.19304,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 1",9826528,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide",C16H14F3IN2O4,482.19,3.0,90.8,4,8,7,26,,SUDAHWBOROXANE-SECBINFHSA-N
AZD1775,CIDs24856436,MK-1775,500.59538,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,Serine/threonine-protein kinase WEE1,24856436,"1-[6-(2-hydroxypropan-2-yl)-2-pyridinyl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one",C27H32N8O2,500.6,3.1,101.0,2,9,7,37,,BKWJAKQVGHWELA-UHFFFAOYSA-N
MK-4827,CIDs24958200,niraparib,320.3883,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2",24958200,2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide,C19H20N4O,320.4,2.2,72.9,2,3,3,24,,PCHKPVIQAHNQLW-CQSZACIVSA-N
MK-8669,CIDs11520894,ridaforolimus,990.206122,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,Serine/threonine-protein kinase mTOR,11520894,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",C53H84NO14P,990.2,5.9,202.0,2,14,8,69,,BUROJSBIWGDYCN-GAUTUEMISA-N
Dinaciclib,CIDs46926350,dinaciclib,396.48602,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 2, Cyclin-dependent kinase 5, Cyclin-dependent kinase 9",46926350,"2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol",C21H28N6O2,396.5,1.9,91.2,2,6,7,29,,PIMQWRZWLQKKBJ-SFHVURJKSA-N
Sunitinib,CIDs05329102,sunitinib,398.473783,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor beta, Platelet-derived growth factor receptor alpha, Vascular endothelial growth factor receptor 1, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor 3, Macrophage colony stimulating factor receptor",5329102,"N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide",C22H27FN4O2,398.5,2.6,77.2,3,4,7,29,,WINHZLLDWRZWRT-ATVHPVEESA-N
Zolinza,CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 6, Histone deacetylase 3, Histone deacetylase 1, Histone deacetylase 2",5311,N'-hydroxy-N-phenyloctanediamide,C14H20N2O3,264.32,1.9,78.4,3,3,8,19,,WAEXFXRVDQXREF-UHFFFAOYSA-N
5-FU,CIDs00003385,5-fluorouracil,130.077223,C1=C(C(=O)NC(=O)N1)F,C1=C(C(=O)NC(=O)N1)F,"Thymidylate synthase, RNA, DNA",3385,"5-fluoro-1H-pyrimidine-2,4-dione",C4H3FN2O2,130.08,-0.9,58.2,2,3,0,9,,GHASVSINZRGABV-UHFFFAOYSA-N
6-Thioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"Inosine-5'-monophosphate dehydrogenase (IMPDH), DNA",2723601,"2-amino-3,7-dihydropurine-6-thione",C5H5N5S,167.19,-0.1,111.0,3,2,0,11,,WYWHKKSPHMUBEB-UHFFFAOYSA-N
Pemetrexed Disodium ,CIDs135413520,,0.0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],"Dihydrofolate reductase, Thymidylate synthase, GAR transformylase",135413520,"disodium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate",C20H19N5Na2O6,471.4,,193.0,4,7,7,33,,NYDXNILOWQXUOF-GXKRWWSZSA-L
Estramustine phosphate sodium,CIDs00444000,MUZ9585Y7B,564.346701,CC12CCC3C(C1CCC2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+],CC12CCC3C(C1CCC2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+],"Estrogen receptor beta, DNA",444000,"disodium;[(8R,9S,13S,14S,17S)-3-[bis(2-chloroethyl)carbamoyloxy]-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] phosphate",C23H30Cl2NNa2O6P,564.3,,102.0,0,6,7,35,,IIUMCNJTGSMNRO-VVSKJQCTSA-L
Erlotinib hydrochloride,CIDs00176871,,0.0,,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,Epidermal growth factor receptor erbB1,176871,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride",C22H24ClN3O4,429.9,,74.7,2,7,11,30,,GTTBEUCJPZQMDZ-UHFFFAOYSA-N
Pazopanib hydrochloride,CIDs11525740,,0.0,,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,"Tyrosine-protein kinase LCK, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Vascular endothelial growth factor receptor, Tyrosine-protein kinase ITK/TSK, Fibroblast growth factor receptor 1, Platelet-derived growth factor receptor, Macrophage colony stimulating factor receptor",11525740,"5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride",C21H24ClN7O2S,474.0,,127.0,3,8,5,32,,MQHIQUBXFFAOMK-UHFFFAOYSA-N
PYRIDOSTIGMINE BROMIDE,CIDs00007550,none,0.0,none,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],Acetylcholinesterase,7550,"(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate bromide",C9H13BrN2O2,261.12,,33.4,0,3,2,14,,VNYBTNPBYXSMOO-UHFFFAOYSA-M
PENTOLINIUM TARTRATE,CIDs00005849,pentolinium,538.58578,C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C.C(C(C(=O)[O-])O)(C(=O)O)O.C(C(C(=O)[O-])O)(C(=O)O)O,C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C.C(C(C(=O)[O-])O)(C(=O)O)O.C(C(C(=O)[O-])O)(C(=O)O)O,Neuronal acetylcholine receptor; alpha3/beta4,5849,"1-methyl-1-[5-(1-methylpyrrolidin-1-ium-1-yl)pentyl]pyrrolidin-1-ium;bis((2R,3R)-2,3,4-trihydroxy-4-oxobutanoate)",C23H42N2O12,538.6,,236.0,6,12,10,37,,HSMKTIKKPMTUQH-WBPXWQEISA-L
ETHINYL ESTRADIOL,CIDs00005991,ethynylestradiol,296.40336,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha,5991,"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",C20H24O2,296.4,3.7,40.5,2,2,1,22,,BFPYWIDHMRZLRN-SLHNCBLASA-N
OLMESARTAN MEDOXOMIL,CIDs00130881,olmesartan medoxomil,558.5851,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Type-1 angiotensin II receptor,130881,"(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate",C29H30N6O6,558.6,3.8,154.0,2,10,11,41,,UQGKUQLKSCSZGY-UHFFFAOYSA-N
RUFINAMIDE,CIDs00129228,rufinamide,238.193526,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,Sodium channel alpha subunit,129228,"1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide",C10H8F2N4O,238.19,0.7,73.8,1,5,3,17,,POGQSBRIGCQNEG-UHFFFAOYSA-N
ZALEPLON,CIDs00005719,zaleplon,305.3339,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,GABA A receptor alpha-1/beta-1/gamma-2,5719,"N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide",C17H15N5O,305.33,1.0,74.3,0,4,3,23,,HUNXMJYCHXQEGX-UHFFFAOYSA-N
TESTOLACTONE,CIDs00013769,testolactone,300.39206,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Cytochrome P450 19A1,13769,"(4aS,4bR,10aR,10bS,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,10b,11,12-octahydro-3H-naphtho[2,1-f]chromene-2,8-dione",C19H24O3,300.4,3.0,43.4,0,3,0,22,,BPEWUONYVDABNZ-DZBHQSCQSA-N
ACETOHEXAMIDE,CIDs00001989,acetohexamide,324.3953,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,"Sulfonylurea receptor 1, Kir6.2",1989,1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea,C15H20N2O4S,324.4,2.4,101.0,2,4,4,22,,VGZSUPCWNCWDAN-UHFFFAOYSA-N
CLOPIDOGREL,CIDs00060606,clopidogrel,321.82174,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Purinergic receptor P2Y12,60606,"methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate",C16H16ClNO2S,321.8,3.8,57.8,0,4,4,21,,GKTWGGQPFAXNFI-HNNXBMFYSA-N
CILASTATIN,CIDs06435415,cilastatin,358.45304,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,Renal dipeptidase,6435415,"(Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid",C16H26N2O5S,358.5,-1.0,155.0,4,7,11,24,,DHSUYTOATWAVLW-WFVMDLQDSA-N
OXYPHENONIUM BROMIDE,CIDs00005748,oxyphenonium,428.40356,CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.[Br-],CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.[Br-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M1",5748,2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium bromide,C21H34BrNO3,428.4,,46.5,1,4,9,26,,UKLQXHUGTKWPSR-UHFFFAOYSA-M
PROBENECID,CIDs00004911,probenecid,285.35926,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,"Solute carrier family 22 member 6, Solute carrier family 22 member 8, Solute carrier family 22 member 11",4911,4-(dipropylsulfamoyl)benzoic acid,C13H19NO4S,285.36,3.2,83.1,1,5,7,19,,DBABZHXKTCFAPX-UHFFFAOYSA-N
METYROSINE,CIDs00441350,alpha-methyl-p-tyrosine,195.21512,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,Tyrosine 3-hydroxylase,441350,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid,C10H13NO3,195.21,-1.6,83.6,3,4,3,14,,NHTGHBARYWONDQ-JTQLQIEISA-N
ALBENDAZOLE,CIDs00002082,albendazole,265.3314,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Tubulin,2082,methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate,C12H15N3O2S,265.33,2.9,92.3,2,4,5,18,,HXHWSAZORRCQMX-UHFFFAOYSA-N
VALPROIC ACID,CIDs00003121,valproate,144.21144,CCCC(CCC)C(=O)O,CCCC(CCC)C(=O)O,Succinate semialdehyde dehydrogenase,3121,2-propylpentanoic acid,C8H16O2,144.21,2.8,37.3,1,2,5,10,,NIJJYAXOARWZEE-UHFFFAOYSA-N
ILOPROST,CIDs05311181,iloprost,360.48708,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,Prostanoid IP receptor,5311181,"(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",C22H32O4,360.5,2.8,77.8,3,4,8,26,,HIFJCPQKFCZDDL-ACWOEMLNSA-N
TRIFLUPROMAZINE,CIDs00005568,triflupromazine,352.41707,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,Dopamine D2 receptor,5568,"N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine",C18H19F3N2S,352.4,5.2,31.8,0,6,4,24,,XSCGXQMFQXDFCW-UHFFFAOYSA-N
ENTACAPONE,CIDs05281081,entacapone,305.286,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,Catechol O-methyltransferase,5281081,"(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide",C14H15N3O5,305.29,2.1,130.0,2,6,4,22,,JRURYQJSLYLRLN-BJMVGYQFSA-N
ATENOLOL,CIDs00002249,atenolol,266.33608,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Beta-1 adrenergic receptor,2249,2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,C14H22N2O3,266.34,0.2,84.6,3,4,8,19,,METKIMKYRPQLGS-UHFFFAOYSA-N
SPIRONOLACTONE,CIDs00005833,spironolactone,416.57348,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Mineralocorticoid receptor,5833,"S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate",C24H32O4S,416.6,2.9,85.7,0,5,2,29,,LXMSZDCAJNLERA-ZHYRCANASA-N
CISAPRIDE,CIDs00002769,cisapride,465.945463,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,Serotonin 4 (5-HT4) receptor,2769,4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide,C23H29ClFN3O4,465.9,3.4,86.1,2,7,9,32,,DCSUBABJRXZOMT-UHFFFAOYSA-N
ARMODAFINIL,CIDs09690109,armodafinil,273.3501,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Dopamine transporter,9690109,2-[(R)-benzhydrylsulfinyl]acetamide,C15H15NO2S,273.4,1.7,79.4,1,3,5,19,,YFGHCGITMMYXAQ-LJQANCHMSA-N
4-AMINOSALICYLIC ACID,CIDs00004649,APAs,153.13538,C1=CC(=C(C=C1N)O)C(=O)O,C1=CC(=C(C=C1N)O)C(=O)O,Dihydrofolate reductase,4649,4-amino-2-hydroxybenzoic acid,C7H7NO3,153.14,1.3,83.6,3,4,1,11,,WUBBRNOQWQTFEX-UHFFFAOYSA-N
TRIAMTERENE,CIDs00005546,triamterene,253.26264,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,"Amiloride-sensitive sodium channel, ENaC",5546,"6-phenylpteridine-2,4,7-triamine",C12H11N7,253.26,1.0,130.0,3,7,1,19,,FNYLWPVRPXGIIP-UHFFFAOYSA-N
RISPERIDONE,CIDs00005073,risperidone,410.484483,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"Serotonin 2a (5-HT2a) receptor, Dopamine D2 receptor, Serotonin 2c (5-HT2c) receptor",5073,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one",C23H27FN4O2,410.5,2.7,61.9,0,6,4,30,,RAPZEAPATHNIPO-UHFFFAOYSA-N
ACETAZOLAMIDE,CIDs00001986,acetazolamide,222.24544,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,"Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase XII, Carbonic anhydrase IV",1986,"N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide",C4H6N4O3S2,222.3,-0.3,152.0,2,7,2,13,,BZKPWHYZMXOIDC-UHFFFAOYSA-N
DESOXYCORTICOSTERONE PIVALATE,CIDs11876263,desoxycorticosterone pivalate,414.57752,CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C,CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C,Mineralocorticoid receptor,11876263,"[2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate",C26H38O4,414.6,4.5,60.4,0,4,5,30,,VVOIQBFMTVCINR-WWMZEODYSA-N
CARGLUMIC ACID,CIDs00121396,N-carbamylglutamate,190.154,C(CC(=O)O)C(C(=O)O)NC(=O)N,C(CC(=O)O)C(C(=O)O)NC(=O)N,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",121396,(2S)-2-(carbamoylamino)pentanedioic acid,C6H10N2O5,190.15,-2.4,130.0,4,5,5,13,,LCQLHJZYVOQKHU-VKHMYHEASA-N
METHYCLOTHIAZIDE,CIDs00004121,methyclothiazide,360.23734,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,Thiazide-sensitive sodium-chloride cotransporter,4121,"6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide",C9H11Cl2N3O4S2,360.2,1.4,126.0,2,7,2,20,,CESYKOGBSMNBPD-UHFFFAOYSA-N
PHENSUXIMIDE,CIDs00006839,phensuximide,189.21054,CN1C(=O)CC(C1=O)C2=CC=CC=C2,CN1C(=O)CC(C1=O)C2=CC=CC=C2,Voltage-gated T-type calcium channel,6839,"1-methyl-3-phenylpyrrolidine-2,5-dione",C11H11NO2,189.21,0.8,37.4,0,2,1,14,,WLWFNJKHKGIJNW-UHFFFAOYSA-N
BOSENTAN,CIDs00104865,bosentan,551.61406,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,"Endothelin receptor, ET-A/ET-B",104865,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide,C27H29N5O6S,551.6,3.8,154.0,2,11,11,39,,GJPICJJJRGTNOD-UHFFFAOYSA-N
VARENICLINE,CIDs05310966,1) varenicline,211.26242,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,Neuronal acetylcholine receptor; alpha4/beta2,5310966,"(1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene",C13H13N3,211.26,0.8,37.8,1,3,0,16,,JQSHBVHOMNKWFT-DTORHVGOSA-N
SUMATRIPTAN,CIDs00005358,sumatriptan,295.40044,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,"Serotonin 1b (5-HT1b) receptor, Serotonin 1d (5-HT1d) receptor",5358,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,C14H21N3O2S,295.4,0.9,73.6,2,4,6,20,,KQKPFRSPSRPDEB-UHFFFAOYSA-N
EPTIFIBATIDE,CIDs00448812,eptifibatide,831.96186,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,Integrin alpha-IIb/beta-3,448812,"2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid",C35H49N11O9S2,832.0,-2.4,377.0,10,12,10,57,,CZKPOZZJODAYPZ-LROMGURASA-N
ISOSORBIDE DINITRATE,CIDs00006883,isosorbide dinitrate,236.13632,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Soluble guanylate cyclase,6883,"[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate",C6H8N2O8,236.14,1.3,129.0,0,8,2,16,,MOYKHGMNXAOIAT-JGWLITMVSA-N
MESALAZINE,CIDs00004075,mesalazine,153.13538,C1=CC(=C(C=C1N)C(=O)O)O,C1=CC(=C(C=C1N)C(=O)O)O,"Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Cyclooxygenase",4075,5-amino-2-hydroxybenzoic acid,C7H7NO3,153.14,1.3,83.6,3,4,1,11,,KBOPZPXVLCULAV-UHFFFAOYSA-N
SUCCINYLCHOLINE CHLORIDE,CIDs00022475,none,0.0,none,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],Muscle-type nicotinic acetylcholine receptor,22475,trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium dichloride,C14H30Cl2N2O4,361.3,,52.6,0,6,11,22,,YOEWQQVKRJEPAE-UHFFFAOYSA-L
CARBACHOL,CIDs00005831,none,0.0,none,C[N+](C)(C)CCOC(=O)N.[Cl-],Muscarinic acetylcholine receptor M3,5831,2-carbamoyloxyethyl(trimethyl)azanium chloride,C6H15ClN2O2,182.65,,52.3,1,3,4,11,,AIXAANGOTKPUOY-UHFFFAOYSA-N
MEPHENYTOIN,CIDs00004060,mephenytoin,218.25176,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,Sodium channel alpha subunit,4060,"5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione",C12H14N2O2,218.25,1.5,49.4,1,2,2,16,,GMHKMTDVRCWUDX-UHFFFAOYSA-N
TINIDAZOLE,CIDs00005479,tinidazole,247.27152,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,DNA,5479,1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole,C8H13N3O4S,247.27,-0.4,106.0,0,5,4,16,,HJLSLZFTEKNLFI-UHFFFAOYSA-N
LIOTHYRONINE,CIDs00005920,"3,5,3'-triiodothyronine",650.97349,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,Thyroid hormone receptor,5920,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid",C15H12I3NO4,650.97,1.7,92.8,3,5,5,23,,AUYYCJSJGJYCDS-LBPRGKRZSA-N
FURAZOLIDONE,CIDs05323714,furazolidone,225.15828,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],DNA,5323714,"3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one",C8H7N3O5,225.16,-0.1,101.0,0,6,2,16,,PLHJDBGFXBMTGZ-WEVVVXLNSA-N
MIGLUSTAT,CIDs00051634,miglustat,219.27804,CCCCN1CC(C(C(C1CO)O)O)O,CCCCN1CC(C(C(C1CO)O)O)O,Ceramide glucosyltransferase,51634,"(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol",C10H21NO4,219.28,-0.6,84.2,4,5,4,15,,UQRORFVVSGFNRO-UTINFBMNSA-N
DICHLORPHENAMIDE,CIDs00003038,dichlorphenamide,305.15884,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,"Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase XII, Carbonic anhydrase IV",3038,"4,5-dichlorobenzene-1,3-disulfonamide",C6H6Cl2N2O4S2,305.2,0.3,137.0,2,6,2,16,,GJQPMPFPNINLKP-UHFFFAOYSA-N
BACLOFEN,CIDs00002284,baclofen,213.66078,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,GABA-B receptor,2284,4-amino-3-(4-chlorophenyl)butanoic acid,C10H12ClNO2,213.66,-1.0,63.3,2,3,4,14,,KPYSYYIEGFHWSV-UHFFFAOYSA-N
THEOPHYLLINE,CIDs00002153,theophylline,180.16402,CN1C2=C(C(=O)N(C1=O)C)NC=N2,CN1C2=C(C(=O)N(C1=O)C)NC=N2,"Phosphodiesterase 4, Phosphodiesterase 3, Adenosine receptor",2153,"1,3-dimethyl-7H-purine-2,6-dione",C7H8N4O2,180.16,0.0,69.3,1,3,0,13,,ZFXYFBGIUFBOJW-UHFFFAOYSA-N
BRETYLIUM TOSYLATE,CIDs00006100,none,0.0,none,CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-],Norepinephrine transporter,6100,(2-bromophenyl)methyl-ethyl-dimethylazanium;4-methylbenzenesulfonate,C18H24BrNO3S,414.4,,65.6,0,3,3,24,,KVWNWTZZBKCOPM-UHFFFAOYSA-M
CANRENONE,CIDs00013789,canrenone,340.45592,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC45CCC(=O)O5)C,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC45CCC(=O)O5)C,Mineralocorticoid receptor,13789,"(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione",C22H28O3,340.5,2.7,43.4,0,3,0,25,,UJVLDDZCTMKXJK-WNHSNXHDSA-N
ULIPRISTAL ACETATE,CIDs00130904,ulipristal acetate,475.61908,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,Progesterone receptor,130904,"[(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate",C30H37NO4,475.6,3.5,63.7,0,5,5,35,,OOLLAFOLCSJHRE-ZHAKMVSLSA-N
ACETOHYDROXAMIC ACID,CIDs00001990,acetohydroxamic acid,75.0666,CC(=O)NO,CC(=O)NO,Bacterial urease,1990,N-hydroxyacetamide,C2H5NO2,75.07,-1.6,49.3,2,2,0,5,,RRUDCFGSUDOHDG-UHFFFAOYSA-N
DIAZOXIDE,CIDs00003019,diazoxide,230.67138,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,"Potassium channel, inwardly rectifying, subfamily J, member 8, Potassium channel, inwardly rectifying, subfamily J, member 11",3019,"7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide",C8H7ClN2O2S,230.67,1.2,66.9,1,3,0,14,,GDLBFKVLRPITMI-UHFFFAOYSA-N
CHLORZOXAZONE,CIDs00002733,stealth,169.56516,C1=CC2=C(C=C1Cl)NC(=O)O2,C1=CC2=C(C=C1Cl)NC(=O)O2,Intermediate conductance calcium-activated potassium channel protein 4,2733,"5-chloro-3H-1,3-benzoxazol-2-one",C7H4ClNO2,169.56,1.8,38.3,1,2,0,11,,TZFWDZFKRBELIQ-UHFFFAOYSA-N
DIGITOXIN,CIDs00441207,digitoxin,764.93906,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,Sodium/potassium-transporting ATPase,441207,"3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one",C41H64O13,764.9,2.3,183.0,5,13,7,54,,WDJUZGPOPHTGOT-XUDUSOBPSA-N
MELPHALAN HYDROCHLORIDE,CIDs09927978,none,0.0,none,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl,DNA,9927978,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid;hydrochloride,C13H19Cl3N2O2,341.7,,66.6,3,4,8,20,,OUUYBRCCFUEMLH-YDALLXLXSA-N
